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ABSTRACT
CHARACTERIZATION OF THE PROTEIN INTERACTIONS WITHIN THE 




University of New Hampshire, May, 2000 
The mechnisms of transcriptional regulation are well conserved from 
yeast to human cells. Most genes are regulated at the transcriptional 
level, particularly, at the transcription initiation step. In Saccharomvces 
cerevisiae at least one transcriptional activator, ADR1, and one 
transcription complex, CCR4-NOT, participate in the activation of the 
ADH2 gene. The core 1X106 dalton CCR4-NOT complex consists of CCR4, 
CAF1, the five NOT proteins (NO T1-NO T5), and three other 
uncharacterized proteins. Deletion of NOT3. NQT4. or NQT5 did not 
affect the association of CCR4 with CAF1 in the gel filtration analysis. 
In contrast, NOT2 inactivation caused partial destabilization of the 
CCR4-NOT complex. In addition, deletion or mutation in the NOT1 N-
ix
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terminal resulted in the dissociation of CCR4 and CAF1 from the complex. 
TFIID functions in the first step in initiating transcription by binding the 
TATA-box. To investigate interactions of ADR1 with TFIID in detail, a 
series of binding assays between ADR1 transcriptional activation domains 
(TADs) and TFIID components were conducted to identify the individual 
TAF proteins that interact with ADR1 directly. Multiple TAF proteins were 
found to bind three of the four TADs of ADR1. TAF150/TSM -1, 
TAF130/145, TAF60 and TAF61/68 proteins were found to bind TADIV. 
The region of TAF150 that bound TADIV was located to a nonconserved 
region (residues 744-1100) while the sequence of TAF130 that alone is 
capable of binding TADIV was localized to an essential region (residues 
668-865) that is well conserved among TAF130 homologs. The 
physiological roles of these TAF-ADR1 interactions were further 
investigated using S1 nuclease analysis. An intact TFIID complex was 
shown to be required for ADH2 gene expression. Individual mutations in 
TA F150. TAF61. and TAF60 were also shown to reduce ADH2 
transcription. Therefore, just as other activators display multiple physical 
interactions with core transcriptional components, ADR1 also displayed 
multiple apparently redundant interactions. These biochemical
x
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interactions may benefit cells through redundancy and/or may function 
in a sequential or conditional way in response to distinct signal 
transduction pathways.
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General Introduction
Baker’s yeast, Saccharomyces cerevisae. has proven to be an 
excellent model system for studying cellular processes. It is a single cell 
eukaryote with a short life cycle, and its whole genome has been 
sequenced. In addition, its genetics and DNA recombination are well 
characterized. The diploid and haploid yeast life cycle facilitates the 
isolation of both dominant and recessive mutations. It also has unique 
advantages for meiotic analysis, such as easy triggering of sporulation 
and monitoring of landmark events. The spores are associated in an 
ascus, making it easy to reconstruct the recombinant and segregation 
events (Norbeck et al 1997). More importantly, the mechanisms of 
most cellular events are conserved from yeast to human, including that of 
gene expression.
Eukaryotic gene expression is regulated at multiple levels. Chromatin 
structure can be active or inactive, depending on the packaging of 
proteins and modification (such as methylation) of DNA (Hinnebusch et al 
1994). The transcription process can be regulated at initiation, 
elongation, degradation, and termination. Additional controls can be
l
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exerted in regulating transacting proteins, and even the DNA sequence 
itself may influence gene expression. Posttranscriptional regulation may 
also be important and includes exon excision and intron ligation and RNA 
editing (insertion, deletion or replacement of nucleotide as a way of 
regulation) (Lithgow et al 1997). mRNA transport from the nucleus to 
cytosol and stability of RNA are also two ways in which gene expression 
can be controlled. Translational control is another critical control point. It 
involves modification of the translational initiation machinery, regulation 
of availability of tRNA, and effects on ribosome assembly. Protein 
degradation and recycling are also important ways to regulate protein 
activity. All these potential sites of regulation are also related to the 
growth status of cells, including extracellular environmental changes 
(such as nutrients), stress, and the stage of the cell cycle. These signals 
are mediated by numerous cell receptors and a variety of protein kinases. 
All these events are further complicated by restriction of events in 
organelles, such as nuclei or mitochondria. Furthermore, cross-talk 
between these regulatory pathways present an even more complex 
picture. My focus in this study is on one major controlling event in this 
picture: transcriptional initiation particularly how the CCR4-NOT complex
and ADR1 play their roles in regulating gene expression in yeast.
2
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Access of transcriptional factors to the DNA may be regulated by 
chromatin structure. Chromatin remodeling may therefore be often 
required for transcription activation. Nucleosomes may be the most 
abundant repressors of gene transcription. Disassembling the nucleosomal 
packaging is an ATP-driven process and, in many cases, requires SWI/SNF 
or other DNA or nucleosome-stimulated ATPase activity (Ryan et al
1998). SW I/SNF consists of at least 11 subunits and its essential 
components include the DNA-dependent ATPase SW I2/SNF2. This 
activity increases the binding of certain activators and is required for 
chromatin remodeling and transcriptional activation (Natarajan et al
1999). Other complexes with ATP-dependent activity in yeast include 
RSC (remodel the structure of chromatin) and the ISWI group (Vignali et 
al 2000). SNF/SWI-dependent chromatin remodeling is required but not 
sufficient for transcription activation. However, the extent of nucleosome 
depletion in vivo is correlated with the degree of derepression (Han et al 
1988). In addition, SNF/SW I interact with the SRB mediator associated 
with RNA polymerase II and another chromatin remodeling complex, 
SAGA, probably creates a synergistic action on nuclesome remodeling and 
transcription activation (Roberts et al 1997).
3
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Modification and remodeling of chromatin also involves the SAGA
(SPT-ADA-QCN5-Acetyltransferase) complex. This complex affects a
number of genes such as those involved in amino acid metabolism, mating
pheromone response, mating-type switching, and carbon source
utilization (Robert et al 1997). The histone acetyl transferase (HAT)
activity of GCN5 acetylates lysine 14 in histone 3 and lysine 8 and lysine
16 in histone 4 in vivo (Kuo et al 1996). While GCN5 alone can not
acetylate whole nucleosomes, the SAGA complex is capable of effectively
acetylating histones in nucleosomes (Ogryzko et al 1998).
Hyperacetylation is associated with active chromosomal loci while
hypoacetylation with inactive chromatin (Kuo et al 1998). Chromatin
remodeling is targeted at the promoter but not the whole transcription
unit (Imhof et al 1998). The access of the transcription factors can be
increased by acetylation through topological change (Lee et al 1993,
Wang et al 1998). SAGA has been shown to be the target of a number
of activators (Grant et al 1998). It has also been found closely
associated with the polymerase II holoenzyme and it shares some
components with TFIID , which also has HAT activity in one of its
component TA F130 (Grant et al 1998). Acetylation affects the
transcription activity of the chromatin template and interactions of
4
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histones with nonhistone proteins. In contrast, histone deacetylase is a 
target of a variety of repressors. Though each of the SAGA components 
affect only a subset of genes (Struhl 1998), the effects are based on 
analysis conducted on rich medium and no similar test has been 
conducted under the conditions of amino acid starvation. In addition to 
its minimal effect on 5% of total genes by GCN5 in yeast, SAGA might 
play a broader role under other conditions (Holstege et al 1998).
In addition to the chromatin remodeling systems that affect 
transcription, the assembly of the transcription machinery may also be 
rate-iimiting for gene expression. RNA polymerases and their associated 
factors are the basic machinery for performing transcription. Gene 
transcription is performed by three classes of RNA polymerases. 
Polymerase I transcribes ribosomal RNA (rRNA), polymerase II message 
RNA (mRNA) and some Sn RNAs, and polymerase III transfer RNA 
(tRNA), 5S RNA and the remaining of Sn RNAs. All three classes of 
polymerase depend on TBP, the IATA-box binding protein for initiating 
transcription. Transcription by RNA polymerase II can be divided into 
basal and regulated transcription. Basal transcription requires TFIIB, TBP, 
TFIIA, TFIIE, TFIIF, TFIIH and RNA polymerase II. Regulated transcription
recruits at least two complexes, TFIID (TBP) and RNA holoenzyme (O’Neill
5
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at al 1995). Purified RNA holoenzyme consists of RNA polymerase II, 
general transcription factors (TFIIB, TFIIE, TFIIF, and TFIIH), SRBs and 
mediator components. Transcription activators recruit the TFIID, TFIIA, 
TFIIB, and/or RNA polymerase holoenzyme to initiate gene transcription.
Activated RNA polymerase II transcription requires the participation 
of TFIIB, TFIIE, TFIIF, TFIIH, and, in many cases, TFIIA, and TBP-associated 
factors. In addition, TBP is usually required. TFIID in yeast consists of TBP 
and 12 TBP associated factors (TAF„s) (Table 2), while a number of 
distinct TFIID complexes associated with distinct set of genes may exist in 
higher organisms (Chicca et al 1998). Despite the different forms of 
TFIID, all mediate signal transduction to the transcription machinery. 
They function in promoter recognition, transcription activation or 
repression, histone acetylation and chromatin remodeling and cell cycle 
progression. TAF, and TAFm are TBP associated factors required for rRNA 
and tRNA, respectively. TAF proteins in this study all refer to the type II 
TAF proteins that affect the mRNA transcription unless indicated 
otherwise. Most TAF proteins are well conserved from yeast to human. In 
contrast to the SAGA complex, TFIID is capable of binding promoter DNA. 
Some studies have suggested that TBP binding to TATA element is rate-
limiting for assembling an active RNA polymerase II holoenzyme (Lee et
6
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al 1997, Li et al 1999, and Kuras et al 1999). However, there is 
evidence that TBP is constantly present on some transcriptionally 
inactive but inducible promoters (Gross et al 1990, Chen et al 1994). In 
this case, the conformational changes induced by transcription activators 
are suggested to be rate-limiting. Most recent results, however, showed 
that TFIID  dimerization is rate-limiting for uninduced transcription at 
certain promoters (Jackson-Fisher et al 1999). Or, alternatively, the 
rate-limiting step occurs when TFIID is recruited to the promoter as a 
whole complex or component by component (Gonzalez-couto et al
1997). Therefore, several of the assembly processes could be rate- 
limiting for transcription initiation.
TFIIA is composed of 2 subunits of TOA1 and TOA2 and stimulates 
both basal and activated transcription at some promoters (Kang et al 
1995, Ma et al 1996). It is suggested that it stabilizes the TBP-DNA  
complex (Ozer et al 1998). TOA1 competes with TAF130 N-terminal to 
bind TBP in vitro. In addition, overexpression of TFIIA can suppress the 
growth defect of a TAF130 N-terminal deletion (Kokubo et al 1998). 
Therefore, TFIIA may be a coactivator while TAF130 might participate in 
chromatin remodeling through its HAT activity (Kang et al 1995,
Lieberman et al 1997). The role of TFIIA may be a result of counteracting
7
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the repressing role of MOT1 that disrupts the TBP-TATA interaction 
(Madison et al 1997). The coactivator role of TFIIA has been further 
substantiated by the fact that transcriptional activators such as VP-16  
and Zta bind to TFIIA and stimulate transcriptional activation (Kobayashi 
et al 1995).
TFIIB/SUA7 in yeast was isolated as a suppressor of a start site 
alteration in the cycl promoter (Pinto et al 1992). This is the same 
phenotype caused by a mutation in the largest subunit of RNA 
polymerase II, consistent with the known role for TFIIB in transcription 
start site selection (Pardee et al 1998). TFIIB is capable of interacting 
with TFIIF, RNA polymerase II, and connecting TFIID to the remaining of 
the RNA polymerase holoenzyme (Bangur et al 1997, Goodrich et al
1993). TFIIB binds simultaneously with TFIIA to the TBP-TATA complex 
and there is no overlapping contacts and no direct contact with each 
other (Keener et al 1997). TFIIB and TFIIA stabilize the orientation, but 
do not fix the orientation of TBP binding to the TATA element. The C- 
terminal domain of TFIIB interacts with TBP, though this interaction is not 
rate-limiting for most genes.
TFIID and TFIIA are suggested to start transcription initiation by
binding to a promoter TATA-box upon activator binding. Then,
8
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polymerase II is recruited to the promoter at least partially through the 
function of TFIIB and the carboxy terminal domain of the largest subunit 
of RNA polymerase II which in this active preinitiation complex (PIC) is 
not phosphorylated (Ranish et al 1999). The recruited TFIIB assists the 
recruitment of TFIIF and RNA polymerase II by direct interaction with 
TFIIF. TF IIF  consists of two subunit, RAP74 and RAP30, and both are 
believed to participate in the recruitment of RNA polymerase II (Henry et 
al 1994).
TFIIE and TFIIH are subsequently assembled into this RNA 
polymerase PIC formation. Upon ATP hydrolysis, an open complex is 
formed. The change of a closed inactive PIC to an open active PIC  
requires ATP, TFIIH helicase activity and TFIIE, which has been suggested 
to regulate the ATPase, helicase, and kinase activity of TFIIH (Henry et al
1994). However, recent studies also showed that TFIIE may participate in 
TFIID funtion and TFIIH contributes to promoter melting (Yokomori et al 
1998). The helicase and ATPase activities of TFIIH are suggested to 
participate in the last rate-limiting steps before initiation (Yan et al 
1997, Holstege et al 1997). In addition to its role in promoter escape, 
TFIIH also participates in nucleotide excision repair (NER) and possibly in
repairing actively transcribed genes (Svejstrup et al 1996).
9
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TFIIH is also one of the three kinases that phosphorylate the 
carboxyl terminal domain (CTD) of the largest subunit of RNA polymerase 
II. So far at least three CTD kinases have been identified, each of which 
pair up with a cyclin to form a regulated kinase. They are CTK1/CTK2, 
KIN28/CCL1 (KIN28 is the catalytic subunit of TFIIH), and SRB10/SRB11 
(Andrews et al 1998, Kuchin et al 1998). These three kinases, KIN28, 
CTK1, SRB10, are suggested to phosphorylate the CTD at different 
residues at distinct times (Hengartner et al 1998). For instance, SRB10 
phosphorylates CTD at Ser 2 and Ser 5 whereas TFIIH at Ser 5 only 
(Trigon et al 1998). Functionally, CTD phosphorylation by SRB10 is 
inhibitory, occurring in a preinitiation process, whereas TFIIH  
phosphorylation of CTD stimulates transcription when occuring later in 
the transcription initiation process (Hengartner et al 1998).
Activated transcription requires activator binding to DNA, which 
induces chromatin remodeling and transcription initiation. Activators can 
interfere with or disassemble the repressing chromatin or increase the 
affinity of GTF for chromatin (Wilson et al 1996). In addition, activators 
often interact with multiple components in the RNA polymerase II 
holoenzyme directly or indirectly to initiate transcription. The interactions
of activators with RNA polymerasse II holoenzyme are usually mediated by
10
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adaptors/mediators /cofactors, which include SRBs (suppressor of BNA 
polymerase B> which is later named RNA polymerase II) and TAFs. 
Mediator activity was originally identified by a squelching assay (Flanagan 
et al 1991). Addition of one activator could interfere with the 
stimulation of transcription by another, indicating that they share a 
common target. The mediator complex plays an intermediary role 
between activators or repressors and the CTD of RNA polymerase II 
(Kuchin et al 1995). Subsequent biochemical data revealed that 
mediator activity cofractionates with RNA polymerase II and with TFIIF 
when the antibody against the CTD of the largest subunit of RNA 
polymerase II was used (Kelieher et al 1990).
One of the purified mediator complexes contains about 20 
polypeptides. It is capable of supporting and stimulating basal and 
activated transcription and also stimulates the phosphorylation of the 
CTD by TFIIH. Other evidence shows that the mediator complex is 
important for both transcription activation and repression in vivo (Sayer 
et al 1992). Many of these mediator proteins were identified as 
suppressors of a phenotype associated with truncation of the CTD of RNA 
polymerase B. These proteins were called SRB (Ushera et al 1992). In
addition, a mammalian RNA polymerase II purified with the antibody
11
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against one of the SRB also contains TFIIE and TFIIH, indicating close 
association of the mediator with the GTF (Chao et al 1996). The SRB 
complex appears, therefore, to connect transcription factors with the 
general transcriptional machinery. SRB mediator proteins (SRB2-6 and 
MEDs) are required for gene-specific activation, while SRB8-11 are 
suggested to be involved in transcription repression.
In addition to the trans-acting factors, cis DNA elements also affect 
RNA polymerase II transcription. Cis-acting elements include enhancers or 
upstream activating sequences (UAS, binding site of activators), 
silencers, and core promoters. The core promoter consists of the TATA 
box, transcription start site, and perhaps other sites where other factors 
bind (Mosch et al 1992, Lagrange et al 1998). The TATA-box is located 
about 40-120 nucleotide from the transcription start site in yeast but 30 
nucleotides in higher eukaryotes (Hahn et al 1989). At many promoters 
there are extra cis-elements such as the initiator element (encompassing 
the transcription start site)(Mosch et al 1992) and the TFIIB recognition 
element (BRE) (Lagrange et al 1998). Core promoter strength is 
indicative of net total effects of these elements and their associated 
factors.
12
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Recycling of RNA polymerase II and reinitiation are still under much 
investigation. The degree to which the promoter retains the TFIID-TFIIA  
complex after the release of the RNA polymerase II might be one of the 
determinants of reinitiation rate (Yean et al 1999).
Therefore, transcription regulation is controlled at multiple steps from 
initiation, elongation to termination and reinitiation and the whole process 
requires the coordinate action of numerous factors. My study is mainly 
focused on the interactions of activators with components involved in 
transcription initiation.
13
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CHAPTER 1
BIOCHEMICAL 
INTERACTIONS WITH THE CCR4-NOT COMPLEX
Introduction
Yeast growth can be divided into fermentative and nonfermentative 
growth depending on the available carbon source. In general, yeast can 
grow on glucose (fermentative) or ethanol (non-fermentative). However, 
yeast prefer glucose as their carbon source and glucose represses 
expression of a variety of genes involved in carbon source metabolism 
other than glucose, for instance, galactose, sucrose, glycerol, and ethanol 
(Ronne et al 1995). Because yeast metabolism of glucose to ethanol can 
occur anaerobically, genes required for aerobic growth are switched off 
when ceils are grown on glucose. This phenomenon is called glucose 
repression or carbon catabolite repression (Hardie et al 1994). Partially 
glucose-repressed cells exhibit a short cell cycle and a high rate of 
glycolysis. The ADHI enzyme is required for the metabolism of glucose to 
ethanol and its expression is reduced 10 times on ethanol (Denis et al 
1983). The growth on ethanol or glycerol is called nonfermentative and
requires the respiration chain and the citric acid cycle (Russell et al 1983,
14
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Young et al 1985). The ADHII protein is required for the conversion of 
ethanol to acetaldehyde, which can be utilized in the citric acid cycle and 
glyoxylate pathways. ADHII is repressed by glucose and derepressed 
when glucose is depleted. The metabolic pathways involving ADHI and 
ADHII enzymes are summarized in Figure 1.
Multiple genes are involved in glucose repression and derepression. 
Glucose repression and derepression are closely related events. Proteins 
involved in glucose repression include, SSN20/SPT6, REG1, HXK1/2 and 
SNF1 (Ronne et al 1995). A REG1 mutation causes glucose-insensitive 
expression of galactose— related metabolism. HXK1/2 encode a 
hexokinase used in the glycotic pathway and its mutation reduces 
glucose repression and up-regulates REG1 expression (Ulery et al 1994). 
REG1 and SNF1 also affect derepression of mitochondria transcripts 
(Celenza et al 1989). SNF1/CCR1/CAT1 is a glucose-repressible 
serine/threonine protein kinase conserved from yeast to mammals 
(Hardie et al 1994). It was isolated as a mutant which can not grow on 
sucrose. In addition to affecting glucose-repressible genes such as SUC2. 
and COX6. it is unable to accumulate glycogen (Thompson-Jaeger et al 
1991). The kinase activity of SNF1 is regulated by the regulatory subunit
15












I \ fatty acid synthesis
citric acid cycle
Figure 1. ADH enzymes in metabolic pathways.
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SNF4 (Celenza et al 1989). SNF1-SNF4 can phosphorylate and inactivate 
enzymes involved in nonfermentative growth in vitro (Hunter et al 1997, 
Mitchelhill et al 1994). Association with SNF4 is regulated by glucose 
(Lee et al 1998, Lesage et al 1996) and SNF1 kinase activity is increased 
when glucose is depleted from the medium. The AMP:ATP ratio may 
regulate glucose derepression through regulating SNF1 kinase activity 
(Jiang et al 1997).
CCR4 and CAF1 are required for glucose derepression and ADH2 
expression. Both of them have been purified with several NOT proteins 
and these proteins are characterized as a complex named CCR4-NOT (Liu 
et al 1998). The core of CCR4-NOT is a 1X106 dalton (mD) complex (Liu 
et al 1998, Bai et al 1999). The 1 mD complex consists of CCR4, CAF1, 
NOT1-5 and three other uncharacterized factors (Draper et al 1994, 
1995, Liu et al 1998, Y.C. Chiang and J. Chen, unpub. Observ.). A 1.9 
mD complex was also identified and it apparently includes the core CCR4- 
NOT components. In addition, it may also includes DHH1 (Hata et al
1998), CAF4, CAF16 (Liu et al unpublished observation), DBF2 (Liu et al
1997), and MOB1 (Komarnistsky et al 1998). Importantly, the 
association of CCR4 with the 1.9 mD complex is not affected by a caf1
17
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deletion whereas CAF1 is absolutely required for CCR4 association in the 
1 mD complex (Liu et al 1998, Bai et al 1999).
CCR4 (837 amino acids ( aa) in length) was originally identified by 
mutations that suppressed the increase of ADH2 mRNA levels caused by 
cre1/spt10 (Denis 1984). CCR4 has five leucine repeats between 
residues 350-467 aa (Matvar et al 1990). The leucine-rich repeat is 
required for CCR4 association in the 1 mD CCR4-NOT complex (Draper et 
al 1994, 1995). CCR4 shares similar phenotypes with CAF1/POP2. Both 
affect ADH2 under glucose-derepressing conditions and they are capable 
of suppressing ^pilQ.-enhanced ADHII activity (Denis et al 1984, Draper 
et al 1995). They also display staurosporine and caffeine sensitivity (Hata 
et al 1998), temperature sensitive growth at 37°C on non-fermentative
medium and cold-sensitivity (Sakai et al 1992, Liu et al 1997 and Hata 
et al 1998). CAF1 (444 aa in length) also contains some motifs typical 
of transcription factors such as a glutamine-rich region, proline-rich region 
and serine/threonine-rich region. It is strongly associated with CCR4 
through its C-terminus (Draper et al 1995).
CCR4 and CAF1 mutations can suppress spt6 and sp t10 phenotypes 
at the his4-912delta locus. his4-912delta contains a Ty insertion at the
HIS4 promoter turning off normal HIS4 expression. SPT6/CRE2/SSN20
18
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and SPT10/CRE1/SUD1 are proteins involved in several cellular process. 
SPT represents SuPpressor of Iy .  spt6 and spt10 mutations increase 
ADH2 expression under glucose-repressing conditions and also alter HIS4 
transcription at the his4-912 delta locus (Denis 1984, Clark-Adams et al 
1987). SPT6 overproduction affects ADH2 expression both through its 
upstream activationg sequence 2 (UAS2) and other sequences (Donoviel 
et al 1996). Phenotypes of spt6 are similar to those caused by alteration 
in histone abundance, suggesting an SPT6 involvement in chromatin 
structure (Neigeborn et al 1987). In addition, SPT6 has been shown to 
interact strongly with histone H3 and weakly with histone H4 (Bortvin et 
al 1996).
CAF1 was also found to interact with SRB9/CAF3. SRB8-11 were 
originally isolated as suppressors of mutations in the protein kinase SNF1 
which play a major role in glucose repression (Li et al 1995). 
SRB10/SRB11 is a cyclin-dependent kinase with a role in transcriptional 
repression by SSN6/TUP1, a global corepressor (Kuchin et al 1998). So 
far three CCR4 associated factors, including CAF1 in the core complex, 
have been found to interact with SRB9-11, suggesting that the CCR4- 
NOT complex may have close physical interactions with SRB9-11 proteins.
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NOT proteins have been found to be part of the CCR4 complex and 
exhibit multiple phenotypes (Liu et al 1998). NOT proteins have been 
extensively studied at the yeast H IS3 promoter. The upstream of this 
promoter has two TATA elements, TR is located at -4 7  to -4 0  and 
mediates transcription starting at +1 while Tc is located at -5 4  to -8 3  
and starts transcription at +13 (Struhl 1986, Collart et al 1996). Only TR 
can be activated by the transcriptional activator GCN4 (Colgan et al 
1992, Ham et al 1994). N O T1/C D C 39, N O T2/C D C 36, NOT3, 
NOT4/SIG1/MOT2, NOT5 specifically repress Tc-dependent transcription 
(Collart et al 1993, 1994, Oberholzer et al 1998). Mutants in these 
genes cause cell resistance to 3-aminotriazol (3 -AT), which is a 
competitive inhibitor of the HIS3 protein (Collart et al 1993). Tc is a non- 
typical TATA-less element, though it also requires TBP for transcription 
initiation (Cormack 1992). Compared with a canonical TATA element, 
transcription from a Tc promoter is much less efficient (Colgan et al 
1992, Collart et al 1996, Ponticell et al 1990). The transcription from a 
TATA-less promoter is also less dependent on the TBP protein and the Tc 
sequence is resistant to point mutations (Iyer et al 1995). In addition, the 
Tc sequence does not yield DNA I footprints with TFIID nor does it show
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micrococcal nuclease resistance (Collart et al 1993, Oettinger et al 
19 8 5 ).
NOT1 is an essential nuclear protein with two molecular forms, 185 
kD and 195 kD in size. The 185 kD species is the more abundant form, 
lacking approximately 100 residues from the N-terminus (Liu et al 1998). 
The C-terminal 1490-2108 residues of NOT1 is required for cells to 
remain viable. Mutations in NOT1. NOT2(CDC36). NOT4 or NOT5 possess 
some unique features as compared to CCR4 and CAF1. For instance, the 
five NOT genes when mutated display 3-AT sensitivity in a gcn4 
background. In contrast, ccr4 does not display this phenotype and cafl 
exhibits only a weak 3-AT phenotype (Liu et al 1998). At the same time, 
phenotypes associated with loss of function of the NOTs share many 
similarities with the phenotypes associated with defects in CCR4 and 
CAF1 (Liu et al 1998), including caffeine sensitivity, temperature 
sensitivity, and increased sensitivity to magnesium. Taken together, while 
the NOT proteins and CCR4/CAF1 may function differently at some 
promoters, they probably share functions at other promoters.
NOT proteins may play their roles through interacting with TFIID.
The repression at Tc by NOT proteins does not involve TUP1 or CYC8
(Collart et al 1993) nor does it occur through the inhibition of
21
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transcription factors, not mutations can suppress TBP overproduction 
toxicity in mot-1 mutants (Collart et al 1996), indicating that there exist 
some genetic interactions between NOT proteins and TBP and its 
associated factor MOT1. NOT1 protein also immunoprecipitate with TBP, 
suggesting a physical interaction between NOTs and TFIID (Lee et al 
1998). In addition, NOT2 and NOT5 have also been shown to 
coimmunoprecipitate with TBP and NOT5 also interacts with several 
TAF proteins (Badarinarayana et al 2000). Genetic interactions between 
CCR4-NOT components and TFIID were also characterized. In addition, 
NOT2 has also been shown to interact with components in SAGA, a 
complex required for chromatin remodeling and for transcription initiation 
(Benson et al 1998).
My research on CCR4-NOT is aimed at understanding the protein 
interactions within the CCR4-NOT complex and the physical positions of 
each component. Previously it has been shown that CCR4 binds CAF1 
which in turn binds NOT1 (Liu et al 1998, Draper et al 1994) and that 
CCR4 and NOT proteins were identified through distinct genetic screens. 
Therefore, the hypothesis that CCR4 and CAF1 may associate 
independently of NOT proteins physically and functionally is tested using
a series of gel filtration and immunoprecipitation experiments.
22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Material And Methods
Yeast strains grow th conditions and  e n zv m e  a s s a y s
Yeast strains are listed in Table 1. Yeast were grown at 30 °Con YEP
medium (2% yeast extract, 1% bactopeptone) or selective medium (Cook 
et al 1994) that was supplemented with 5% glucose or 2%  
galactose/raffinose. The yeast transformation protocol was described as 
previously (Ito 1983 and Cook et al 1994)).
DNA constructions
In order to purify large amount of proteins to produce antibody against 
DHH1, the yeast vector containing GAL-DHH1 was cut with Sma I and 
Xho I and ligated into a £  coli expression vector pEG-KG cut with the 
same two enzymes. This resultant GST-DHH1 construct was cut with 
EcoR I and the large fragment was filled in and self-ligated to give the 
GST-DHH1 N-terminus (1-266 aa) expression vector. The small fragment 
was ligated to pGEX-1 lamda cut with Sma I to yield the GST-DHH1 C- 
terminus (267-506 aa) expression vector.
Antibodies and im m u n o p rec iD ita tio n
For western analysis the antibodies were directed against GST-CAF1,
GST-NOT2, 6-His- NOT5, GST-NOT1 (1480-2109 aa), and GST-DHH1
23
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Table 1. Strains and their genotypes
Strains genotypes
KY803 MATa US Ieu2-PET56 tro l-A l ura3-52 aal2 acn4-Al
MY8 isogenic to KY803 except not 1-2
MY1737 MATa his3::TRP1 Ieu2 trp1 ura3 not1::LEU2 DRS316-NOT1-396- 
2109
MY1738 MATa ieu2 ura3 trDi not1::LEU2 pRS316-NOT1-1319-2109
MY16 isogenic to KV803 except not2-1
1393-4a MATa his3/his2 Ieu2 ura3 not2::TRP1
MY1735 Isogenic to KY803 except not5::URA3
MY508 isogenic to KY803 except not3::URA3
MY537 isogenic to KY803 except not4::URA3
EGY188 MATa adh1-11 ura3his3tro1 LexA-LEU2
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(267-506 aa) fusion proteins. GST protein was purified as described 
(Frangion et al 1993). Western analysis was conducted as described 
(Draper et al 1995). Immunoprecipitations were carried out as previously 
described (Cook et al 1994, Draper et al 1995). The CAF1 antibody was 
partially purified as described (Hagop et al 1998).
Gel filtration chromatography
A Superose 6 10/30 column was first balanced with 10 volumes of 
running buffer(50mM Tris Oac, pH7.9, 150mMKOAc, 0.02% Tween-20). 
The protein extract was made with 3A extract buffer (150m M  
TrisOAc,pH7.9, 450mM KOAc, 30% glycerol, 5mM DTT, 3mM EDTA). The 
procedure has been described in detail (Liu et al 1998). The flow rate was 
0.2 ml/min and 0.5 ml was collected per fraction. The precleared protein 
sample was loaded into a 200 ul loop and a fraction collector was then 
started to collect fraction after 6 mi of running buffer had passed 
through the column. Fractions 2 to 20 were analyzed by Western blot 
analysis. Molecular weights for each fraction was calculated based on the 
elution volumes of Blue dextran (7.5 ml), Thyroglobin (12 ml) and BSA 
(16 ml).
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Results
Formation of the 1 mD CCR4-NOT complex does not require the presence 
of NOT3. NOT4 or NOT5 proteins.
It has been shown that the CCR4-NOT1 complex forms two 
multicomponent complexes with approximate molecular weights of 1.9 
mD and 1 mD, respectively (Liu et al 1998). To determine whether a 
not5 deletion affects the association of CCR4 and CAF1 in these two 
complexes, the CCR4-NOT complexes from a not5 strain was analyzed by 
gel filtration analysis. To conduct this experiment protein extract from a 
not5 strain was analysed using a Superose 6 10/30 column (Figure 2). 
Both CCR4 and CAF1 copurified in 1.9 (fraction 3) and 1.0 mD (fraction 
11-12) complexes in a nfliS background (Figure 2, lower panel). Similarly, 
not4 did not have a significant impact on the formation of these two 
complexes (Figure 2). A not3 deletion, however, appears to have an 
effect on the complex as it caused CCR4 association to become less 
concentrated in the 1 mD complex and appeared to affect the stablity of 
the 1 mD complex. In conclusion, deletion of NOT3. NOT4 or NQT5 does 
not affect the stable association of CCR4 with CAF1 in either of these 
two complexes. This data agrees with other data indicating that within
26
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Figure 2. CCR4 associates with CAF1 in the absence of NQT3. NQT4. and 
NOT5. Yeast extracts from KY803(wt), 1393-4a fnot21. and MY1735 
(not5) were analyzed by gel filtration chromatography using a Superose 6 
10/30 column. The protein extracts were precleared by centrifuging at 
100,000g for 1 min. and 200 ul of sample was loaded onto the column. 
The flow rate was 0.2 ml/min and 0.5 ml volume was collected in each 
fraction. 100 ul from each fraction were analyzed by SDS-PAGE and 
Western blotting using CCR4 and CAF1 antibodies. The molecular weight 
markers for the gel filtration experiment were blue dextran (2x106 
dalton), thyroglobulin (0.67x10® dalton), and BSA (6.6x104 dalton).
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the CCR4-NOT complex that NOT3, NOT4, and NOT5 are physically 
separated from CCR4 and CAF1.
not2 affects association of CCR4 and CAF1 within the 1 mD complex.
Using a similar analysis as described above, the effect of not2 alleles 
on CCR4 and CAF1 association in the CCR4-NOT complexes was 
evaluated. As shown in Figure 5A, CCR4 and CAF1 cofractionated at both 
1.9 mD and 1 mD in wild-type KY803 strain. In contrast, CCR4 ran in a 
altered pattern in the not2 background (Figure 3). The not2-1 mutation 
reduced the CCR4 protein levels in the 1 mD complex while not2 deletion 
in a different strain background caused partial dissociation of CCR4 from 
the 1 mD CCR4-NOT complex. However, no conclusion in regard to CAF1 
can be drawn based on the available data despite results for CAF1 were 
shown. Therefore, NOT2 at least partially contribute to the stable 
formation of the 1 mD CCR4-NOT complex.
The N-terminal 395 aa of NOT1 protein contribute to the association of
CCR4 with CAF1.
After examining the effects of the NOT3, NOT4, NOT5, and NOT2
components on the association of CCR4 and CAF1 in the 1 mD complex,
the effect of another major component NOT1 was also investigated using
different NOT1 deletion or mutation strains. First, the association of CCR4
28
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Figure 3. Gel filtration of extracts from not2 deletion and mutation 
strains. Strains MY16 fnot2-1 mutation) and 1393-4a fnot2 deletion) 
were grown and analysed as described in figure legend 2.
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Figure 4. The N-terminal 396 residues of NOT1 is not required for the 
association of CCR4-NOT complex. Immunoprecipitations were conducted 
in strain MY1737 (notl pNOT1-396-2108) and wild-type backgrounds 
with CAF1 antibody. Lanes 1 and 2 contain one tenth of the crude 
extract protein input used for the immunoprecipitations in lanes 3 and 4. 
Western analysis was conducted using anti-CCR4 and -NOT antibodies as 
indicated. NOT4 and NOT2 proteins in the crude extracts in lanes 1 and 2 
were visible in the original westerns and were in equal abundance for the 
two strains. An ECL-based system was used for CCR4 westerns for lanes 
1-4, whereas an alkaline phosphatase-based system was used for the 
remainder of the results. Molecular weights are indicated at the left.
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with CAF1 was examined in a N-terminal deletion strain of NOT1. As 
shown in Figure 4, CAF1 immunoprecipitated the CCR4 protein as well as 
NOT4, NOT5 and NOT2 proteins in n o tl-396-2108 and wild-type strains. 
Compared with the wild-type, the CCR4 protein level brought down with 
CAF1 antibody in n o tl-396-2108 background is reduced while other 
proteins were not affected significantly. Therefore, NOT1 residues 1-395 
are required for the complete association of CCR4 with CAF1.
The N-terminal half of NOT1 was required for forming the 1 mD CCR4- 
NOT complex.
Three notl mutation or deletion strains were analyzed by gel filtration 
chromatography. First, a not1-2 strain expressing about 90% of 
truncated N-terminal NOT1 that is about 1100 aa in length and 10% of 
full-length NOT1 was analyzed (Bai et al 1999, Figure 5D). Though the 
not1-2 strain shared some similar phenotypes as n o t l -1 3 1 9 -2 1 0 8  such 
as temperature sensitivity and 3-AT resistance, the CCR4-NOT complex in 
a not1-2 background was distinct from that observed in a n o tl-1 3 1 9 -  
21Q£_ background. The gel filtration profile of not1-2 showed that CCR4 
and CAF1 were still associated in the 1.9 mD complex, but there was a 
slight shift of the 1 mD peak for about 2 fractions, equal to a MW shift
of about 200 kD. Second, the NOT1 N-terminal deletion strain was
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examined (Figure 5C). n o tl-396-2108 had no effect on CCR4 association 
in either the 1.9 or 1 mD complexes, although it did affect CAF1 
association in the 1 mD complex. The fact that in a n o tl-396-2108  
background CCR4 was still present in the 1.9 mD and 1 mD complexes 
and that CCR4 could immunoprecipitate with CAF1 antibody (Figure 4) 
may explain why a n o tl-396-2108 strain is not temperature sensitive and 
has no effects on ADH2 expression.
Third, the effect of deleting the N-terminal 1318 aa of NOT1 was 
analyzed using gel filtration (Figure 5B). The not1-1319-21Q8 strain is 
temperature sensitive and has decreased ADHII activity (Bai et al 1999). 
Removing residues 1-1318 of NOT1 caused the dissociation of CCR4 and 
CAF1 from the 1 mD complex, suggesting that amino acids 1-1318 of 
NOT1 is required for the physical integrity of this CCR4-NOT complex. 
Also, in a notl-1319-2108 background very little CAF1 was observed 
following gel filtration chromatography. Deletion of the N-terminal domain 
of NOT1 might cause severe instability of CAF1 in the CCR4-NOT complex 
and result in dissociation of most of the CAF1 from both the 1.9 mD and 
1 mD complexes.
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Figure 5. Gel filtration analysis of CCR4 and CAF1 in NQT1 mutant 
backgrounds. A- strain KY803 (wt); B- strain MY1738 fnotl pNOT1- 
1319-2108 ); C- strain MY1737 fnotl pNOT1 -396-2108); D- strain MY8 
(not1-21. Gel filtration chromatography was conducted as described in 
Figure 3. Anti-CCR4 antibody was used to detect the CCR4 protein.
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Effects of not mutation on CCR4. CAF1. and NQT5 protein levels.
In order to determine whether the running pattern of CAF1 protein in gel 
filtration analysis is due to the decreased CAF1 in the crude extract, a 
series of western analysis were conducted in various not mutant 
backgrounds (Figure 6A). DHH1 protein levels was used as an internal 
control because DHH1 is not a component of the 1 mD CCR4-NOT 
complex. As shown in Figure 6A, CAF1 protein levels were significantly 
lowered in not1-1319-21Q8 and not2 backgrounds and NOT5 levels were 
decreased significantly in the not2 and n o tl-1319-2109 backgrounds. 
However, this reduction in CAF1 protein level can not alone explain the 
extreme low level of total CAF1 in all fractions of n o t l -1 3 1 9 -2 1 0 8 . 
CAF1 protein may also become more susceptible to protease degradation 
when N-terminal 1318 aa of NOT1 is deleted.
Carbon source and the natural genetic background are two factors
that contribute to the difference in CCR4 and CAF1 levels in wild-type
strains. The CCR4 level in the wild-type strain such as EGY188 is severely
repressed under glucose growth conditions compared with that on
galactose or ethanol medium (Figure 6B). When the sequence surrounding
CCR4 is changed in strains like MD 9-7c(+) (MAT* adh1-11 his3 trp1 ura3
34
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Figure 6A. CCR4, CAF1, and NOT5 protein levels in not mutant 
backgrounds. All strains were grown to mid-log phase in YEP medium 
containing 5% glucose. Cells were harvested, broken with glass beads, 
and 40 ug of total protein was loaded in each lane. The RNA helicase 
homolog DHH1 was used as an internal control to demonstrate equivalent 
loading onto the SDS-PAGE gel. Strains used are KY803 (wt), MY8 (n o tl-  
Z), M Y1737 (notl pNOT1 -396-2108), MY1738 fn o tl pNOT1-1319- 
2108), MY16 fnot2-1). 1393-4a (not21. MY508 (not3 ). MY537 (not4 
), MY1735 (not5 ). Western blot analysis was conducted with antibodies 
directed against CCR4, CAF1, NOT5, and DHH1 as indicated.
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Figure 6B. CCR4 levels in wide-type, dhhl. and KY803 (gcn4^ strains. 
Yeast were grown on 5% glucose, collected and extracts were prepared 
fresh without prior freezing. Proteins were measured with Bradford assay. 
40 ug of protein extract was loaded for each lane and western blot 
analysis was conducted with antibodies against CCR4.
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ccr4-1 Q::CCR4-TRP1). the difference due to carbon source no longer 
exists (Draper et al 1994).
Comparing the CCR4 and CAF1 levels from the KY803 ( ga!2 gcn41 
strain with that of the GAL2 GCN4 strain EGY188, the CCR4 level is 
dramatically increased in a gcn4 strain on glucose medium. This suggests 
that there might be a cross interaction between the pathways of amino 
acid synthesis and glucose repression or low levels of amino acids are 
associated with gluocose derepression.
Conclusions and Discussion
The N-terminal domain of NOT1 is required for the formation of the CCR4- 
NOT 1 mD complex.
There are at least three lines of evidence that support the N-terminal 
domain of NOT1 as being required for formation of the functional CCR4- 
NOT complex. First, the N-terminal 1-1152 residues of NOT1 can be 
immunoprecipitated using either CCR4 or CAF1 antibody (Bai et al 1999). 
Moreover, the 667-1152 residue piece of NOT1 is sufficient for 
association with CCR4. Second, deletion of the N-terminal domain of
NOT 1 reduces the ability of ADH2 to derepress to the same extent as a
37
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n o tl mutation. ADH2 expression appears closely related to the formation 
of a functional CCR4-NOT complex. Third, gel filtration chromatography 
using strain notl-1319-2108 showed that without the N-terminus (1- 
1318 residues) of NOT1, both CCR4 and CAF1 dissociated from the 1mD 
complex and probably exist as free individual protein molecules or 
subcomplexes composed of at most several proteins.
NOT2 Dlavs an important role for the 1 mD CCR4-NOT complex.
Functionally, not2 decreases ADH2 derepression by 8 fold (Liu et al 
1998), similar to the effects of ccr4 or c a f l . In contrast. not3 and not4  
strains decrease the ADH2 expression by at most two-fold, and deletion 
of either of them did not apparently affect the CCR4-NOT complex. 
Therefore, there is a strong correlation between physical integrity of the 
complex and functional activity in terms of ADH2 expression.
The integrity of the 1 mD complex is correlated with CCR4-NQT funtion.
The 1 mD complex, compared with the 1.9 mD complex, is an indicator 
of the functional CCR4-NOT complex. The 1.9 mD complex remains intact 
in both n o tl and not2 mutation and/or deletion strains while the 1 mD 
complex is disrupted to different extents. In addition, genetic data also 
showed that the functions of CCR4-NOT were also severely affected when
the 1 mD complex is disrupted (Bai et al 1999).
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Figure 7. Model for protein contacts in CCR4-NOT complex. Based on the 
results presented herein CAF1 is presumed to bind to 667-1152 of 
NOT1, CCR4 binds to CAF1, and NOT2 and NOT5 interact with the C- 
terminal 1490-2108 residues of NOT1 in no particular order. NOT4 is 
placed on the periphery of NOT2 and NOT5 and it is presumed that NOT3 
makes contacts to both NOT2, NOT5, or NOT4 and to the N-terminus of 
NOT1.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Combined with previous data (Bai et al 1999), a model is proposed 
concerning the physical association of the 1mD CCR4-NOT complex 
(Figure 7). Association of CCR4 with NOT1 is mediated by CAF1. CAF1 
binds to the N-terminus domain of NOT1, while NOT2, NOT4 and NOT5 
bind to the C-terminus domain of NOT1. NOT3 has an extensive but 
weak interaction with various components in this complex.
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CHAPTER 2
INTERACTIONS OF THE TRANSCRIPTIONAL ACTIVATOR ADR1 WITH TFIID
COMPONENTS
Introduction
Transcriptional activators turn on the expression of specific genes 
through interactions with transcriptional components such as TFIID, SRB 
proteins, and TFIIB (Bangur et al 1997, Lee et al 1998, Lagrange et al 
1998,and Figure 8). Activators such as GCN4 and GAL4 have been 
extensively studied. GCN4 (280 aa in length) is required for genes 
induced by amino acid starvation (Hope et al 1986) and it has two 
functionally redundant activation domains each of which alone can 
support efficient activation of GCN4 targeted genes (Drysdale et al
1998). GCN4 has been shown to interact with the SWI/SNF complex 
(Neely et al 1999), SAGA components (Silverman et al 1997), SRB 
mediator subunits (Natarajan et al 1999) and TFIID components (Drysdale 
et al 1998). Similarly, GAL4 has also been shown to interact with 
SWI/SNF (Burns et al 1997), SRB10 (Hirst et al 1999) and TBP and TFIIB  
(Wu et al 1996). Another activator protein is the ADR1. It is
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Figure 8. A proposed model on activated transcription. This model was 
based on the following references: Balciunas et al 1995 and Werner et al 
1997.
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essential for the nuclesome conformational change at the ADH2 gene 
(Verdone et al 1996, 1997) and interactions of ADR1 with the general 
transcription machinery is required for transcriptional activation of ADH2 
gene (Chiang et al 1996, Komarnitsky et al 1998b).
The ADH2 gene has two UAS elements. UAS1 is a 22 bp palindrome
sequence and is ADR1 -dependent and UAS2 is SPT6- and MEU1-
dependent (Multicopy Enhancer of iJAS2, Donoviel et al 1996). Deletion
of UAS1 causes a 10-fold reduction of AQH2 expression, but does not
abolish ADH2 transcription. Deletion of UAS2 also severely reduces
ADH2 expression and the UAS2-dependent ADH2 expression is repressed
by glucose. Inactivation of MEU1 causes only 2-fold reduction in ADH2
expression, indicating the presence of other UAS2-dependent activator
proteins (Donoviel et al 1996). The correct phasing between UAS1 and
UAS2 (25 bp apart) is important and UAS1 and UAS2 appear to activate
ADH2 expression synergistically. ADH2 expression is regulated by
glucose repression and no induction is required. However, a repressor may
be removed when ethanol or glycerol is the only available carbon source.
The expression of ADH2 is increased several hundred-fold following
growth on a nonfermentable carbon source (such as ethanol) as
compared with growth on a fermentable carbon source (such as
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glucose). Several repressors are known to control glucose repressed 
genes in yeast. In the case of ADH2. REG1 but not SSN6 or TUP1 is 
required for glucose repression of ADH2 expression (Dombek et al 1993). 
Inactivation of REG1 increases ADH2 transcription either directly or 
indirectly through affecting ADR1 expression and modification (Dombek 
et al 1993). Glucose regulates ADR1 mRNA stability and the rate of ADR1 
protein synthesis but not ADR1 transcription rate (Vallari et al 1992). 
Post-translational modifications may also participate in ADR1 regulation 
(Cook et al 1994b).
ADR1, SNF1, and SNF4 proteins function as global regulators of 
glucose-derepressible genes and have been shown to activate 
peroxisomal genes, such as CTA1. FOX2 and FOX3 (Simon et al 1991, 
1992). The observation that CTA1 expression depends more on the 
action of ADR1 while FOX3 relies more on the SNF1 protein suggests that 
ADR1 and SNF1 proteins do not display simple upstream and downstream 
relationships (Simon et al 1992, Navarro et al 1994). For instance, SNF1 
may act on factors other than ADR1.
As a transcriptional activator of ADH2. ADR1 functions by increasing 
transcription initiation and possibly the formation of an active RNA
polymerase II holoenzyme. ADR1 binds to the UAS1 of the ADH2 gene as
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a dimer (Cook et al 1994a, Blumberg et al 1987, Kratzer et al 1997). 
The minimal DNA-binding domain of ADR1 consists of two Cys2-His2 zinc 
finger motifs (residues 99-155) and an additional 20 residues N-terminal 
to the zinc finger motif (Schmiedeskamp et al 1997). A conformational 
change in this DNA binding domain is induced upon binding the UAS1 
sequence (Hyre et al 1998). Both zinc fingers are necessary for ADR1 
activity (Blumberg et al 1987). However, ADR1 binding to DNA is 
required but not sufficient for transcriptional activation in vivo (Yu et al 
1989) .
ADR1 is composed of four transcriptional activation domains (TADs), 
TADI (residues 148-262), TADII (residues 263-359), TADIII (residues 
420-462), and TADIV (residues 642-704) (Cook et al 1994a, Chiang et 
al 1996, Figure 9). ADR1 also contains an inhibitory region (residues 
227-239) deletion of which enhances ADR1 function (Cook et al 1994b). 
Mutations within this region allows ADH2 chromatin remodeling and 
enhances ADH2 expression on glucose. ADH2 chromatin remodeling 
requires ADR1. However, chromatin remodeling upon activator binding 
itself is not sufficient for the transcriptional activation of ADH2 gene 
(Verdone et al 1996, 1997). Although it has been reported that a
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ADR1 protein
83 155 263 359 642 704
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Figure 9. Functional domains of the transcriptional activator ADR1. ADR1 
has a DNA-binding domain with 2 zinc-finger motifs. Four activation 
domains have been identified in the N-terminal region and extend from 
residues 148-242, 262-359, 420-462, and 642-704 respectively. A 
domain related to inhibiting ADHII activity is located at residues 220-262. 
A sequence overlapping TADII and TADIII is characterized as a domain 
regulating growth on glycerol. ADR1 expression is mostly regulated at 
the translation level and this protein level control appears to be mediated 
by the residues 262-642.
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mini-ADR1 containing only the DNA binding domain of ADR1 and TADIII is 
capable of substituting for full-length ADR1 using a UAS1-containing 
reporter genes, deletion of this particular TAD (residues 420-462) in wild- 
type background causes no significant reduction in ADH2 expression 
(Cook et al 1994a). In addition, TADII and TADIV can also support 
transcription activity of ADR1 for growth on ethanol and /or glycerol. So 
multiple TADs of ADR1 are still required for the full expression of ADH2 
and certainly many peroxisome and oleic acid metabolism genes.
ADR1 has been shown to interact with components in the TFIID and 
SAGA complex and at least several interactions appear physiologically 
relevant to ADH2 expression (Chiang et al 1996). TFIID in yeast consists 
of TBP and 12 TBP associated factors (TAF„s) (Table 2). TBP is required 
for all three RNA polymerases (Cormack et al 1992, Tansey et al 1997). 
Ribosomal promoters typically have intrinsic curvature while TBP is 
responsible for conferring curvature on to RNA polymerase II promoters 
(Schatz et al 1997). The approximate 45°C bending of TATA-box induced
by TBP binding, however, does not disrupt the Watson-Crick base-pairing 
or cause a conformational strain (Schatz et al 1997). A consequence of 
this convex structure is that the upper surface of TBP exposed and
available for protein-protein interactions. The major contact of TBP with
47
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TATA element is a hydrophobic contact between monomer TBP and the 
minor groove (Horikoshi et al 1990). The major groove, however, also 
contributes to the full function of the promoter (Burley et al 1998). TBP 
binding TATA-box is essential for basal transcription (Poon et al 1991). 
However, TFIID rather than TBP is the functional entity in vivo. TBP or 
TFIID binding to the promoter is enhanced by transcriptional activators 
and GTFs or reduced by repressors (Li et al 1999, Kuras et al 1999).
The TAF proteins may mediate the interactions of transcription 
activators with the general transcriptional machinery. Several lines of 
evidence suggest that TAFs play a variety of roles, such as a 
cofactor/mediator and in cell cycle progression. TAFs also contribute to 
the recruitment or induction of an active RNA polymerase II through 
interacting with the GTFs at least at some promoters (Chen et al 1994, 
Verrijzer et al 1994). However, it is still under much debate and 
investigation whether the TAF proteins play a general role in transcription 
(Reese et al 1994, Walker et al 1996). TAFs function as coactivators or 
corepressors at many genes and associate with the core promoters 
(Reese et al 1994, Manley et al 1996). To date the TAFs that share 
histone motifs appear to play a broad role in gene transcription while
other TAFs are only required for a small set of genes (Apone et al 1998,
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Michel et al 1998, Natarajan et al 1998). For instance, TAF40 and 
TAF90 only affect a set of genes (Klebanow et al 1997). For TATA-less 
promoters, TBP-TATA binding is dispensible while TAFs are required for 
basal transcription (Martinez et al 1994). Though each of the TAF 
proteins do not play a general role in transcription, they are essential for 
cell viability (Poon et al 1995).
Two large size TAF proteins, TAF150 and TAF130, are essential for 
a number of cyclin genes and may play roles in promoter selection and 
downstream contacts (Nishikawa et al 1997). TSM-1/TAF150 is required 
for G2/M phase progression. In addition, the drosophila TAF150 homolog 
(C-terminal 489 aa) binds to a promoter element named initiator element 
(Inr). Inr is pyrimidine-rich (YYA+1 N(T/A)YY) and is located around the 
transcription start site (Verrijzer et al 1994). This Inr is especially 
important for TATA-less promoters and recognition of Inr by dTAF150 is 
required for activation of at least some promoters (Hansen et al 1995).
TAF130/145 is well conserved from yeast to human and its 
homologs in drosophila and human have been isolated and characterized 
(Ruppert et al 1993). Like its homologs, TAF130 in yeast possesses HAT 
activity (Mizzen et al 1996). This protein has been structurally
characterized and the essential region includes residues 208-303 and
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367-1037 (Bai et al 1997, Figure 10). The N-terminal residues 2-115 of 
TAF130 mimics the hydrophobic minor groove face of a TATA element 
and binds TBP competing with TBP’s interaction with the TATA-box 
(Burley et al 1998). This domain can actively dissociate TBP from TATA 
-box promoters in vitro and this negative effect is physiologically 
important (Kotani et al 1998). However, other regions of TAF130, such 
as the region between the conserved essential domains and the HMG 
(tLigh-mobility group), are also required for TBP interaction (Kokubo et al 
1994). TAF130 might also compete with activators for binding TBP 
(Nishikawa et al 1997). Microarray analysis reveals that inactivation of 
TAF130 only elevates the transcription of around 1% of total genes in 
yeast and this effect is independent of its cell cycle effect (Holstege et 
al 1998). However, this is a very conservative estimate of TAF130 
effects on gene expression because these effects were only quantitated 
following growth on rich medium. As the only known TAF protein that 
contacts TBP directly, TAF130 also participates in promoter selection 
and its activity is core promoter-dependent (Shen et al 1997). This role 
does not require upstream activating sequences but requires the 
sequence around the TATA-box. Its role in promoter selection may
involve recruiting other TAF proteins.
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Figure 10. Comparison of yeast TAF130 and TAF150 proteins with their 
homologs in drosophila and human. References are Bai et al 1997, 
Verrijzer et al 1994 and Mizzen et al 1996. Regions interacting with 
TADIV of ADR1 are highlighted.
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Histone motif-containing TAF proteins such as TAF60 (H4-like), 
TAF61/68 (H2B-like), and TAF17 (H3-like) appear to play broad roles 
(Michel et al 1998, Natarajan et al 1998 and Holstege et al 1998). Tight 
ts mutations in these TAFs confer significant reduction in total poly A+ 
RNA and several tested mRNAs. So these TAFs are likely to be required at 
most genes. The broad roles of these TAFs have been suggested to 
related to the fact that they are also part of SAGA complex (Apone et 
al 1998). But some evidence suggest that its broad role is not related to 
their roles in the SAGA. Disruption of SAGA caused by deletion of the 
SPT20 subunit does not result in a general reduction in mRNA (Michel et 
al 1998). It has been suggested that these histone-like TAF proteins 
increase TFIID  affinity for the promoter through forming a histone- 
octamer-like structure.
TAF61 is required for SAGA integrity and the HAT activity of the 
whole complex. It has been shown to mediate the interactions of the 
transcriptional activators like GCN4 with the SAGA complex (Natarajan et 
al 1998). The drosophila homolog of TAF17 contacts both TFIIB and 
the upstream activator. TAF17 is required by a number of genes (Apone 
et al 1998) and DNA microarray analysis demonstrated that a TAF17
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defect affected 67% of the total 5349 transcripts tested (Holstege et al 
1998).
Previously, it has been demonstrated that ADR1 requires the TFIID  
complex for activating ADH2 gene (Komarnitsky et al 1998b). TADI and 
TADIV also interacted in vitro with the C-terminal region of TFIIB while 
TADII of ADR1 could bind ADA2 and all four TADs interacted with 
another SAGA component GCN5. Most importantly, it has been shown 
that deletion of the GCN5 or ADA2 gene affects the nucleosome 
positioning and the transcription activation of ADH2 upon glucose 
depletion (Caserta, M.. personal commun.). TFIID components also 
interact with TADII and TADIV and these interactions appear 
physiologically relevant to the ADH2 gene activation. Both TADII and 
TADIV interact with TAF130 and TADIV also binds several other TAF 
proteins (Komarnitsky et al 1998b). A mutation in TAF130 was also 
found to affect the transcriptional activity of LexA-ADR1-TADIV. In 
addition, ADR1 was shown to co-immunoprecipitate with TFIID  
components in crude protein extracts.
A systematic binding study was therefore conducted to determine 
which TAF proteins interact with TADs of ADR1. Twelve TAF proteins
were expressed in vitro and examined individually for binding TADs. These
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interactions were confirmed using purified TAF proteins in the binding 
assay. Furthermore, the regions of TAF150 and TAF130 that bound 
TADIV were localized. To examine the physiological relevance of these 
interactions, effects on ADH2 expression of inactivation or mutation of 
these TAFs or upon TFIID disruption were determined using Northern 
analysis and S1 nuclease assay. Inactivation of different TAF proteins 
exhibited distinct effects on ADH2 transcription, from no effect to a 
significant effect. Different sets of TAF proteins may be required at 
different promoters and at one promoter, such as ADH2. they may act 
synergistically by sequential or conditional interactions with the 
transcriptional activators.
Material and Methods
Yeast Strains And Growth Media
Yeast strains are listed in Table 3. BYA2 strains were grown on YP rich
medium supplemented with 2% ethanol/2%glycerol. All other TAF 
mutation strains were first grown on YP medium with 4% glucose to OD600 
0.5 and then shifted to 2% ethanol/2% glycerol. Cells were washed 
once and after washing no glucose was detectable using a glucose strip
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Table 3. ADR1 -related yeast strains
Strains Genotype
BYA2/WT-TBP MATa ura3-52 ade2-101 trp1-Al Iys2-801 GALAleu2 ASPT15 
YCP22-TRP1 -TBP
BYA2/K151 L,K156Y same as above except YCP22-K151L K156Y
A893 MATa ura3 adel his4 Ieu2 tsm1(ts)
YSW87 ura3 taf145::LEU2 pTAF130/145:HIS3
YSW90 isogenic to YSW87 except ptaf130/145-ts1
YSW93 isogenic to YSW87 except ptaf130/145-ts2
TAF60 MATa ura3-52 TRP1 Ieu2 LEU2::taf60 pRS313-HIS3-TAF60
TAF60-12 isogenic to TAF60 except pRS313-HIS3-TAF60-12
TAF60-19 isogenic to TAF60 except pRS313-HIS3-TAF60-19
TAF61-A1 MATaadhl ura3-52 trp1-Al leu2::pET5b LEU2::taf61 pRS313- 
HIS3-TAF61
TAF61-12-A1 isogenic to TAF61-A1 except pRS313-HIS3-taf61-12
TAF61-23-A1 isogenic to TAF61-A1 except pRS313-HIS3-taf61-23
TAF61-108-A1 isogenic to TAF61-A1 except pRS313-HIS3-taf61-108
TAF61-226-A1 isogenic to TAF61-A1 except pRS313-HIS3-taf61-226
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test. These strains were then grown in YP medium containing 2%  
ethanol/2% glycerol for another 1.5 to 2 hrs at 30°C and then moved to
3 7°C for another 1.5 to 2 hrs.
DNA Constructions
TAF130/145-668-865 was constructed by Yeuh-Chin Chang
(University of New Hampshire). pSPTAF130 was cut with EcoRI and 
Hindlll and the small fragment was ligated to the pET23d T7 vector 
digested with the same enzymes. The construct was checked by 
digestion with the two enzymes, and in an in vitro expression system only 
one protein band running around 20 KD was observed. Two T7 vectors 
were constructed for expressing the N- and C- terminal of TAF40 proteins 
in vitro. pET-15b-TAF40 was cut with Nhel and the larger fragment was 
self-ligated to form the TAF-40-N (1-466 nucleotides) vector, expressing 
the N-terminal 1-155 aa of TAF40. To construct TAD40-C, pET-15b- 
TAF40 was cut with Nhel and BamHI and the small segment was ligated 
to pET-28a-c(+) plasmid digested with the same two enzymes. TAD-40- 
C without the T7 tag contains nucleotide 466 to 1024 or 466 to 1041 
and expresses amino acids 156-340 or 156-346. Based on the restriction 
maps of pET-28a-c(+) and TAF40 gene, if the BamHI cut at 1041
nucleotide, the C-terminal 6His tag is not in frame and if the enzyme cut
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at 1024 nucleotide, the C-terminal 6His will be expressed. Both the N- 
terminal and C-terminal constructs were expressed in vitro using a wheat 
germ extract and a single protein band was observed for each when 
translated in vitro.
ADHII Enzyme Assay
Native gels were run as described previously (Williamson et al 1981). 
Protein levels were measured using Bradford assay and equal amounts of 
protein (25 ug or 50 ug) were loaded into each lane. PAGE gels were run 
overnight at 4°C.
In Vitro Binding Assay
The procedure for binding 35S-Met labeled proteins was conducted as 
described in detail (Chiang et al 1996). T7 and SP6 Promega wheat germ 
kits for in vitro expression were adopted for different TAF proteins. GST 
fusion proteins to ADR1 TADs I to IV and TADIV deletion constructs were 
overexpressed and purifed from £  ggii cells (Chiang et al 1996). Purifed 
TAF150, TAF130, TAF90, TAF60, and TAF61 proteins were a gift from 
Dr. P. Anthony Weil. The ECL-based detection system was used for 
Western analysis of TAF proteins and all antibodies were also gifts from 
Dr. P. Anthony Weil and diluted as instructed.
S1 Nuclease Analysis
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S1 nuclease analysis was conducted as described (Jackson-Fisher et 
al 1999). The exception is that 10 nucleotides were added to the 3’ end 
of the A0Jd2_probe. The sequence is 5 ’ GGAGCA CTTTGC ACCGGC  
TGGCAA ACCAAC CAAGAC AACAGT ACCGTT CGCCCT ACAG 3’. The 
controls were two tRNA probes (isoleucine and tryptophan) synthesized 
as described (Cormack et al 1992). [y-32P]ATP was from ICN and the
specific activity was 2000 uci/ 12 ul.
Bfisutts
Transcriptional Activation Domains of A D R 1 Bind to only Certain TAF 
Proteins.
Previous studies have shown that TAD domains of ADR1 can retain 
TAF components of TFIID from the yeast extract. Therefore, a systematic 
survey was conducted to investigate which individual TAFs of the total of 
12 present in TFIID  were capable of binding TADIV of ADR1. We 
expressed TADIV as a GST-fusion protein and used it to individually bind in 
vitro expressed TAF proteins. A total of five TAF proteins, TAF150, 
TAF130, TAF61, TAF60 and TAF40, were found to bind TADIV and the 
binding results of TAF150, TAF130 and TAF60 which I studied are shown 
in Figure 11. Approximately 2 to 5% of the total input protein for each of
these TAFs was found to bind TADIV. In addition to using GST as a
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Figure 11. In vitro translated TAF proteins bind TADIV. All TAFs were 
expressed in vitro using a Promega wheat germ expression kit. all TAFs 
except for TAF150 were full length in size. GST, GST-VpU and GST-TADIV 
were expressed in £  coli. and purified using glutathione beads obtained 
from Sigma. Equal amounts of GST fusion proteins were used to bind the 
TAF proteins individually. Inputs were all 5% of the amount used for the 
binding except for TAF130 that was 2%  of the total proteins.
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negative control, GST-Vpu, an HIV AIDS viral protein was also used as a 
negative control in which case little or no binding was observed to the in 
vitro translated TAF proteins. All TAF proteins were full-length except in 
the case of TAF150. For TAF150, two truncated overlapping fragments 
were analyzed and both were capable of binding TADIV. However, this 
does not exclude the possibility that other regions of the large TAF150 
protein also interacted with TADIV. The residues 744-1100 of TAF150 
that bind TADIV is located in a non-conserved region of the protein 
(Figure 10). Therefore, a total of five TAF proteins interacted with TADIV 
of ADR1.
We also analyzed the ability of other ADR1 TADs to bind to twelve
TAFs. TADI and TADII were found to bind TAF130, TAF60 and TAF61
(Figure 12, data not shown for TAF61 whose binding assay was done by
Karen Reed, who was a postdoctoral fellow in our lab). In vitro expressed
TAF130 displays multiple bands below the full-length sequence of 130
kD, indicating that there exists either degradation products or
mistranslation peptides from internal methionines. These truncated
products were capable of binding much better to TADII or TADI when
compared with full length TAF130 (data not shown). TAF60 and TAF40
also specifically bound TADII (Figure 12 and Figure 13). Considering
61




s  O Q O
-  >  *  S  i?
3 *1 hi
<0 <0 CO CO
£  O  O  O O
t
Figure 12. Binding of TADI, TADII, TADIII to TAF130 and TAF60. The 
same binding procedure as described in Figure 11 legend was used for the 
binding. Purified GST-VpU, GST-TADI, GST-TADII, and GST-TADIII proteins 
were examined with Coomassie blue stained SDS-PAGE gel and equal 
amounts were used for the in vitro binding assays.
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Figure 13. Binding of TAF40 N-terminal and C-terminal domains to TADI 
to IV. DNA constructions of TAF40 were described in the Material and 
Methods. There are 3 input lanes for the TAF40 N-terminal binding. Each 
input lane was 5% of the total amount of proteins used for binding.
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TAF150 is huge protein, it is possible that other regions of TAF150 may 
interact with TADI and/or TADII, too. In contrast to the multiple 
interactions of TADII with TAF proteins, TADIII bound none of the 12 TAF  
proteins.
To locate the region of TAF40 that bound TADIV, two DNA constructs 
were made to express the TAF40 N-terminal (residues 1-155) and C- 
terminal (residues 155-341 or 346), respectively. Both of these TAF40 
proteins were found to physically interact with TADIV whereas only the N- 
terminal TAF40 protein interacted with TADII (Figure 13). Combined with 
the above data, it is apparent that multiple TADs in the transcriptional 
activator ADR1 interact with multiple TAF proteins, indicating that there 
is a redundancy and/or coordination in the interaction of ADR1 with TFIID  
components.
Purified TAF Proteins Bind TADIV
Because TADIV had been more well defined than the TADI or TADII,
the subsequent analysis using purified TAF proteins was focused on
TADIV interactions. Purifed TAF proteins were used to bind TADIV in
order to confirm the in vitro TAF binding results described above. Purified
full length TAF150, TAF130, TAF90, TAF60 and TAF61 all were found to
bind TADIV (Figure 14, Bai et al in prep). Purified TAF40, however, did
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Figure 14. Binding of purified TAF proteins to TADIV. The TAF proteins 
that have been shown to bind TADIV as described in Figure 11 were 
examined in their purified form for their ability to bind TADIV. Instead of 
using truncated versions of TAF150, full length TAF150 was used. 
Inputs were 5% for each protein and ECL was used to detect the protein 
following incubation with the proper antibody.
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not bind TADIV (K. Reed, pers. comm.)- Therefore, a total of four TAF 
proteins, TAF150, TAF130, TAF60, and TAF61, bind to TADIV in either in 
vitro translated form using wheat germ extract or in purified form. 
Residues 668-865 of TAF130 Alone Bound TADIV.
Since TAF130 is the most extensively studied TAF protein, our 
subsequent studies focused on its binding to TADIV. A series of TAF130  
deletion constructs that covered the whole sequence of TAF13Q was 
used to identify the region of TAF130 protein that was responsible for 
binding TADIV (Figure 15A). Three TAF130 deletion constructs (A12,
A13, A14) exhibited significant reduction in binding TADIV among the 17
deletion constructs analyzed (Figure 15A, lane 3). In constrast, TADII 
bound these three TAF130 deletion proteins to the same extent as other 
TAF130 deletion constructs (lane 4). These results suggest that residues 
692-860 represent the region that ADR1 TADIV interacts with TAF130. 
To confirm this hypothesis, residues 668-865 of TAF130 were placed 
under T7 promoter control in order to express TAF130-668-865 in vitro. 
Binding studies with this expressed protein showed that by itself it was 
capable of binding TADIV (Figure 15B). Therefore, the residues 668-865 
are responsible for the interaction of TADIV with TAF130 and this region
is located in a well conserved region in the TAF130 protein (Figure 10).
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Figure 15A. Binding of TAF130 deletion proteins to TADIV. All TAF130 
deletion constructs were expressed in vitro under an SP6 promoter. Each 
of these TAF130 deletion proteins was used for binding GST-VpU (lane 
2), GST-TADII (lane 4) and GST-TADIV (lane 3). The input was 5% of the 
total protein used for binding.
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Figure 15B. Binding of residues 668-865 of TAF130 with GST-TADIV. 
The region of TAF130 corresponding to amino acids 668 to 685 was put 
under control of a T7 promoter and expressed using an in vitro expression 
system as described in Figure 15B. Five percent of total protein used for 
binding was loaded into the input lane.
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Residues 698-704 Of TADIV Are Essential For TAF Protein Interaction As 
Well As For Transactivation.
It has been shown that deletion of residues 698-704 dramatically 
affect the transactivation ability of LexA-TADIV (Kormanitsky et al 
1998b). To determine how deletions within TADIV protein affects the 
ability to bind individual TAFs, all four relevant TAF proteins that were 
capable of binding TADIV were used for binding a series of TADIV deletion 
proteins as described (Komarnitsky et al 1998b). Biochemical data as 
shown in Figure 16A demonstrated that residues 698-704 were essential 
for TADIV binding to TAF150, TAF130 and TAF60. Previously, Karen 
Reed, a postdoctoral fellow in our lab, also showed that TAF61 exhibited 
a similar binding pattern with the TADIV deletion constructs (Bai et al in 
prep). Therefore, all four TAF proteins that bind to TADIV require the 
698-704 residues in the TADIV.
Mutation analysis of TADIV was conducted to identify residues that 
may be essential for binding each TAF protein and for transactivation of a 
reporter gene. Mutation analysis in the region of residues 675 to 704 
revealed that certain residues were essential for the transactivation of 
the reporter gene B-galactosidase. As shown in Table 4, all of the
mutations affected the transactivation by two fold or less except F685A
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Figure 16A. Binding of TAF150, TAF130 and TAF60 to TADIV deletion
proteins.
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188/34 strains carrying the LexA-TADIV or LexA-TADIV mutations 
were grown on 2% galactose/ 2% raffinose and the p-galactosidase 
activity was assayed as describled (Kormanitsky et al 1998). The 
values represent the average of more than 7 times assays.
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which reduced the p-galactosidase activity much more significantly. Two
of these mutated TADIV constructs were analyzed to correlate their 
trans-activity with their capability of binding to the TAF proteins. As 
shown in Figure 16B, while the mutation I703A did not alter TADIV  
binding to any of the TAF proteins, the mutation F685A caused severe 
reduction in binding all four TAF proteins. These results suggest that the 
hydrophobic residue at 685 may be important for TADIV function 
because it affected binding to all four TAFs. Alternatively, it could also be 
important for maintaining the three-dimensional structure of this region. 
Inactivation Of TAF130 Did Not Affect ADH2 Transcription and TAF150 
Might Have An Effect On ADH2 Transcription When the Diauxic Shift 
Occurs.
Because most of the above experiments solely represent biochemical 
interactions, it was also important to explore the physiological role of 
these TAF proteins in ADH2 expression. Wild-type and TAF mutation 
strains were analyzed for their effects on ADH2 mRNA levels and ADHII 
enzyme levels. For TAF130 two temperature sensitive (ts) strains 
carrying separate TAF13Q ts mutations were used for the study. All 
strains were pregrown in 4% glucose and then shifted to ethanol (diauxic
shift). There was no significant alteration in the ADHII enzyme activity for
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Figure 16B. Binding of TAF150, TAF130, TAF61, and TAF60 to TADIV- 
F685A and Y703A and to wild-type TADIV. Deletion or mutation 
constructs extending from residues 675 to 704 were expressed as GST  
fusion proteins. Equal amount of these proteins were used to pull down 
the in vitro radioactively-labeled TAF150, TAF130, TAF61 and TAF60 
proteins, respectively.
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all strains and conditions tested (Figure 17A) . Also, when the total RNA 
was subsequently isolated from each strain and analysed by Northern 
analysis, there was no dramatic change of ADH2 transcripts in the wt as 
compared to the TAF130 ts strains (data not shown). It is necessary to 
point out that all TAF130 strains are abnormal when compared with other 
stains we work with. Unlike other wild-type strains that grow very well on 
2% ethanol /2%  glycerol at 30°C, we observed that they grow very
poorly possibly due to lack of ADH2 expression. Therefore, TAF130  
might not have dramatic effect on ADH2 expression.
TAF150 strains were also grown on 2% ethanol or by depleting 
glucose and ADHII enzyme assays were conducted on TAF150 protein 
extract. There was no significant alteration of the ADHII enzyme activity 
when tsm -1/taf1  50 strains was shifted to restrictive temperature (Figure 
17B). When the total RNA extract were subjected to Northern and S1 
nuclease assay, there was no effects observed when the ts strains were 
shifted to restrictive temperature on 4% glucose or 2% ethanol (data not 
shown). But when the cells were subject to diauxic shift, there were 
dramatic reduction of ADH2 transcripts for taf150-ts strains grown at 
37° compared with the strain grown at 30° (Figure 17C). Because no
wild-type strains with the same genotype as the TAF150-ts strain were
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5%glucose diauxic shift 2%ethanol/2%glycerol
Figure 17A. ADHII enzyme assay of TAF130 wild-type and ts proteins. 
Total proteins were extracted from freshly collected cells and quantified 
by the Bradford assay. Fifty ug was loaded in each lane. YSW 87 (wt), 
YSW90 (taf13Q-ts1T and YSW 93 ftaf 130-ts2) were grown on 4%  
glucose, 2% ethanol/glycerol or subject to a diauxic shift.
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TAF150-tS 
diauxic shift 2% ethanol /  2% glycerol
Figure 17B. ADHII enzyme assays of proteins from TAF150 and taf150-ts 
strains. Strain A893 (taf150-ts) were either grown on 4% glucose and 
shifted to 2% ethanol or on 2% ethanol continuously. Zero, one, and two 
hours represent the times cells were shifted to 37°C.
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Figure 17C. S1 nuclease assay of RNA from TAF15Q and taf15Q/tsm-1 ts 
strains. The strain A893 upon shifting to restrictive temperature was 
grown on 4% glucose to an OD600 0.5 and then shifted to 2%
ethanol/2% glycerol for another 2 hrs. Half of the culture was 
subsequently shifted to the restrictive temperature for another 2 hrs 
growth. The culture that had been growing at 30°C was used as the 
control and designated as wild-type. In addition, another wt strain 
(BYA2) was used as a control and subject to the same growth conditions 
as strain A893.
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available, two other wild-type strains, EGY188 and BYA2, were used for
S1 nuclease protection analysis (data not shown for 188, Figure 17C, 
lane 1 and 2). However, this TAF150 ts strain may not contain a 
mutation that is expressed as a null protein. Therefore, the inactivation of 
TAF150 may not necessarily inactivate the protein completely and its 
effect on ADH2 transcription needs further investigation.
TAF61 and TAF60 Affect ADH2 Transcription.
All TAF61 and TAF60 wild-type and ts mutation strains were examined 
similarly as for the TAF130 and TAF150 strains to determine whether 
they affected the ADH2 gene in vivo. They were first grown on 4% 
glucose and the cells were collected and resuspended in fresh medium 
with 2% ethanol/2% glycerol and allowed to grow at 30° for 2 hrs. All
cultures were shifted to 37° for another 2 hrs. There was no significant
changes in ADHII enzyme activity in these taf61 and taf60 backgrounds 
(Figure 18A). However, primary Northern analysis of the total RNA from 
each strain indicated that there were several-fold reduction of ADH2 
transcripts in a number of these taf61 mutation background and dramatic 
decrease in the two taf60 ts strains (data not shown). To confirm these 
data, S1 nuclease protection analysis was used to quantify the ADH2
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Figure 18A. ADHli enzyme assays in TAF60 and TAF61 strain and their 
corresponding ts strains. All strains were grown on 4% glucose to reach 
mid-log growth and then shifted to medium supplemented with 2% 
ethanol/2% glycerol for another 2 hrs. Cells were broken in native 
extraction buffer (Draper et al 1994) and 25 ug fresh extract was loaded 
for each lane.
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mRNA level. As shown in Figure 18B, a several-fold reduction was 
observed in all taf61 ts strains except ta f6 1 -2 2 6 . while dramatic 
decreases in ADH2 transcripts occurred in both taf60 ts strains. These 
data suggest that the effects at the transcriptional level do not 
necessarily lead to changes at the protein level due to the multilevel 
regulation of gene expression. Alternatively the standards used for these 
analyses were not representative and therefore misrepresented the true 
level of ADHII enzyme or RNA levels.
TFIID Disruption Affects ADH2 Transcription And Expression.
If individual TAFs are important for ADH2 transcription, the 
assembly of the whole TFIID should also be essential for ADH2 gene 
expression. To determine the effect of the TFIID structure disruption on 
ADH2 expression, a strain carrying a TBP mutation was used. The 
mutations K151L K156Y in TBP caused the disruption of the TFIID  
complex at the restrictive temperature of 38°C. To examine the effect of
TFIID disruption on ADH2 expression, the total RNA and proteins from
these strains grown on 2% ethanol/2% glycerol were analyzed. Both
Northern and S1 nuclease assay data exhibited a significant reduction of
ADH2 transcripts (data not shown, Figure 19A), respectively. tRNA! and
tRNAw were were used as the internal controls for comparison.
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Figure 18B. S1 nuclease assay of ADH2 transcripts from TAF6Q and 
TAF61 wt and ts strains. Yeast strains were grown as described in Figure 
18A legend and were subsequently transferred to the restrictive 
temperature of 37°C to inactivate the relevant TAF protein. tRNAw 
(tryptophan) and tRNAj (isoleucine) were used as internal controls.
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Figure 19A. S1 nuclease assay of RNA isolated from W T and TFIID  
disruption strains. The BYA2 and the strain carrying ifcja K151L K156Y  
were grown on 2%  ethanol/2% glycerol and then both were shifted to the 
restrictive temperature. The amount of RNA was adjusted to show equal 
tRNA transcripts.
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Therefore, the effect shown in Figure 19A represents a minimal effect on 
ADH2 expression. It is necessary to point out that rRNA transcription was 
also severely reduced in this TFIID disruption strain and to a lesser extent, 
tRNA* and tRNAw, when compared with the strains, the strain containing 
the TFIID disruption also conferred a reduction in ADH2 enzyme activity 
(Figure 19B). Therefore, the disruption of TFIID structure not only 
reduced the ADH2 transcription but also its protein expression. 
Considering TAF61 and TAF60 are components for both the SAGA and 
the TFIID complexes, this set of data also suggest that TFIID is specifically 
required at the ADH2 gene.
Discussion
In this work we investigated the biochemical and physiological 
interactions of ADR1 with TFIID. Three TADs of ADR1 were shown to 
interact with TAF150, TAF130, TAF60, and TAF61. Though these TAF 
proteins bound the same region in TADIV, their roles in vivo were distinct. 
When TAF130, the only TAF that displays HAT activity that is related to 
chromatin remodeling, was inactivated, there was no effect on ADH2 
transcription. The ts mutant of TAF150 did not affect ADH2 expression 
following growth on ethanol, but it could have had an effect when glucose
is depleted. Inactivation of TAF61 or TAF60 caused severe reduction in
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Figure 19B. ADH2 enzyme assay of extract prepared from wild-type 
(BYA2) and TFIID disruption strain described in A legend. Proteins were
extracted from freshly collected cells, measured with Bradford and 50 
ug was subjected to native PAGE as described above.
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ADH2 transcripts. TFIID disruption also conferred significant decrease in 
ADH2 transcription and reduction of ADHII activity at the protein level.
Multiple TAF Proteins Physically Interact With Transcriptional Activator
ADR1 But Do Not Necessarily Affect The Transcription Of ADH2.
Residues 668-865 of TAF130 that itself is capable of binding TADIV 
is located in an essential region (residues 367-1037) of TAF130. This 
conserved region is required for supporting cell viability (Bai et al 1997). 
TAF130 also displays HAT activity that may be related to the acetylation 
of nucleosomes (Mizzen et al. 1996). Acetylation is thought to confer 
remodeling of the nuclesomes and the resultant disassembled template is 
simutaneouly or subsequently used for transcription. Chromatin 
remodeling is a requirement for transcription activation but it alone can 
not lead to transcription activation. For instance. spt6 mutants affect 
the chromatin structure of SUC2 gene but do not affect its transcription 
(Bortvin et al 1996). Similarly, previous studies have shown that 
nuclesome remodeling is required but not sufficient for ADH2 gene 
expression and that the transcriptional activator ADR1 is required for the 
chromatin remodeling at the ADH2 (Verdone et al 1996). Therefore, if 
TAF130 is required for the chromatin remodeling at ADH2 gene upon
ADR1 binding to the UAS1, this effect may not be detected by assays
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designed for detecting transcriptional changes. The observation that the 
taf 130 mutations did not affect ADH2 expression can, therefore, be 
explained in four ways. Either these mutations were not specific or severe 
enough to affect ADR1 and ADH2 expression or that ta f1 30 inactivation 
may affect only the chromatin remodeling function and therefore have no 
observable effect on ADH2 expression. Alternatively. taf130 inactivation 
has no effect on ADH2 chromatin or activation and the observed binding 
is artifactual. Finally, it is possible that the TAF130-TADIV interaction is 
important but other redundant TAF-ADR1 interactions can compensate 
for defective TAF130-ADR1 interactions.
The region of TAF150 that ADR1 TADIV was shown to bind to, amino 
acids 774-1100, is located in a nonessential and non-conserved region of 
TAF150. However, other regions of this huge protein may interact with 
TADIV and/or other TADs of ADR1. Based on Northern and S1 nuclease 
protection data TAF150 might be specifically required by the cells to 
express ADH2 when glucose is depleted. TAF150 is known to affect the 
cell cycle. Upon glucose depletion, cells utilize the previously excreted 
ethanol as an energy and carbon source via oxidative respiration and 
gluconeogenesis. This diauxic shift also causes the cell to arrest in the
G1 phase of the cell cycle. Cross-talk between the cell cycle pathway and
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adaptation to metabolic changes may be occuring through TAF150  
interactions with specific proteins like ADR1 being important for this 
adaptation to glucose depletion.
TAF60 and TAF61 have been shown to participate in the transcriptional 
activation of many genes (Michel et al 1998, Natarajan et al 1998). It is 
not surprising that they are also required for the ADH2 gene.
Based on the physical interaction and S1 nuclease assay data, TADIV 
interactions with multiple TAF proteins can be explained in at least three 
ways. First, each individual TAF interacts with TADIV in response to the 
different upstream transduction signals and only one or two TAF proteins 
interact with TADIV at one time. Second, sequential interactions of 
individual TAF with TADIV could lead to coordinate transcriptional 
activation, starting with nucleosome remodeling and followed by 
promoter binding and mediation of activation. Third, different residues in 
TADIV might be required for the contact with each individual TAF protein. 
To investigate these possibilities, in vitro transcription assay and 
mutagenesis of the TADIV region will help to exam these hypotheses. 
Multiple Activation Domains Of ADR1 Participate In The Transcription 
Activation Of ADH2 Gene.
Though our study is mainly focused on TADIV interactions with TFIID
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components, TADII also interacts with TAF60, TAF61, TAF130, and 
possibly, TAF150. Some of these interactions may be redundant but 
these multiple interactions probably act synergistically. Redundant 
activation domains are beneficial for ceil survival. Mutations or 
inactivation of one activation domain will not significantly affect the 
transcription activity. ADR1 is presumed to interact with other GTFs as 
shown in the model (described in Figure 20). It has also been shown that 
TADI, II, IV interact with TFIIB and with SAGA components ADA2 and 
GCN5. Interactions of ADR1 with TFIID components might also involve 
TADI and other regions of ADR1 not yet characterized such as the 
inhibitory domain extending from residues 227 to 239. A number of 
mutations in this domain (ADR1C1 cause constitutive ADH2 expression on 
glucose without affecting ADR1 expression (Denis et al 1986).
Multiple Contacts Between The Transcription Activator And TFIID  Is
Typical.
Numerous previous studies have shown that one transcriptional
activator can interact with multiple mediators or coregulators. For 
instance, VP16 makes specific protein-protein contacts with TFIIB,TFIIH, 
TAF40, TAF32, TBP and the RNA polymerase holoenzyme (Nishikawa et al
1997). GAL4 protein interacts with TBP, TFIIB, ADA2, GAL11, SRB2,
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SRB10 and SRB11, and other mediator components (Melcher et al 1995, 
Chang et al 1997, Hirst et al 1999). Mutation in one of the non-essential 
mediator genes only partially compromises the activation of GAL4. 
Similarly, yeast GCN4 activator has two redundant activation domains. A 
single activation domain may act in several steps in the overall process of 
activation. GCN4 protein binds TAF19, TAF60, TAF90 and ADA2 and 
ADA3. In addition, it also interacts with SRB mediator components, 
SRB2, SRB4 and SRB7, independently of the TFIID and SAGA components 
(Drysdale et al 1998). All these activators have multiple activation 
domains and their redundancy may have an evolutionary benefit. In the 
case of TFIID contacts, multiple interactions between activator domains 
and TAFs can strongly increase the binding of TFIID to the promoter and 
coordinately activate transcription (Kuras et al 1998). Multiple 
contacts also contribute partially to promoter selectivity as well as the 
specificity of the DNA-binding domain of the activator. In addition, one 
activator may be required at a variety of genes so some of these 
interactions with a particular GTF may be required for some promoters 
while the other interactions at other promoters. Therefore different 
activators may require distinct sets of coactivators (Chen et al 1994).
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Meanwhile, one coactivator may be a target of several activators, 
creating additional synergistic actions (Sauer et al 1997).
Different And Common Features Of CCR4 And ADR1
CCR4 is required for cell wall integrity and has a leucine-rich repeat 
motif that is required for protein-protein interactions. In contrast, ADR1, 
which has a zinc-finger motif and binds DNA directly, is required for 
peroxisome genes and genes involved in fatty acid synthesis. As shown 
in Figure 20, these two proteins share several common features. First, 
both are required for full expression of the ADH2 gene. Second, their 
protein levels are both elevated significantly on ethanol compared with 
those on glucose medium. Third, ADR1 and SNF1 both are required for 
derepression of glucose while CCR4 suppress snfl and other components 
in the CCR4-NOT may mediate the interaction of CCR4 with SRB/SSN  
mediator, which also suppresses the phenotypes of snfl (refer to 
introduction, Chapterl). Fourth, both interact with TFIID  and SAGA 
directly or indirectly. NOT2 in the CCR4-NOT complex interacts with GCN5 
genetically and NOT1 associates with TBP/SPT15 biochemically (Kuras et 
al 1998, Badarinarayana et al 2000, Lee et al 1998). ADR1 physically 
interacts withs GCN5 (Chiang et al 1996) and also exhibited multiple
interactions with TFIID (Kormanitsky et al 1998, Bai in prep).
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Figure 20. Model of the CCR4-NOT complex and ADR1 in the 
transcriptional activation at ADH2 aene. This drawing represents one of 
the current model on activated transcription as well as the results of 
numerous studies on ADR1. Transcriptional activator (s) bind(s) 
upstream activating sequence and induce(s) or stabilize(s) an active 
preinitiation complex (PIC) through interacting with multiple components 
in the PIC.
91
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
References
Adam, W. Rapatz, W.Spevak, and H. Ruis (1991) The Saccharomyce 
cerevisiae ADR1 gene is a positive regulator of transcription of genes 
encoding peroxisomal proteins. Mol. Cell. Biol. 11:699-705
Allison L.A., M. Moyle, M. Shales, C. J. Ingles (1985) Extensive homology 
among the largest subunits of eukaryotic and prokaryotic RNA 
polymerases. Cell 42:599-610
Andrews B. and V. Measday (1998) The cyclin family of budding yeast: 
abundance use of a good idea. Trend in Genetics 14:66-69
Apone, L. M., C. M. Virbasius, J. C. Reese, and M. R. Green (1996) Yeast 
TAFII90 is required for cell-cycle progression through G2/M but not for 
general transcription activation. Genes Dev. 10:2368-2380
Apone, L. M., C. A. Virbasius, F.C.P. Holstege, J. Wang, R.A. Young, and M. 
R. Green (1998) Broad, but not universal, transcriptional requirement for 
yTAFII17, a histone H3-like TAFII present in TFIID and SAGA. Mol Cell 
2:653-661
Badarinarayana, V., Chiang Y-C, and C. L. Denis (2000) Functional 
interaction of CCR4-NOT proteins with TBP and its associated 
factors . Genetics submitted.
Bai, Y., G.M. Perez, J.M. Beechem, and P. A. Weil (1997) Structure- 
function analysis of TAF130: Identification and characterization of a a 
high-affinity TATA-binding protein interaction domain in the N-terminus 
of yeast TAFII130 Mol. Cell. Biol. 17: 3081-3093
Bai,Y., C. Savardore, Y-C Chiang, M. A. Collart, H. Liu, and C. L. Dennis 
(1999) The CCR4 and CAF1 proteins of the CCR4-NOT complex are 
physically and functionally separated from NOT2, NOT4 and NOT5. Mol. 
Cell. Biol. 19:6642-51
92
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Balciunas, D, and H. Ronne (1995) Three subunits of the RNA polymerase 
II mediator complexes are involved in glucose repression. Nucleic Acid 
Res. 23: 4421-4425
Bangur, C.S., T. S. Pardee and A. S. Ponticeli (1997) Mutational analysis 
of the D1/E1 core helices and the conserved N-terminal region of yeast 
transcription factor IIB (TFIIB): Identification of an N-terminal mutant that 
stabilizes TATA-binding protein-TFIIB-DNA complexes. Mol. Cell. Biol. 17: 
6 7 8 4 -6 7 9 3
de Barros, M. Lopes, J. Y. Ho, and S. I. Reed (1990) Mutations in cell 
division cycle genes CDC36 and CDC39 activate the Saccharomyces 
cerevisiae mating pheromone response pathway. Mol. Cell. Biol. 10:2966- 
2 9 7 2
Bemis, L.T. and C. L. Denis (1988) Identification of functional regions in 
the yeast transcriptional activator ADR1. Mol. Cell. Biol. 8: 2125-2131
Bemis, L.T. and C. L. Denis (1989) Characterization of the adr1-1 
nonsense mutation identifies the translational start of the yeast 
transcriptional activator ADR1 Yeast 5:291-298
Benson, J. D., M. Benson, P. M. Howley and K. Struhl (1998) Association 
of distinct yeast Not2 funtional domains with components of Gcn5 
histone acetylase and Ccr4 transcriptional regulatory complexes. EMBO J. 
1 7 :6 7 14 -6 7 2 2
Berk A. J. (1995) Biochemistry meets genetics in the holoenzyme. Proc. 
Natl. Acad. Sci. U.S.A. 92: 11952-11954
Blumberg, H., A. Eisen, A. Sledziewski, D. Bader and E. T. Young (1987) 
Two zinc fingers of a yeast regulatory protein shown by genetic evidence 
to be essential for its function Nature 328: 443-445
Bortvin, A., and F. Winston (1996) Evidence that Spt6p controls 
chromatin structure by a direct interaction with histones. Science 
2 7 2 :1 4 7 3 -1 4 7 6
93
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Bot, N. U. Oberholzer, Y. K. Hong, E. O. Shuster, and M. A. Collart 
Characterization of NOT 1 protein mutants defines functionally separable 
N- and C- terminal domains, (in progress)
Burley, S. K, and R. G. Roeder (1998) TATA box mimicry by TFIID: 
antoinhibition of polymerase II transcription Cell 94: 551-3
Burns, L.G., and C.L. Peterson (1997) The yeast SWI-SNF complex 
facilitates binding of a transcriptional activator to nucleosomal sites in 
vivo. Mol Cell Biol 17:4811-9
Cairns B.R., Y.J.Kim, M. H. Sayre, B.C. Laurent , R.D.Kornberg . (1994) A 
multisubunit complex containing the SW I1/ADR6, SW I2/SNF2, SWI3, 
SNF5, and SNF6 gene products isolated from yeast. Proc Natl Acad Sci U 
S A. 91:1950-4.
Celenza, J. L., and M. Carlson (1989) Mutational analysis of the 
Saccharomyces cerevisiae SNF1 protein kinase and evidence for functional 
interaction with the SNF4 protein. Mol. Cell. Biol. 9:5034-5044
Celenza, J. L., F. J. Eng, and M. Carlson (1989) Molecular analysis of the 
SNF4 gene of Saccharomyces cerevisiae: evidence for physical association 
of the SNF4 protein with the SNF1 protein kinase. Mol. Cell. Biol. 9:5045- 
50 5 4
Chang, M. and J. A. Jaehing (1997) A multiplicity of mediators alternative 
forms of transcription complexes communicate with transcriptional 
regulators. Nucleic Acid Res. 25: 4861-4865
Chang, M., D. French-Cornay, H-Y. Fan, H. Klein, C. L. Denis and J. A. 
Jaehning (1999) A complex containing RNA polymerase II, Paflp, Cdc73p, 
Hprlp and Ccr4p plays a role in protein kinase C signaling. Mol. Cell. Biol. 
19 :1056 -1067
Chao, D. M. , E. L. Gadbois, P. J. Murray, S. F. Anderson, M. S. Sonu, J. D. 
Parrin, and R. A. Young (1996) A mammalian SRB protein associated with 
an RNA polymerase II holoenzyme Nature 380:82-85
94
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chen, J-L., L. D. Attardi, C.P. Verrijzer, K. Yokomori, and R. Tjian (1994) 
Assembly of recombinant TFIID  reveals differential coactivator 
requirements for distinct transcriptional activators Cell 79:93-105
Cheng, C., N. Kacherovsky, K. M. Dombek, S. Camier, S. K. Thukral, E. 
Rhim, and E.T. Young (1994) Identification of potential target genes for 
Adrlp through characterization of essential nucleotides in UAS1. Mol. 
Cell. Biol. 14:3842-3852
Cherry, J.R., T.R. Johnson, C. Dollard, J-R. Shuster, and C. L. Denis (1989) 
Cyclin AMP-dependent protein kinase phosphorylates and inactivates the 
yeast transcriptional activator ADR1. Cell 56:409-419
Cherry, J.R., and C. L. Denis (1989) Overexpression of the yeast 
transcriptional activator ADR1 induces mutation of the mitochondrial 
genome. Curr. Genet. 15:311-317
Chiang, Y-C., P. Komarnistsky, D. Chase, and C. L. Denis (1996) ADR1 
activation domains contact the histone acetyltransferase GCN5 and the 
core transcriptional factor TFIIB. J. Biol. Chem. 271:32359-32365
Chicca, J.J., D.T. Auble, and B. F. Pugh (1998) Cloning and biochemical 
characterization of TAF-172, a human homolog of yeast Mot1. Mol. Cell. 
Biol. 18:1701-1710
Ciriacy M. (1977) Isolation and characterization of yeast mutants 
defective in intermedediary carbon metabolism and in carbon catabolite 
repression. Mol. Gen. Genet. 154:213-220
Clark-Adams, C. D. and F. Winston (1987) The SPT6 gene is essential for 
growth and is required for 5-mediated transcription in Saccharomyces 
cerevisiae. Mol. Cell. Biol. 7:679-686
Colgan, J. , and J. L. Manley (1992) TFIID can be rate-limiting in vivo for 
TATA-containing, but not TATA-lacking RNA polymerase II promoters. 
Genes Dev. 6:304-315
95
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Collart, M. A. and K. Struhl (1993) CDC39, an esential nuclear protein 
that negatively regulates transcription and differentially affects the 
constitutive and inducible his3 promoters. EMBO J. 12:177-186
Collart, M. A. and K. Struhl (1994) NOT1(CDC39),NOT2(CDC36), NOT3 
and NOT4 encode a global-negative regulator of trnascription that 
differentially affects TATA-element utilization. Genes Dev. 8:525-537
Collart, M.A. (1996) The NOT, SPT3, and MOT1 genes functionally 
interact to regulate transcription at core promoters. Mol. Cell Biol. 
1 6 :6 6 6 8 -6 6 7 6
Cook, W.J., D. Chase, D.C. Audino, and C.L. Denis (1994a) Dissection of 
the ADR1 protein reveals multiple, functionally redundant activation 
domains interspersed with inhibitory regions: evidence for a repressor 
binding to the ADR1C region. Mol. Cell. Biol. 14:629-640
Cook, W.J., S.P. Mosley, D.C. Audino, D. L. Mullaney, a. Rovelli, G. Stewart, 
and C. L. Denis (1994b) Mutations in the zinc-finger region of the yeast 
regulatory protein ADR1 affect, both DNA binding and transcriptional 
activation. J. Biol. Chem. 269:9374-9379
Cormack, B.P., and K, Struhl (1992) The TATA-binding protein is required 
for transcription by all three nuclear RNA polymerases in yeast cells. Cell 
6 9 :6 8 5 -6 9 6
Damania, B.f and J.C. Alwine (1996) TAF-like function of SV40 large T  
antigen. Genes & Dev. 10:1369-1381
Denis, C.L. and E.T. Young (1983) Isolation and characterization of the 
positive regulatory gene ADR1 from Saccharomyce cerevisiae. Mol. Cell. 
Biol. 3:360-370
Denis, C.L., and C. Gallo (1986) Constitutive RNA synthesis for the yeast 
activator ADR1 and identification of the ADR1-5C mutation: implications in 
posttranscriptionai control of ADR1. Mol. Cell. Biol. 6:4026-4030
Denis, C. L., J. Ferguson, and E. T. Young (1983) mRNA levels for the 
fermentative alcohol dehydrogenase of Saccharomyces cerevisiae
96
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
decrease upon growth on a nonfermentable carbon source J. Biol. Chem. 
258:1165-71
Denis, C. L. (1984) Identification of new genes involved in the regulation 
of yeast alcohol dehydrogenase II. Genetics 108: 833-844
Denis C. L., J. Ferguson, E. T. Young(1983) mRNA levels for the 
fermentative alcohol dehydrogenase of Saccharomyces cerevisiae 
decrease upon growth on a nonfermentatable carbon source. J. Biol. 
Chem. 258:1163-1171
Denis, C.L. and T. Malvar (1990) The CCR4 gene from Saccharomyces 
cerevisiae is required for both nonfermentative and spt-mediated gene 
expression. Genetics 124:283-291
Denis, C. L., M. P. Draper, H. Y. Liu, T. Malvar, R. C. Vallari, and W. J. Cook 
(1994) The yeast CCR4 protein is neither regulated by nor associated 
with the SPT6 and SPT10 proteins and forms a functionally distinct 
complex from that of the SNF/SWI transcription factors. Genetics 138: 
10 05 -10 13
Derrick, S. and P. J. Large (1993) Activities of the enzymes of the Ehrlich 
pathway and formation of branched-chain alcohols in Saccharomyces 
cerevisiae and Candida utilis grown in continuous culture on valine or 
ammonium as sole nitrogen source. J. Gen. Microbiol 139:2783-2792
Dombek.K.M., S. Camier, and E. T. Young (1993) ADH2 expression is 
repressed by REG1 independently of mutations that alter the 
phosphorylation of the yeast transcription factor ADR1. Mol. Cell. Biol. 
13 :4391 -4399
Donoviel, M. S. and E. T. Young (1996) Isolation and identification of 
genes activating UAS2-dependent ADH2 expression in Saccharomyces 
cerevisiae. Genetics 143:1137-1148
Donoviel, M .S., N. Kacherovsky, and E. T. Young (1995) Synergistic 
activation of ADH2 expression is sensitive to upstream activation 
sequence 2 (UAS2) orientation, copy number, and UAS2-UAS1 helical 
phasing. Mol. Cell. Biol. 15: 3442-3449
97
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Donoviel, M.S. and E. T. Young (1996) Isolation and identification of 
genes activating UAS2-dependent ADH2 expression in Saccharomyces 
cerevisae. Genetics 143:1137-1148
Draper,M.P. H. Y. Liu, A. H. Nelsbach, S. P. Mosley, and C. L. Denis (1994) 
CCR4p is a glucose-regulated transcription factor whose leucine-rich 
repeat binds several proteins important for placing CCR4 in its proper 
promoter context. Mol.Cell Biol. 14:4522-4531
Draper, M. P., C. Saivadore, and C. L. Denis (1995) Identification of a 
mouse protein whose homolog in Saccharomyces cerevisiae is a 
component of the CCR4 transcriptional regulatory complex. Mol. Cell Biol. 
15: 3487-3495
Drysdale, C. M., B. M. Jackson, R. Mcreigh, E.R. Klebanow, Y. Bai, T. 
Kokubo, M. Swanson, Y. Nakatani, P.A. Weil and A. G. Hinnebusch (1998) 
The Gcn4p activation domain interacts specifically in vitro with RNA 
polymerase II holoenzyme, TFIID, and the Adap-Gcn5p coactivator 
complex. Mol. Cell. Biol. 18:1711-1724
Eisenmann, D. M., K.M. Arndt, S.L. Ricupero, J. W. Rooney, and F. Winston 
(1992) SPT3 interacts with TFIID  to allow normal transcription in 
Saccharomyce cerevisiae. Genes Dev. 6:1319-1331
Filipits, M., M.M. Simon, W. Rapatz, B. Hamilton, and H. Ruis (1993) A 
Saccharomyce cerevisiae upstream activating sequence mediates 
induction of peroxisome proliferation by fatty acids. Gene 132:49-57
Flanagan P.M., R. J.3d Kelleher, M. H. Sayre, H. Tschochner, R. D. Kornberg 
(1991) A mediator required for activation of RNA polymerase II 
transcription in vitro. Nature 350:436-438
Frangion, J.V. and B. G. Neel (1993) Solubilization and purification of 
enzymatically actively glutathione S-transferase (pGEX) fusion proteins. 
Analytical Biochem. 210:179-187
Gonzalez-Couto, E., N. Klages, and M. Strubin (1997) Synergistic and 
promoter-selective activation of transcription by recruitment of
98
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
transcription factors TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 94:8036- 
8041
Grunstein M. (1997) Histone acetylation in chromatin structure and 
transcription. Nature 389:349-352
Grant, P.A., D. Schieltz, M.G. Pray-Grant, D.J. Steger, J.C. Reese, J.R. Yates 
III, and J. L. Workman (1998) A subset of TAFIIs are integral components 
of the SAGA complex required for nuclesome acetylation and transcription 
stimulation. Cell 94:45-53
Ha I, Roberts S, Maldonado E, Sun X, Kim LU, Green M, Reinberg D. (1993) 
Multiple functional domains of human transcription factor IIB: distinct 
interactions with two general transcription factors and RNA polymerase II. 
Genes Dev. 7:1021-32.
Hahn, S., S. Buratowski, P. A. Sharp and L. Guarente (1989) Identification 
of a yeast protein homologous in function to the mammalian general 
transcription factor, TFIIA. EMBO J. 8:3379-3382
Ham, J., G. Steger, and M. Yaniv (1994) Cooperativity in vivo between the 
E2 transactivator and the TATA box binding protein depends on core 
promoter structure. EMBO J. 13:147-157
Hansen, S.K, and R. Tjian (1995) TAFs and TFIIA mediate differential 
utilization of the tandem Adh promoters. Cell 82:565-575
Hardie D. G. (1994) Introduction: protein kinases— cellular switching 
mechanisms Semi. Cell Biol. 5:365-366
Hardie, D. G. D. Carling and N. Halford (1994) Roles of the 
Snf1/Rkin1/AMP-activated protein kinase family in the response to 
environmental and nutritional stess. Semi, in Cell Biol. 5:409-416
Hata.H., H. Mitsui, H. Liu, Y. Bai, C. L. Denis, Y. Shimizu, and A. Sakai
(1998) Dhh1p,a putative RNA helicase, associates with the general 
transcription factors Pop2p and Ccr4p from Saccaromyces cerevisiae. 
Genetics 148: 571-579
99
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Hengartner, C.J., V.E. Meyer, S.M. Liao, C.J. Wilson, S.S. Koh, and R. A. 
Young (1998) Temporal regulation of RNA polymerase II bySrblO and 
Kin28 cyclin-dependent kinase. Mol Cell 2:43-53
Henry, N.L., A. M. Campbell, W. J. Feaver, D. Poon, P. A. Weil and R. D. 
Komberg (1994) TFIIF-TAF-RNA polymerase II connection. Genes Dev. 
8:2 86 8 -2 87 8
Hirose, Y., and J. L. Manley (1998) RNA polymease II is an essential mRNA 
polyadenylation factor. Nature 395:93-96
Hirst, M., M. S. Kobor, N. Kuriakose, J. Greenblatt, and I. Sadowski
(1999)GAL4 is regulated by the RNA polymerase II holoenzyme- 
associated cyclin-dependent protein kinase SRB10/CDK8. Mol. Cell 
3:673 -678
Hofmann K. and P. Bucher (1996) The UBA domain: a sequence motif 
present in multiple enzyme classes of the ubiquitination pathway. Trends 
Biochem. Sci. 21: 172-173
Holstege, F. G., U. Fiedler and H. Th. M. Timmers (1997) Three transitions 
in the RNA polymerase II transcription complex during initiation. EMBO J. 
16 :7468 -74 80
Hope, I. A., and K. Struhl (1986) Functional dissection of a eukaryotic 
transcriptional activator protein, GCN4 of yeast. Cell 46:885-894.
Hinnebusch, A. G. (1994) The elF-2a kinases: regulators of protein 
synthesis in starvation and stress. Semi, in Cell Biol. 5:417-426
Hunter T. and G. D. Plowman (1997) The protein kinases of budding 
yeast: six score and more. Trends Biochem. Sci. 22 :18 -22
Holstege, F.C.P., E.G. Jannings, J.J. Wyrick, T. I. Lee, C. J. Hengartner, M. 
R. Green, T. R. Golub, E.S. Lander and R. A. Young (1998) Disseting the 
regulatory circuitry of a eukaryotic genome. Cell 95:717-728
100
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Horikoshi, M. T. Yamamoto, Y. Ohkuma, P.A. Weil and R. G. Roeder (1990) 
Analysis of structure-function relationships of yeast TATA box binding 
factor TFIID. Cell 61:1171-1178
Hyre, D. E. and R. E.KIevit (1998) A disorder-to-order transition coupled 
to DNA binding in the essential zinc-finger DNA-binding domain of yeast 
ADR1. J. Mol. Biol. 279:929-943
Imhof, A. and A. P. Wolffe (1998) Transcription: Gene control by targeted 
histone acetylation. Current Biology 8:R422-424
Iyer, V. and K. Struhl (1995) Mechanism of differential utilization of the 
HIS3 TR and Tc TATA elements. Mol. Cell. Biol. 15:7059-7066
Jackson-Fisher, A. J., C. Chitikila, M. Mitro, and B. F. Pugh (1999) A role 
for TBP dimerization in preventing unregulated gene expression. Mol. Cell 
3 :7 17 -72 7
Jiang, R. and M. Carlson (1997) The Snfl protein kinase and its activating 
subunit, Snf4, interact with distinct domains of the Sip1/Sip2/Gal83 
component in the kinase complex. Mol. Cell. Biol. 17:2099-2106
Johnston, L. H., S. L. Eberly, J. W. Chapman, H. Araki and A. Sugino 
(1990) The product of the Saccharomyces cerevisiae cell cycle gene 
DBF2 has homology with protein kinases and is periodically expressed in 
the cell cycle. Mol. Cell. Biol. 10:1358-1366
Kamakaka P. T. (1997) Silencers and locus control regions:opposite sides 
of the same coin. Trends Biochem. Sci. 22:104-107
Kang, J.J., D.T. Auble, J. A. Ranish, and S. Hahn (1995) Analysis of the 
yeast transcription factor TFIIA: distinct functional regions and a 
polymerase ll-specific role in basal and activated transcription. Mol. Cell. 
Biol. 15:1234-1243
Keener, J., J.A. Dodd, D. Lalo, and M. Nomura (1997) Histones H3 and 
H4 are components of upstream activator factor required for the high- 
level transcription of yeast rDNA by RNA polymerase I. Proc. Natl. Acad. 
Sci. USA 94:13458-13462
101
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Kelleher RJ 3d, P. M. Flanagan, and R. D. Kornberg (1990) A novel 
mediator between activator proteins and the RNA polymerase II 
transcription apparatus. Cell 61:1209-1215
Kim, Y-J., S. Bjorklund, Y. Li, M. H. Sayre, and R. D. Kornberg (1994) A 
multiprotein mediator of transcriptional activation and its interaction 
with the C-terminal repeat domain of RNA polymerase II. Cell 77:599- 
608
Kim, T. K., T. lagrange, Y.H. Wang, J.D. Griffith, D. Reinberg, and R. H. 
Ebright (1997) Trajectory of DNA in the RNA polymerase II transcription 
preinitiation complex. Proc. Natl. Acad. Sci. USA 94: 12268-12273
Klebanow, E. R. , D. Poon, S. Zhou and P. A. Weil (1997) Cloning and 
characterization of an essential Saccharomyce cerevisiae gene, TAF40, 
which encodes yTAFII40, an RNA polymerase ll-specific TATA-binding 
protein-associated factor. J. Biol. Chem. 272:9436-9342
Kobayashi, N., T. Boyer, and A. J. Berk (1995) A class of activation 
domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter 
complex assembly. Mol. Cell. Biol. 15:6465-6473
Kokubo, T., S. Yamashita, M. Horikoshi, R. G. Roeder, and Y. Nakatani 
(1994) Interaction between the N-terminal domain of the 230-kda 
subunit and the TATA box-binding subunit of TFIID negatively regulates 
TATA-box binding. Proc. Natl. Acad. Sci. USA 91:3520-3524
Kokubo, T. , M.J. Swanson, J. I. Nishikkawa, A. G. Hinnebusch, and Y. 
Nakatani (1998) The yeast TAF145 inhibitory domain and TFIIA  
competitively bind to TATA-binding protein. Mol. Cell. Biol. 18:1003- 
1012
Komarnistsky, S. I., Y-C Chiang, F. C. Luca, J. Chen, J. H. Toyn, M. Winey, 
L. H. Jonhston, and C. L. Denis (1998) DBF2 protein kinase binds to and 
acts through the cell-cycle-regulated MOB1 protein. Mol. Cell. Biol. 
18 :2100 -21 07
102
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Komarnistsky, P., ER. Klebanow, P. A. Weil, and C. L. Denis (1998) ADR1- 
mediated transcriptional activation requires the presence of an intact 
TFIID complex. Mol Cell. Biol. 18: 5861-5867
Kornberg, R.D. (1996) RNA polymerase II transcription control. Trends 
Biochem. Sci. 21: 325-327
Kotani. T., t. Miyake, Y. Tsukihashi, A. G. Hinnebusch, Y. Natatani, M. 
Kawaichi and T. Kokubo (1998) Identification of highly conserved amino- 
terminal segments of dTAFII230 and yTAFII145 that are functionally 
interchangeable for inhibitory TBP-DNA interactions in vitro and in 
promoting yeast cell growth in vivo. J. Biol. Chem. 273: 32254-32264
Kratzer, S., H. J. Schuller (1997) Transcriptional control of the yeast 
acetyl-CoA synthetase gene, ACS1, by the positive regulators CAT8 and 
ADR1 and the pleiotropic repressor UME6. Mol. Microbiol. 26: 631-641
Kuchin,S. and M. Carlson (1998) Functional relationships of Srb10-Srb11 
kinase carboxy-terminal domain kinase CTDK-1, and transcriptional 
corepressor Ssn6-Tup1. Mol. Cell Biol. 18:1163-1171
Kuchin,S., P. Veghiayan, and M. Calson (1995) Cyclin-dependent protein 
kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional 
control in yeast. Proc. Natl. Acad. Sci. USA 92:4006-4010
Kuo M.H., J.E. Brownell, R.E. Sobel, T.A. Ranalli, R.G. Cook, D.G. 
Edmondson, S. Y.Roth, , and C. D. Allis (1996) Transcription-linked 
acetylation by Gcn5p of histones H3 and H4 at specific lysines. 
Nature. 19;383:269-72.
Kuo, M-H, J. Zhou, P. Jambeck, M. E. A. Churchill, and C. D. Allis (1998) 
Histone acetly transferase activity of yeast Gcn5p is required for the 
activation of target genes in vivo . Genes Dev. 12:627-639
Kuras, L. and K, Struhl (1998) Binding of TBP to promoters in vivo is 
stimulated by activators and requires polymerase II holoenzyme. Nature 
399:6 09 -61 3
103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Lagrange, T., A.N. Kapanidis, H. Tang, D. Reinberg and R. H. Ebright
(1998) New core promoter element in RNA polymerase ll-dependent 
transcription: sequence-specific DNA binding by transcription factor MB. 
Genes Dev. 12:34-44
Lee, D.K., K.C. Wang, and R. G. Roeder (1997) Functional significance of 
the TATA element major groove in transcription initiation by RNA 
polymerase II. Nucleic Acids Res. 25:4338-4345
Lee D.Y.,J.J. Hayes, D.Pruss, A. P.Wolffe (1993)A positive role for histone 
acetylation in transcription factor access to nucleosomal DNA. Cell. 
15;72:73-84.
Lee, T.I., and R. A. Young (1998) Regulation of gene expression by TBP- 
associated proteins. Genes Dev. 12:1398-1408
Lee, T. I. , J. J. Wyrick, S. S. Koh, E. G. Jennings, E. L. Gadbois, and R. A. 
Young (1998) Interplay of positive and negative regulators in 
transcription initiation by RNA polymerase II holoenzyme. Mol. Cell. Biol. 
18 :4455 -4462
Lesage, P., S. Yang, M. Carlson (1996) Yeast SNF1 protein kinase 
interacts with SIP4, a C6 zinc cluster transcriptional activator: a new role 
for SNF1 in the glucose response. Mol. Cell. Biol. 16:1921-1928
Li, Y., S. Bjorklund, Y. W. Jiang, Y. J. Kim, W. S. Lane, D. J. Stillman and R. 
D. Kornberg (1995) Yeast global transcriptional regulators Sin4 and Rgl 
are components of mediator complex-RNA polymerase II holoenzyme. 
Proc. Natl. Acad. Sci 92:10864-10868
Li, X-Y., A. Virbasius, X. Zhu, and M. R. Green (1999) Enhancement of 
TBP binding by activators and general transcription factors. Nature 
399:605 -609
Lieberman, P. M., J. Ozer, and D. B. Gursel (1997) Requirement for 
transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends 
on promoter structure and template competition. Mol. Cell. Biol. 
17 :6624 -6632
104
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Lin, Y-S., and M. R. Green (1991) Mechanism of action of an acidic 
transcription activation in vitro. Cell 64:971-981
Lithgow, T., J. M. Cuezva and P. A. Silver (1997) Highways for protein 
delivery to the mitochondria. Trends Biochem. Sci. 22:40-44
Liu, H.Y, Y. Chiang, J. Pan, C. Salvadore, J. Chen, and C. L. Denis The 
CCR4-NOT complex and its associated factors contact the SRB9, -10.and 
-11 components of the RNA polymerase II holoenzyme. in prep
Liu,H., V. Badarinarayana, D. Audino, J. Rappsilber, M. Mann, and C. L. 
Denis (1998) The NOT proteins are part of the CCR4 transcriptional 
complex and affect gene expression both positively and negatively. EMBO 
J. 17:1096-1106
Liu, D., R. Ishima, K. I. Tong, S. Bagby, T. Kokubo, D. R. Muhandiram, L. E. 
Kay, Y. Nakatani, and M. Ikura (1998) Solution structure of a TBP- 
TAFII230 complex: protein mimicry of the minor groove surface of the 
TATA box unwound by TBP. Cell 94:573-583
Lopes,M.B., J. R. Ho, and S. I. Reed, (1990) Mutations in cell division 
cycle genes CDC36 and CDC39 activated the Saccharomyces cerevisiae 
mating pheromone response pathway. Mol. Cell Biol. 102:2966-2972
Madison, J.M., and F. Winston (1997) Evidence that Spt3 functionally 
interacts with Mot1, TFIIA and TATA-binding protein to confer promoter- 
specific transcriptional control in Saccaromyce cerevisiae. Mol. Cell. Biol. 
17: 287-295
Mahadevan, S., and K. Struhl (1990) Tc, an unusual promoter element 
required for constitutive transcription of the yeast HIS3 gene. Mol. Cell 
Biol. 10:4447-4455
Maldonado, E., R. Shiekhattar, M. Sheldon, H. Cho, R. Drapkin, R. Rickert, E. 
Lees, C. W. Anderson, S. Linn, and D. Reinberg (1996) A human RNA 
polymerase II complex associated with SRB and DNA-repair proteins. 
Nature 381:86-89
105
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Malik, S., M. Guermah, and R. G. Roeder (1998) A dynamic model for PC4  
coactivator function in RNA polymerase II transcription. Proc. Natl. Acad. 
Sci. USA 95: 2192-2197
Malvar, T., R. W. Biron, D. B. Kaback, and C. L. Denis (1992) The C C R 4  
protein from Saccharomyces cerevisiae contains a leucine-rich repeat 
region which is required for its control of ADH2 gene expression. 
Genetics 132:951-962
Martinez E., C.M. Chiang, H. Ge, and R.G. Roeder (1994) TATA-binding 
protein-associated factor(s) in TFIID  function through the initiator to 
direct basal transcription from a TATA-less class II promoter. EMBO J. 
13:3115-26
Manley, J. L., M. Um, C. Li, and a. Ashali (1996) Mechanisms of 
transcriptional activation and repression can both involve TFIID. Philos. 
Trans. R. Soc. Lond. B. Biol. Sci 351: 517-526
McCracken S, N. Fong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S. 
D. Patterson, M. Wickens, and D. L. Bentley (1997)The C-terminal domain 
of RNA polymerase II couples mRNA processing to transcription. Nature 
385:357-61 .
Melcher, K. and S. A. Johnston (1995) GAL4 interacts with TATA-binding 
protein and coactivators Mol. Cell. Biol. 15:2839-2848
Michel, B. , P. Komarnitsky, and S. Buratowski (1998) Histone-like TAFs  
are essential for transcription in vivo. Mol. Cell 2:663-673
Mitchelhill, K. I., D. Stapleton, G. Gao, C. House, B. Michell, F. Katsis, L.A. 
Witters, and B. E. Kemp (1994) Mammalian AMP-activated protein kinase 
shares structural and functional homology with the catalytic domain of 
yeast Snfl protein kinase. J. Biol. Chem. 269: 2361-2364
Mizzen, C. A., X-J. Yang, T. Kokubo, J.E. Brounell, A. J. Bannister, T. Owen- 
Hughes, J. Workman, L. Wang, S.L. Berger, T. Kouzarides, Y. Nakatani, and 
C.D. Allis (1996) The TA FII250 subunit of TFIID has histone 
acetyltransferase activity. Cell 87:1261-1270
106
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Moqtaderi. Z., J.D . Yale, K. Struhl and S. Buratowski (1996) Yeast 
homologues of higher eukaryotic TFIID subuints. Proc. Natl. Acad, Sci. 
USA 93:14654-14658
Moqtaderi, Z., Y. Bai, D. Poon, P.A. Weil and K. Struhl (1996) TBP- 
associated factors are not generally required for transcriptional activation 
in yeast. Nature 383: 188-191
Mosch, H.U., R. Graf, and G. H. Braus (1992) Sequence-specific initiator 
elements focus initiation of transcription to distinct sites in the yeast 
TRP4 promoter. EMBO J. 11:4583-4590
Mosch, H. U., and G. R. Fink (1997) Dissection of filamentous growth by 
transposon mutagenesis in Saccharomyces cerevisiae. Genetics 145:671- 
684
Myers, L. C. , C. M. Gustafsson, D. A. Bushnell, M. Lui, H. Erdjument- 
bromage, P. Tempst, and R. D. Kornberg (1997) The Med proteins of 
yeast and their function through the RNA polymerase II carboxy-terminal 
domain. Genes & Devel. 12:45-54
Natarajan, K,, B. M. Jackson, E. Rhee, and A. G. Hinnebusch (1998) 
yTAFII61 has a general role in RNA polymerase II transcription and is 
required by GCN4p to recruit the SAGA coactivator complex. Mol. Cell 
2:6 83 -692
Natarajan,K., B. M. Jackson, H. Zhou, F. Winston, and A. G. Hinnebusch
(1999) Transcriptional activation by Gcn4p involves independent 
interactions with the SWI/SNF complex and the SRB/Mediator. Mol. Cell 
4:6 57 -664
Navarro, B. and J. C. Igual (1994) ADR1 and SNF1 mediate different 
mechanisms in transcriptional regulation of yeast POT1 gene. Biophys. 
Res. Commun. 202:960-967
Neely, K.E., A. H. Hassan, A.E. Wallberg, D.J. Steger, B.R. Cairns, A.P.H. 
Wright, and J.L. Workman (1999) Activation domain-mediated targeting 
of the SW I/SNF complex to promoters stimulates transcription from 
nuclesome arrays. Mol. Cell 4:649-655
107
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Neigeborn, L., J. L. Celenza and M. Carlson (1987) SSN2Q is an essential 
gene with mutant alleles that suppress defects in SUC2 transcription in 
Saccharomyces cerevisiae. Mol. Cell. Biol. 7:672-678
Neuwald, A. F. and D. Landsman (1997) GCN5-related histone N- 
acetyltransferases belong to a diverse superfamily that includes the yeast 
SPT10 protein. Trends Biochem. Sci. 22:154-155
Nishikawa, J-l, T. Kokubo, M. Horikoshi, R. G. Roeder, and Y. Nakatani 
(1997) Drosophila TAFII230 and the transcriptional activator VP16 bind 
competitively to the TATA box-binding domain of the TATA box-binding 
protein. Proc. Natl. Acad. Sci. USA 94:85-90
Norbeck,J., and A. Blomberg (1997) A two-dimensional electrophoretic 
separation of yeast proteins usinga non-linear wide range (pH3-10) 
immobilized pH gradient in the first dimension: reproducibility and 
evidence for isoelectric focusing of alkaline(pl>7) proteins. Yeast 
1 3 :1 5 1 9 -1 5 3 4
Oettinger, M. A. and K. Struhl (1985) Suppressors of Saccharomyces 
cerevisiae HIS3 promoter mutations lacking the upstream element. Mol 
Cell Biol. 5:1901-9
Ogryzko, V. V., T. Kotani, X. Zhang, R. L. Schiltz, T. Howard, X-J. Young, B. 
H. Howard, J. Qin, and Y. Nakatani (1998) Histone-like TAFs within the 
PCAF histone acetylase complex. Cell 94: 35-44
O ’Neil, E. M. and E. K. O’Shea (1995) Cyclins in initiation Nature 374: 
1 2 1 -1 2 3
Ozer, J., K. Mitsouras, D. Zerby, M. Carey, and P. M. Lieberman (1998) 
Transcription factor IIA derepresses TATA-binding protein (TBP)- 
associated factor inhibition of TBP-DNA binding. J. Biol. Chem. 
2 7 3 :1 4 2 9 3 -1 4 3 0 0
Pardee, T.S., C. S. Bangur, and A. S. Ponticelli (1997) The N-terminal 
region of yeast TFIIB contains two adjacent functional domains invovled in
108
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
stable RNA polymerase II binding and transcription start site selection. J. 
Biol. Chem. 273: 17859-17864
Pazin, M. J. and J. T. Kadonaga (1997) SWI2/SNF2 and related proteins 
ATP-driven motors that disrupt protein-DNA interactions? Cell 88: 737- 
7 4 0
Peterson, C. L. and I. Herskowitz (1992) Characterization of the yeast 
SWI1, SWI2, and SWI3 genes, which encode a global activator of 
transcription. Cell 68: 573-581
Pinto, I. , D. E. Wane, and M. Hampsey (1992) The yeast SUA7 gene 
encodes a homolog of human transcription factor TFIIB and is required for 
normal start site selection in vivo. Cell 61:1187-1197
Pinto I, D.E.Ware, and M. Hampsey (1992) The yeast SUA7 gene 
encodes a homolog of human transcription factor TFIIB and is required for 
normal start site selection in vivo. Cell. 68:977-988
Planta, R.J. (1997) Regulation of ribosome synthesis in yeast. Yeast 13: 
1 5 0 5 -15 1 8
Ponticell, A. S. and K. Struhl (1990) Analysis of yeast HIS3 transcription 
in vitro: biochemical support for multiple mechanisms of transcription. 
Mol. Cell. Biol. 10:2832-2839
Poon, D. , Y. Bai, A. M. Campbell, S. Bjorklund, Y-J. Kim, S. Zhou, R. D. 
Kornberg, and P. A. Weil (1995) Identification and characterization of a 
TFIID-like multiprotein complex from Saccharomyce cerevisiae. Proc. Natl. 
Acad. Sci. USA 92:8224-8228
Poon, D., S. Schroeder, C. K. Wang, T. Yamamoto, M. Horikoshi, R.G. 
Roeder and P. A. Weil (1991) The conserved carboxy-terminal doamin of 
Saccharomyce cerevisiae TFIID is sufficient to support normall cell 
growth. Mol. Cell. Biol 11:4809-4821
Ranish, J.A., N. Yudkovsky, S. Hahn (1999) Intermediates in formation 
and activity of the RNA polymerase II preinitiation complex: holoenzyme
109
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
recruitment and a postrecruitment role for the TATA box and TFIIB. 
Genes Dev. 13:49-63
Reese, J.C., L. Apone, S. S. Walker, L.A. Griffin and M. R. Green (1994) 
Yeast TA FIIS  in a multisubunit complex required for activated 
transcription. Nature 371:523-528
Roberts, S. M. and F. Winston (1997) Essential functional interactions of 
SAGA, a Saccharomyce cerevisae complex of Spt, Ada, and Gcn5 proteins, 
with the Snf/Swi and Srb mediator complexes. Genetics 147: 451-465
Ronne, H. (1995) Glucose repression in fungi. Trends Genet. 11:12-17
Ruppert, S., E.H. Wang and R. Tjian (1993) Cloning and expression of 
human TAFII250: a TBP-associated factor implicated in cell cycle 
regulation 362:175-179
Russell, D. W. and M. Smith (1983) Nucleotide sequence of the yeast 
alcohol dehydrogenase II gene. J. of Biol. Chem 258:2674-2682
Ryan, M .P., R. Jones, and R. H. Morse (1998) SW I-SN F complex 
participation in transcriptional activation at a step subsequent to 
activator binding. Mol. Cell. Biol. 18:1774-1782
Sakai, A., T. Chibazakura, Y. Shimmizu, and F. Hishinuma (1992) Molecular 
analysis of POP2 gene, a gene required for glucose-derepression of gene 
expression in Saccharomyces cerevisiae. Nucleic Acids Res. 20:6227- 
6 2 3 3
Sauer, F., S. K. Hansen and R. Tjian (1997) DNA template and activator- 
coactivator requirements for transcriptional synergism by Drosophila 
bicoid. Science 270:1825-1828
Sayre M.H., H. Tschochner, R. D. Kornberg (1992) Reconstitution of 
transcription with five purified initiation factors and RNA polymerase II 
from Saccharomyces cerevisiae. J Biol Chem. 267:23376-82
Schatz, T., and J. Langowski (1997) Curvature and sequence analysis of 
eukaryotic promoters. J. Biomol. Struc. 15:265-275
110
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Scully R., S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. 
Livingston, J. D. Parvin (1997) BRCA1 is a component of the RNA 
polymerase II holoenzyme. Proc Natl Acad Sci U S A .  94:5605-10
Shen, W-C. and M.R. Green (1997) Yeast TAFII 145 functions as a core 
promoter selectivity factor, not a general coactivator. Cell 90: 615-524
Shi, X., M. Chang, A. J. Wolf, C-H. Chang, A. A. Frazer, P. A. Wade, Z. F. 
Burton and J. A. Jaehning (1997) Cdc73p and Paflp  are found in a novel 
RNA polymerase ll-containg complex distinct from the Srbp-containing 
holoenzyme Mol. Cell. Biol. 17:1160-1169
Shuster, J., J. Yu, D. Cox, V.L. Chan, M. Smith and E. Young (1986) ADR1- 
mediated regulation of ADH2 requires an inverted repeat sequence. Mol. 
Cell. Biol. 6:1894-1902
Silverman, N. and L. Guarente (1997) Acetylation, activation, and 
toxicity: the role of ADA/GCN5 complex in transcription. Nucleic Acids 
Mol. Biol. 11: 309-323
Simon, M.M., G. Shuster, E. O. and B. Byers (1989) Pachytene arrest and 
other meiotic effects of the start mutations in Saccharomyces cerevisiae. 
Genetics 123:29-43
Simon, M.M., G. Binder, G. Adam, A. Hartig, and H. Ruis (1992) Control of 
peroxisome proliferation in Saccharomyce cerevisiae by ADR1, 
SNF1/CAF1/CCR1) and SNF4/CAT3. Yeast 8:303-308
Sterner, D.E., P.A. Grant, S.M. Roberts, L. J. Duggan, R. Belotserkovskaya, 
L.A. Pacella, F. Winston, J. L. Workman, and S. L. Berger (1999) 
Functional organization of the yeast SAGA complex: distinct components 
involved in structural integrity, nucleosome acetylation, and TATA-binding 
protien interaction. Mol. Cell. Biol. 19: 86-98
Struhl, K. (1986) Constitutive and inducible Saccharomyces cerevisiae 
promoters: Evidence for two distinct molecular mechanisms Mol. Cell. 
Biol. 6:3847-3853
111
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Struhl, K. (1996) Chromatin structure and RNA polymerase II connection: 
implications for transcription. Cell 84:179-182
Struhl, K. (1998) Histone acetylation and transcriptional regulatory 
mechanisms. Genes Dev. 12:599-606
Svejstrup, J. Q, , P. Vichi and J.-M, Egly (1996) The multiple roles of 
transcription/repair factor TFIIH. TIBS 21:346-350
Tansey WP, and W. Herr (1997) TAFs: guilt by association? Cell. 88:729- 
7 3 2
Thompson, C.M., A. J. Koleske,, O. M. Chao, and R. A. Young (1993) A 
multisubunit complex associated with the RNA polymerase CTD and 
TATA-binding protein in yeast. Cell 73:1361-1375
Thompson-Jaeger, S.. J. Francois, J. P. Gaughran, and K. Tatchell (1991) 
Deletion of SNF1 affects the nutrient response of yeast and resembles 
mutations which activate the adenylate cyclase pathway. Genetics 
129:607 -706
Trigon, S., H. Serizawa, J. W. Conaway, R. C. Conaway, S.P. Jackson, and 
M. Morange (1998) Characterization of the residues phosphorylated in 
vitro by different C-terminal domain kinases. J. Biol. Chem. 273:6769- 
6 7 7 5
Ulery, T. L., S. H. Jang and J. A. Jaehning (1994) Glucose repression of 
yeast mitochondrial transcription kinetics of derepression and role of 
nuclear genes. Mol. Cell. Biol. 14:1160-1170
Usheva, A., E. Maldonado, A. Goldring, H. Lu, C. Houbavi, D. Reinberg and 
Y. Aloni (1992) Specific interactions between the nonphosphorylated 
form of RNA polymerase and the TATA-binding protein. Cell 69:871-881
Vallari, R. C., W.J. Cook, D. C. Audino, M. J. Morgan, D.E. Jensen, A.P. 
Laudano, and C. L. Denis (1992) Glucose repression of the yeast ADH2 
gene occurs through multiple mechanisms, including control of the protein 
synthesis of its transcriptional activatro ADR1. Mol. Cell. Biol. 12:1663- 
16 73
112
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Verdone, L., G. Camilloni, E. Di. Mauro and M. Caserta (1996) Chromatin 
remodeling during Saccharomyce cerevisiae ADH2 gene activation. Mol. 
Cell. Biol. 16:1978-1988
Verdone, L., F. Cesari, C. L. Denis, E. Di. Mauro, and M. Caserta (1997) 
Factors affecting Saccharomyce cerevisiae ADH2 chromatin remodeling 
and transcription. J. Biol. Chem. 272:30828-30834
Verrijzer, C. P., K, Yokomori, J. L. Chen, and R. Tjian (1994) Drosophila 
TAFII150: similarity to yeast gene TSM-1 and specific binding to core 
promoter DNA. Science 264: 933-941
Vignali, M., A. H. Hassan, K.E. Neely, and J. L. Workman (2000) ATP- 
dependent chromatin-remodeling complexes. Mol. Cell. Biol. 20: 1899- 
1910
Wade, P.A., D. Pruss and A. P. Wolffe (1997) Histone acetylation: 
chromatin in action. TIBS 22:128-132
Wade PA, W. Werel, R. C. Fentzke, N. E. Thompson, J. F. Leykam, R. R. 
Burgess, J. A. Jaehning, Z. F. Burton (1996) A novel collection of 
accessory factors associated with yeast RNA polymerase II. Protein Expr 
Purif. 8:85-90
Walker, S. S., J. C. Reese, L. M. Apone and M. R. Green (1996) 
Transcription activation in cells lacking TAFIIS. Nature 383:185-188
Walker, S. S., W-C. Shen, J.C. Reese, L. M. Apone, and M. R. Green (1997) 
Yeast TAFII145 required for transcriptional of G1/S cyclins genes and 
regluated by the cellular growth state, Cell 90: 607-614
Wang, L. , L. Liu, and S. L. Berger (1998) Critical residues for histone 
acetylation by Gcn5, functioning in Ada and SAGA complexes, are also 
required for transcriptional function in vivo. Genes Dev. 12: 640-653
Weisenfeld, M., I. Schimpfessel, and R. Crokaert (1975) Multiple forms of 
mitochondrial alcohol dehydrogenase in Saccharomyces cerevisiae. 
Biochim. Biophys. Acta 405:500-512
113
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Werner, M.H., and S. K. Burley (1997) Architectural transcription factors: 
proteins that remodeling ONA. Cell 88:733-736
Wilson, W. A., S. A. Hawley, and D. G. Hardie (1996) Glucose 
repression/derepression in budding yeast: SNF1 protein kinase is 
activated by phosphorylation under derepressing conditions, and this 
correlates with a high AMP:ATP ratio. Curr. Biol. 6: 1426-1434
Wilson, C. J., D. M. Chao, A.N.Imbalzano, G. R. Schnitzler, R. E. Kingston, 
and R. A. Young (1996) RNA polymerase II holoenzyme contains SW I/SNF  
regulators invovled in chromatin remodeling. Cell 84:235-244
Wu Y., R.J. Reece, and M. Ptashne (1996) Quantitation of putative 
activator-target affinities predicts transcriptional activating potentials. 
EMBO J. 15:3951-63
Yamahita, I. (1993) Isolation and characterization of the SUD1 gene, 
which encodes a global repressor of core promoter activity in 
Saccharomyces cerevisiae. Mol. Gen. Genet. 241:616-626
Yan, M. and J.D. Gralla (1997) Multiple ATP-dependent steps in RNA 
polymerase II promoter melting and initiation. EMBO J. 16:7457-7467
Yean, D., and J. D. Gralla (1999) Transcription reinitiation rate: a potential 
role for TATA box stabilization of the TFIID:TFIIA:DNA complex. Nucleic 
Acids Res. 27:831 -838
Yokomori, K„ C.P. Verrijer, and R. Tjian (1998) An interplay between 
TATA box-binding protein and transcription factors HE and IIA modulates 
DNA binding and transcription. Proc. Natl. Acad. Sci. USA 95:6722-6727
Young, E. T., and D. Pilgrim (1985) Isolation and DNA sequence of ADH3. 
a nuclear gene encoding the mitochondrial isozyme of alcohol 
dehydrogenases in Saccharomyces cerevisiae. Mol. Cell. Biol. 5 :3 0 2 4 -  
3 0 3 4
Young, E. T., J. Saario, N. Kacherovsky, A. Chao, J. S. Sloan, and K. M. 
Dombek (1998) Characterization of a p53-related activation domain in
114
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Adrip that is sufficient for ADR 1-dependent gene expression. J. Biol. 
Chem. 273:32080-32087
Yu, J., M. S. Donoviel, and E. T. Young (1989) Adjacent upstream 
activation sequence elements synergistically regulate transcription of 
ADH2 in Saccharomyce cerevisiae. Mol. Cell. Biol. 9:34-42
Zimmermann, F. K., I. Kaufmann, H. Rasenberger, and P. Haussman (1977) 
Genetics of carbon ctabolite repression in Saccharomyces cerevisiae 
genes involved in the derepression process. Mol Gen Genet. 1951:95- 
103
Zhu Y., C. L. Peterson, M. F. Christman (1995) HPR1 encodes a global 
positive regulator of transcription in Saccharomyces cerevisiae. Mol Cell 
Biol. 15:1698-1708.
115
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Copyright O 1998 by the Genetics Society o f America
D h h lp , a Putative R N A  Helicase, Associates w ith the G eneral Transcription  
Factors Pop2p and Ccr4p from  Saccharomyces cerevisiae
H iroald H ata,1 FDsayuki M itsui,1 H ong Liu,3 Yongii Bai,4 Clyde L. D enis,4 Yuld Shim izu 
and Akira Sakai
Cellular Signaling Group, Mitsubishi Kasd Institute of Life Sciences, Tokyo 194, Japan 
Manuscript received June 26, 1997 
Accepted for publication October 8, 1997
ABSTRACT
The POP2 (C afl) protein in Saccharomyces cerevisiae aflccts a variety o f transcriptional processes and is a 
component o f the Ccr4p complex. We have isolated five multicopy suppressor genes of a pop2 deletion mu­
tation: CCR4, D H H 1  (a putative RNA helicase), PKC1, STM ], and M P T5  (multicopy suppressor of pop two). 
Overexpression o f either the CCR4 or D H H l genes effectively suppressed phenotypes associated with pop2 
mutant cells; overexpression of PK C I, STM1, or M PT5 genes produced only partial suppression. Disrup­
tion o f the CCR4 o r D H H l genes resulted in phenotypes similar to those observed for pop2 cells. In addi­
tion, overexpression o f the D H H l gene also suppressed the co4 mutation, suggesting a close relationship 
between the POP2, CCR4, and D H H l genes. TWo-hybrid analysis and coimmunopredpitation experiments 
revealed that Pop2p and Dhhlp interact physically, and these and other data suggest that Dhhlp is also a 
component of the Ccr4p complex. Finally, we investigated the genetic interaction between factors associ­
ated with POP2 and the PKCI pathway. The temperature-sensitive growth defect o f dhhl or mpt5 cells was 
suppressed by overexpression of PK C I, and the defect o f mpkl cells was suppressed by overexpression of 
MPT5. These results and phenotypic analysis of double mutants from the POP2 and PKCI pathways sug­
gested that the POP2 and the PKC I pathways are independent but have some overlapping functions.
TH E  PO P2 ( CAF1) gene is required fo r glucose derepression o f gene expression in  Saccharomyces 
cerevisiae ( S a k a i rt aL 1992; D r a p e s  cl aL 1995). The 
pop2 m utant cells exh ib it m any defects, including re­
duced levels o f reserve carbohydrates, resistance to glu­
cose derepression, tem perature sensitivity fo r growth, 
increased PCK 1  transcription during stationary phase, 
and reduced levels o f alcohol dehydrogenase n, isoci­
trate lyase, and invertase ( S a k a i et aL 1992; D r a p e r  et 
aL 1995). Pop2p has been shown to be p art o f the 
Ccr4p com plex ( D r a p e r  et aL 1995; L iu  et aL 1997). 
Ccr4p, a general transcription factor, is required for 
the transcription o f m any genes, including glucose- 
repressible A D H 2, and the p leio trop ic nature o f defects 
in  CCR4 is sim ilar to that in  PO P2 ( D e n is  and M a lv a r  
1990; M a lv a r  et aL 1992; S a k a i et aL 1992). Homologs
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o f the PO P2 gene have been identified from  hum ans, 
m ice, Caenarhabditis etegans, and Arabidopsis th a lian a  
( D r a p e r  et aL  1995). The high degree o f evolutionary  
conservation and th e ir functional interchangeability  
suggest th at the PO P2 gene plays an im portan t func­
tional role in  cells.
We have iden tified  several new phenotypes o f pop2 
mutants. First, pop2 cells are sensitive to staurosporine, 
a potent in h ib ito r o f protein kinase C  that is encoded by 
P K C I. Second, pop2 cells are also sensitive to caffeine (L iu  
et aL 1997). In  addition, the tem perature-sensitive phe­
notype o f pop2 is suppressed by the addition o f 1 M  sorbi­
tol to the m edium . These phenotypes are characteristic 
o f mutants involved in  the P K C l-M P K l pathway (THEV- 
r r  f in  1994), which controls cell wall integrity. Cells car­
rying p k c lii o r mpAM cannot use glycerol as a sole car­
bon source ( C o s t ic a n  et aL 1994), and this suggests the  
involvem ent o f the P K C l-M P K l pathway in  the tran­
scription o f genes required fo r glycerol u tilization . To  
understand the functions o f Pop2p, we have searched 
fo r m ulticopy suppressor genes o f a pop2 deletion m u­
tation. This approach has proved to be quite useful fo r  
analyzing m any cellu lar processes such as the SNF1 ki­
nase pathway ( E s t r u c h  and C a r ls o n  1993; H u b b a r d  
et aL 1994) and the P K C l-M P K l protein kinase pathway 
( L e e  et aL 1993a; N ic k a s  and Y a f f e  1996). Using this 
approach, we hoped to obtain genes encoding proteins  
with functional relationships to POP2: negative regula­
tors o f an antagonistic pathway or positive regulators o f
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TABLE 1 
List o f  yeast (tra in
Strain Genotype Source
D40 M A Ta/M A Ta ade8/ade8 aro7/AR07 his3/his3 Ieu2/leu2 T R P l/trp l ura3/ura3 This work
A475 M A lk  canl gal2 leu2 net 14 tspl um3 rgrlA2:URA3 S a k a i ,  1990
A880 MATa aro7 hisS leu2 uraS pop2-A3::URA3 This work
A ll 23 M A Ta leu2 met 14 trp l ura3 This work
A1152 MATa. aro7 his3 leu2 tmetl4 trp l ura3 sttl-1 (pkclu) This work
A1158 MATa an>7 his3 leu2 trp l ura3 pkclA:JUS3 This work
A1385 M ATa adeS his3 teu2 tspl uraJ dhhlA::URA3 This work
A1413 M A lk  adeS his3 leu2 trp l aro3 m pt!A::lilS3 This work
A1454 MATa aro7adeS his3 leu2 vra3stmlA:tADE8 This work
A1522 M ATa aro7 adeS h isj leu2 trp l ura3 ccr4A::fOS3 This work
612-Id MATa adhl-1 lhis3 leu2 trp l o ra l This work
612-ld-dI MATa adhl-11 his3 trp l leu2 uru3 dhhlA::URA3 This work
EGY188 MATa his3 leu2 trp l ura3 LtxAop-l£U2 This work
EGY191 M ATa hisS Ieu2 trp l ura3 LtxAop-LEU2 This work
L40 M A lk  his3 leu2 trp l um3 LYS::LexAop-HlS3 URA3::LexAop-lacZ T. T a n a k a ,
Sbimanc University
DL251 M ATa/M ATa canl /can l his4/his4 Ieu2-3,ll2/leu2-3,112 trp l-l/trp l-l vra3-52/ D. L. L e v in ,
vra3-52 bcklA::URA3/bcklA::URA3 Johns Hopkins University
DL456 MATa/MATa canl/canl his4/his4 Ieu2-3,112fleu2-3.112 trp l-l/trp l-l um3-S2/ 
itra3-S2 mpklA ::TRPl-/mpk 1A::TRPI
D. L. L e v i n
KAN128 MATk canl his4 leu2-3.112 trpl-1 utoj-52 mkklA:J-UE2 mkk2A::URA3 K. I r i e ,  Nagoya University
a downstream pathway. W e report here the isolation o f 
five m ulticopy suppressor genes o f the pop2 deletion 
m utation in S. cerevisiae. W e also present gcncdc and bio­
chemical evidence ind icating  that Pop2p, Ccr4p, and 
D h h lp  are part o f the same com plex o f proteins. A  pos­
sible interaction between the PO P2  and P K C l-M P K l 
pathways is discussed.
M A TE R IA LS  A N D  M ETH O D S
Strains and genetic methods: The strains o f £  cerevisiae 
used in this study are listed in Table 1. Crossing, sporuladon, 
and tetrad analyse* uere carried out by standard genetic 
methods (S h e rm a n  et aL 1986). Unless otherwise specified, 
the permissive and restrictive temperatures were 24° and 36°, 
respectively. The transformation o f yeast was performed by 
the LiOAc method ( I t o  et aL 1983). Escherichia colt strains 
HB101 and JM109 were used as hosts for constructing and 
propagating plasmids. The transformation of E  coli was per­
formed as described ( H a n a h a n  1983). The basic culture me­
dium used for S. cerevisiae was YPD medium containing 1% 
Bacto-yeast extract, 2% Bacto-peptone, and 2% dextrose 
(S h e rm a n  et aL 1986). The synthetic medium was CSM me­
dium containing 0.67% yeast nitrogen base without amino ac­
ids, 2% dextrose, and amino adds as required ( S iie r m a n  et aL 
1986). The media were solidified with 2% Bacto-agar for 
plates. To test the sensitivity o f various mutants to staurospo- 
rine (Kyowa Medix. Tokyo, Japan), the drug was dissolved in 
dimethyl sulfoxide and added to YPD media to a final concen­
tration o f up to 5 (ig /m l (T a m a o k t et aL 1986; Y o s h id a  et aL 
1992). Tetrad dissection o f heterozygous diploids carrying 
pkclA was performed on a YPD plate containing 1 M  sorbitol. 
Luria broth was supplemented with ampidllin for selection of 
the £  coli transformants as described ( M a n ia t is  a  aL 1982).
Preparation o f DNA and RNA: Preparation o f E. coli DNA
Southern hybridization, and Northern hybridization were 
performed a s  described ( M a n i a t i s  et aL 1 9 8 2 ) .  The prepara­
tion o f yeast DNAs and Northern analysis were performed as 
described ( S h e r m a n  et aL 1 9 8 6 ) .
A D H II assay; Yeast cells were grown in YEP medium sup­
plemented with either 8% glucose or 3% ethanol, and the ac­
tivity o f ADH I I  was measured as described previously (C o o k  
et aL 1994).
Isolation o f  multicopy suppressors o f  pop2-A4-. A  yeast ge­
nomic DNA library (in YEpl3, LEU2 marker) was trans­
formed to an A880 strain carrying the pop2-A4 mutation 
( S a k a i  et aL 1992), and transformants were selected on CSM 
lacking leucine at 24° for 5 days. To isolate suppressors for the 
temperature-sensitive phenotype o f pop2 cells, transformants 
were replica plated on YPD, and the plates were further incu­
bated at 36°. To isolate suppressors for the staurosporine- 
sensitive phenotype of pop2 cells, the transformants were rep­
lica plated on YPD containing 1 (ig /m l staurosporine. O f 
25,000 transformants, 85 colonies were selected. The 85 sup­
pressor plasmids were recovered, analyzed by Southern hy­
bridization and restriction mapping, and divided into six 
classes. The largest class (containing 65 plasmids) was identi­
fied as POP2 itself. The remaining five classes were tentatively 
called MPTs (multicopy suppressor of £op two). The classes of 
M P T I, M PT2. M PT3. MPT4, and M P T ! contained 13, 3, 2, 1. 
and 1 plasmids, respectively. To localize the suppressor activi­
ties for these plasmids, individual restriction fragments were 
subcloned into the YEp213 vector and tested for their abilities 
to grow on YPD plates at the restriction temperature or YPD 
plates containing staurosporine. These M P T  genes were fur­
ther subdoncd into pL'C18, and the nucleotide sequences 
were determined by the Sanger method using a Sequcnase 
Kit (United States Biochemical, Cleveland. O H ). Nucleotide 
sequence analysis revealed that three genes had been identi­
fied previously. M P T I is DHHL, which encodes a putative RNA 
helicase ( S t r a i i i ^ B o l s i n c e r  and T a n n e r  1993), M PT2  is 
identical to CCR4, which is required for the full expression of
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the glucose-repressible ADH2 gene ( D e n is  and M a l v a r  1990; 
M a l v a r  et aL 1992). and MPT3 turned out to be PKCI, a yeast 
homolog o f mammalian protein kinase C ( L e v in  et aL 1990). 
MPT4 is STM I,  a guanine quartet-binding protein ( F r a n t z  
and G i l b e r t  1995). MPT5 is identical to HTR1. The name 
HTR1 had been used for a different gene ( O z c a n  et aL 1993); 
we refer to this gene as MPT5.
Disruption o f  D H Hl, CCR4, PKCI, MPT4, and MPTS-. T h e  
dhh /A.-.- URA3, ccr4A:zHIS3. pkclA:JOS3, stmJS:^WE8. a n d  
mpt5\::HIS3 a l le le s  w e r e  c o n s t r u c t e d  b y  t h e  s t a n d a r d  m e t h o d  
and t r a n s f o r m e d  i n t o  d ip l o id  (D40) c e lls  to  r e p l a c e  t h e  c h r o ­
m o s o m a l  lo c i  b y  t h e  o n e - s te p  g e n e  d is r u p t io n  m e t h o d  ( R o t h -  
STEIN 1983).
Construction of dhhId::URA3i A 2.5-kbp DNA fragment 
(PmdCl-ApaU) bearing the D H R I gene (ORF: 1518 bp) was 
filled in with Klenow enzyme and subdoned into the SmaI  site 
of pBIuescript II. The resulting plasmid DNA was digested 
with flilE II and BglD. This step deleted 115 bp within the cod­
ing region (+438 to +  552). After the ends were filled in with 
Klenow enzyme, a 1.2-kbp URA3 fragment, isolated by diges­
tion ofYEp24 plasmid DNA with /frndlQ and filled in, was in­
serted. The resulting plasmid was digested with Paid and Kpnl 
and used for transformation. After heterozygous disruption 
was confirmed by Southern blotting, the transformants were 
subjected to sporuladon followed by micromanipulation to 
generate haploid cells carrying the dhhl deletion mutation.
Construction of ccr4&:JHS3. The ccr4d::HIS3 allele was in­
troduced in our background and L40 strain using the TM1 
plasmid as described ( M a l v a r  et aL 1992).
Construction ofpkcIS:JUS3: A 4.3-kbp Sp/d-Sphl f r a g m e n t 
b e a r i n g  d i e  PKCI g e n e  w a s  r e c o v e r e d  f ro m  th e  o r ig in a l  MPT3 
p la s m id .  D is r u p t io n  o f  t h e  PKCI g e n e  w as p e r f o r m e d  b y  t h e  
r e p l a c e m e n t  o f  a 0.6-kbp BamHl f r a g m e n t  o f  t h e  PKCI g e n e  
with the HIS3 g e n e  f r o m  p J J2 1 6  a s  d e s c r ib e d  ( Y o s h i d a  et aL 
1992).
Construction of stmlE:M3E& A 1600-bp DNA fragment 
(.PmaCl-Clal) bearing the MPT4 gene (ORF: 819 bp) was 
filled in with Klenow enzyme and subcloned into the Snutl site 
of die pUC18 plasmid whose Psi site was disrupted. The re­
sulting plasmid was digested with Xbdl and Hpal to remove 
33 bp within the MPT4 gene (+283 to +316) and a 1152 bp 
ADES DNA whose ends were Xbal and Smal. The resulting
YPD + 1M Sorb. YPD
1
plasmid was digested with EcaRV and AJICI, and was used for 
transformation.
Construction of mpt5i\::HIS3: A 5-kbp Aad-Aad DNA frag­
ment bearing the MPT5 gene was isolated from the original 
MPT5 plasmid DNA, whose ends were changed to Sail by 
linker ligation, and subcloncd into the Sail sited of pUC18. 
The plasmid DNA was digested with ffspV to remove —420 to 
+3700 of the MPT5 DNA. After the ends were Glled in with 
Klenow enzyme, a 1.8-kbp HIS3 DNA whose ends were filled 
in with Klenow enzyme was inserted. The resulting plasmid 
was digested with EctBl and £coRV, and was used for transfor­
mation.
All disruptions were introduced into D40 cells, and the dis­
ruptions were confirmed by Southern blot analysis. Haploid 
cells carrying the disruption were recovered by standard mi­
crodissection.
Two-hybrid analysis: Plasmid pBTM116 (kindly provided 
by K a t s u k o r i  T a n a k a ,  Shimane Universicy) was used to con­
struct LexA-Pop2p. BamHl sites were introduced into the 
DNA encoding the POP2 protein by PCR. and the resulting 
DNA fragment was subdoned into the BamHl site of 
pBMTl 16 in-frame to LexA. Plasmid pGADGH was pur­
chased from Qontech (Palo Alto. CA) and was used to con­
struct G:il-1 activation domain fusion plasmids (Gal4AD-Ccr4 
and Gal4AD-Dhhl). Yeast strain I .-10 was used as the two-hybrid 
host (Table 1). The activity of p-galacto-sidase was determined 
as described ( M i l l e r  1972). The LcxA-Vpu plasmid contains 
the hydrophilic segment of Vpu (residues 33-81) fused to 
full-length LexA ( C h i a n c  et aL 1996). B42-Pop2p contains 
residues 149-441 of Pop2p fused in frame to the £  cotf-dc- 
rived B42 transcriptional activator ( Z e r v o s  et aL 1993). This 
segment of Pop2p interacts with Ccr4p in the two-hybrid assay 
and coimmunoprcdpicatcs with Ccr4p ( D r a p e r  et aL 1995; 
data not shown). B42-Siplp contains residues 243-500 of 
Siplp ( V a n g  et aL 1992) fused to B42. LexA-Dhhl was con­
structed by removing the complete D H H  I  sequence from the 
Gal4AD-DhhLAD fusion using BamHl and Sail and cloning 
into the BamHl and -So/I sites of LexA-202-l ( C o o k  et aL 
1994).
hnmunopredpitation: Preparation of protein extracts and 
immunoprccipitation were performed as described ( D r a p e r  
et aL 1995). The polyclonal antibody against the Gal4 acliva-
b
Staurosporine (p g /ra l) F i g u r e  I .—Newly found
phenotypes of pop2 cells, (a) 
Q \  Sorbitol-supprcssible, tem­
perature-sensitive growth de­
fect of pop2 deletion cells. (1)
A1123 (wild-type), (2) A1152 
(.sttl-l/pkcl“). (3) A475 (rgrl- 
SZ:URAS) , (4) A880 (pop2- 
\4::U R A 3). Cells were 
streaked on YPD or YPD+1 
M sorbitol plates and were 
incubated at 24° and 37° for 
4 days, (b) Staurosporine 
sensitivity. A1123 (wild-type) 
and A880 (.popZA4::URA3) 
cells were resuspended with 
YPD media, spread on the 
YPD plate containing stau­
rosporine. and incubated at 
24° for 4 days.
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TABLE 2
Phenotypes o f  the deletion mutants
YPD YPD 4  sorbitol YPG YPG 4- sorbitol
Sta. Caf.15° 24° 37° 24° 37° 24° 37° 24° 37°
pop2 - 4 — 4 4 **’• _ - - — —
ccri — 4 — 4 4 — — - — -
dhhl - 4 — 4 + - - - — -
pkcl - - — 4 - -  - - - — —
stml 4 4 4 4 4 4- - 4 - 4 4
mpi5 - 4 - 4 4* 4- - 4 - 4 -
Exponentially growing cells were resuspended in water, and aliquots were spotted on  the plate indicated. 
Plates were incubated a t each tem perature fo r 4 days. Plus signs indicate growing (form ed colony): m inus signs 
indicate no t growing (not form ed colony). Sta., 2 n g /tn l staurosporine in YPD plate: Caf.. 8 m x  caffeine in a 
YPD plate.
* These mutants grew slowly on a Y P G ly c c ro l,  b u t they did not grow on a  CSMGlycerol plate. This phenotype 
varied depending on genetic background.
□on domain was a kind gift from K o u ic h i I s h jc u r o ,  Mitsu­
bishi Kasei Institute of Life Sciences. The Ccr4p antibody was 
described previously ( D r a p e r  et aL 1995). Antibodies against 
the HA1 epitope were commercially obtained. The sequence 
data presented in this paper have been submitted to the Gen- 
Bank Data Libraries under the following accession numbers: 
MPT4, D2618S; MPTS, D26184.
RESULTS
Isolation o f  multicopy suppressors o f  pop2: The tem­
perature-sensitive phenotype o f pop2 mutants suppressed 
b y  the addition o f 1 M  sorbitol in the medium (Figure 
la ). A t the restrictive temperature, the pop2 cells be­
come enlarged and swollen, showing a cell lysis pheno­
type (data not shown). Furthermore, the pop2 ceils are 
also sensitive to staurosporine (1 p g /m l; Figure lb ), a 
potent inh ib itor o f the yeast protein kinase C  homolog 
(P K C I; T a m a o k i  et aL 1986; L e v in - et aL 1990; Y o s h i d a  
et aL 1992). Finally, the growth o f pop2 cells is inhibited  
b y  low levels o f caffeine (8  m M ; Table 2 ). pop2 cells also 
exhibited a weak cold-sensitive growth phenotype that 
is suppressible by 1 M  sorbitol (L iu  et aL 1997). These 
phenotypes are similar to those caused by mutations in 
the P K C I pathway, and they suggest that PO P2 plays a 
role in maintenance o f cell wall integrity in addition to 
its other known phenotypic defects. Since the pop2 mu­
tant affects such varied processes, it was o f interest to us 
to know the multifunctional roles ofPop2p in  cells.
We searched fo r multicopy suppressors o f the tem­
perature- and staurosporine-sensitive growth defects o f 
pop2m utation (sec m a t e r i a l s  a n d  m e t h o d s ) .  We iden­
tified five gene products that suppressed the pop2 phe­
notypes cither completely or partially (Table 3 ). Nucle­
otide sequence analysis revealed that these genes are 
D H H 1, which encodes a putative RNA helicase ( S t r a h l -  
B o l s l n g e r  and T a n n e r  1993), CCR4, which is required 
for the fu ll expression o f the glucose-repressible A D H 2  
gene ( D e n t s  and M a l v a r  1990; M a l v a r  et aL 1992),
PK C I, a yeast homolog o f mamm alian protein kinase C 
( L e v i n  et aL 1990), STM 1, a guanine quartet-binding  
protein ( F r a n t z  and G i l b e r t  1995), and M P T5  (Kntc- 
c h i  et aL 1994; K e n n e d v  et aL 1997). M pt5p contains 
eight tandem copies o f an ~ 3 8  am ino add-repeat, in­
cluding a strong consensus sequence o f 13 amino adds 
(LxxDxFGxxFLQK). This repeat is also found in YGL023 
( C h e n  et aL 1991) and in the Drosophila pum ilio gene 
( B a r k e r  et aL 1992; M a c D o n a l d  1992). TTie biological 
function o f this region remains to be identified.
Overexpression o f e ither CCR4 o r D H H L  suppressed 
all the pop2 phenotypes. In  contrast, overexpression o f 
M PT5, P K C I, and S TM  only suppressed some o f these
TABLES
Summary o f  multicopy suppression
Gene on YEp213
Mutation POP2 C CR4 D H H 1 P K C I S T M 1 M P T 5
ts 4 4 4 - - 4
P°p2 sta 4 4* 4 4 4 -
gty 4 4 4 4 — 4
4 4 _ _ 4ccr4 sta 4 4 ” 4 4
r t _ 4 4dhhl sta — 4 4
pkcl is
_ _ __ 4 —/4 _
sta - - - 4 4 -
ts __ _ 4 __ 4mpt5 caf - - - 4 4 4
Transformants were suspended in water and spotted on YP 
plates containing either 2% glucose. 2% glucose + 2 jig/m l 
staurosporine, 2% glucose +  8 m M  caffeine, or 2% glycerol. 
The plates were incubated at 24° or 37° for 4 days, is, incu­
bated at 37°; sta, 2 p-g/ml staurosporine, caf, 8 mM caffeine; 
gfy. 2% glucose.
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phenotypes (Tkble 3 ). These results suggested a dose 
genetic relationship among POP2, CCR4, and D H H 1, 
while the interaction between POP2 and P K C I, 47 M l, 
o r M P T 5  m ight be relatively weak.
N orthern u r i p k  I t  is possible that th e overexpres­
sion o f these genes in pop2 cells suppressed d ie pheno­
typic defects i f  their transcription were being positively 
regulated by the Pop2. To examine this possibility, we 
measured the mRNA levels o f each suppressor gene in 
wild-type and pop2 deletion cells. No significant differ­
ences in the mRNA amounts were observed between 
wild-type and pop2 deletion cells for any o f the suppres­
sor genes (data not shown).
Genetic interactions among POP2, CCH4, and D fffll:  
Disruptions o f POP2, CCR4, a n tlD H H l were constructed 
(see m a t e r ia ls  a n d  m e th o d s ) ,  and the resulting phe­
notypes were examined. In  addition to the phenotypes 
previously observed for a CCR4 disruption ( M a lv a r  et 
aL 1992; D r a p e r  et aL 1995; Table 2 ), we found that in­
strain backgrounds other than those o f the originally 
reported, ccrfA cells ate also tem perature sensitive for 
growth, which is suppressed by addition o f 1 M  sorbitol 
to the medium. Furtherm ore, the a r 4 \  cells are sensi­
tive to staurosporine and caffeine. W hile it  has been re­
ported that the disruption o f D H H 1  docs not cause any 
phenotype ( S t r a h l- B o ls in g e r  and T a n n e r  1993), we 
found that dAAlA cells in  our genetic background show 
a temperature-sensitive cell lysis phenotype that is sup­
pressed by 1 M  sorbitol (Table 2 ). Proteins with RNA 
helicase activity arc often involved in  m RNA transport 
or RNA processing ( M a r g o s s la n  and B trrow  1996; 
D a lb a D Ie - M c F a r la .v d  and A b e ls o n  1990). To exam­
ine dhhl effects on mRNA transport, d h h l cells were 
shifted to 37° for 1 hr, and m RNA accumulation in the 
nucleus was measured by in situ hybridization with an 
oligo dT  probe. No significant difference was detected 
between dhhl and wild-type cells (data not shown). We 
also failed to detect pre-mRNA accumulation o f the in- 
tron-containing CYH2 gene in  dhhl cells (T. T a x i,  per­
sonal communication). These observations suggest that 
the dhhl mutation did not affect RNA processing. Cells 
carrying the dhhl mutation also showed cold-sensitive 
growth at 15°, do not grow on a CSMGlycerol plate, and 
grow slowly on aYPGlycerol plate. Furtherm ore, dhhl A
TABLE 4
DHH1 ta m f dred for ADH □  rrprrswrw




Wild-type (612-ld) o r  ddhl (612-ld-dl) cells were used. 
Activity of ADH II was determined as described in m a te r ia ls  
a n d  m e th o d s . Standard e rro rs  are <15%.
cells arc sensitive to staurosporine and caffeine (Table 
2. data not shown). Table 4 also shows that D H H 1  is re­
quired for the fu ll expression o f the A D H 2  gene, a phe­
notype previously observed with ccr4 ( D e n is  1984) or 
pop2/cafl-deleted cells ( D r a p e r  et aL 1995). These phe­
notypic analyses confirm  a close functional link between 
POP2, CCR4, and D H H l. In  contrast, disruption o f P K C I, 
STM 1, and M PTS  displays only some phenotypic sim i­
larities to pop2, cct4, and dhh l (Table 2) and their m u­
tant phenotypes were consistent with those observed 
previously ( L e v in  and B a r t le t t - H e u b s h  1992; F r a n t z  
and G ilb e r t  1995; Kncucm et aL 1994; C h e n  and K u r- 
ja n  1997). It  is noteworthy that temperature-sensitive 
growth o f mptS cells was suppressed by 1 M  sorbitol.
Multicopy plasmids carrying POP2, CCR4, and D H H 1  
were introduced into each m utant in  different combi­
nations, and the effects on their growth defects were 
tested. The pop2 m utation was suppressed by CCR4 or 
D H H 1, and the ccr4 m utation was also suppressed by 
D H H 1  (Table 3); however, the growth defects in  d hh l 
cells were not suppressed by either POP2 or CCR4. To 
further test the cpistasis among these genes, cells carry­
ing double mutations were constructed and the pheno­
typic additivity was tested. \Ve d id  not find  any additive 
phenotypes in the double-m utant ceils, suggesting that 
POP2, CCR4, and D H H 1  function in  the same pathway, 
and that CCR4 and D H H 1  genetically function down­
stream o f POP2.
D hhlp  physically interacts w ith Pop2p: The physical 
association o f D h h lp  with Pop2p and Ccr4p was ana­
lyzed by two-hybrid analysis and coimmunoprecipita- 
tion experiments. The com bination o f LexA-Pop2 and  
Gal4AD-DhhlAD in the two-hybrid system resulted in  a 
significant increase in (3-gaIactosidase activity beyond that 
obtained with LexA-Pop2p alone (Figure 2, Table 5 ). 
LexA-Dhhlp also was observed to interact specifically 
with a B42-Pop2 fusion, resulting in 18 U /m g  o f fi-galac- 
tosidase activity as com pared to 2.5 U /m g  activity fo r  
the interaction o f LexA -D hhl with B42 alone. Figure 2 
shows that residues 147—171 o f Pop2p are necessary fo r  
the interaction. This region is sim ilar to that which was 
observed to be necessary fo r the Pop2p and Ccr4p in ­
teraction ( D r a p e r  et aL 1995). Alsp, disruption o f 
CCR4 did not abrogate the interaction between LexA- 
Pop2 and G al4A D-Dhhl (Table 5 ). It  should be noted  
that a cct4 disruption reduced the transcriptional activ­
ity o f LexA-Pop2, which is a general effect that ccr4 has 
on LexA activators ( D r a p e r  et aL 1995). We fu rther 
tested the possibility o f an interaction in  the two-hybrid 
system between LexA-Ccr l  and G al4AD-Dhhl or B42- 
D h h l. and between LexA -D hhl and B42-Ccr4, but we 
were unable to detect any interaction between Ccr4p 
and D h h lp , although each o f these proteins was ex­
pressed in yeast (data not shown). These results suggest 
that Ccr4p and D h h lp  do not interact directly.
To confirm the physical interaction between Pop2p 
and D h h lp , a coim m unoprccipitation experiment was
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|TG*J (U/mg protein)
GaMAD Gal4AD-Ccr4 GaMAD-Dhhl
I LexA I 26 27 66
I 433 ,
I LexA | Pop2p 1 430 4,400 1,700
•0 433
I LexA | 1 P»p2p "I 350 3,400 1.100
147 43?
I LexA | 1 Pop2p 1 91 2,080 520
171 433
f LexA I f Pop2p 1 5 5 5
I 170
I LexA I Pop2p I 5 4 4
1 149
1 LexA | Pop2p | 6 8 I I
LexA |Pop2p|
, Q 1Q 2 P QJST433
Ficuu  2.—Region of 
Pop2p responsible for the 
interaction with Dhhlp. 
P-Galactosidase assays and 
interactions with GaI4p- 
Dhhlp were conducted as 
described in m a tv w a ls  a n d  
m e th o d s . Amino acid resi­
dues of each segment of 
Pop2p are indicated. All as­
says and interactions were 
done in strain L40. All 
LexA-Pop2p derivatives were 
expressed at equivalent lev­
els as assessed by Western 
analysis (data noc shown). 
Schematic illustration shows 
location of the characteristic 
domains. Q l. polyghuamine 
stretch (residues 81-01); Q2, 
polyglutaminc stretch (resi­
dues 112-126); Q3, glu­
tamine-rich region (residues 
364-371); P. proline-rich 
region (residues 139-155); 
S/T, serine/thrconinc-rich 
region (residues 375-391). 
All the values were the aver­
age of at least five indepen­
dent experiments. Standard 
errors were <15%.
carried out using transformants carrying LexA-Dhhl 
and B42-Pop2 that was tagged with the HA1 epitope 
(designated HA l-Pop2 in  Figure 3 ). Im m unoprccipitat- 
ing LexA-Dhhl w ith anti-LexA antibody resulted in  the 
coim m unopreripitadon o f B42-Pop2 (Figure 3, lane 5). 
The presence o f the B42-Pop2 fusion in  the irnmuno- 
precipitated materials was dependent on LexA-Dhhl 
(Figure 3 , lane 6 ) .  S ip lp , a protein ( V a n g  et aL 1992) 
that is not part o f the Ccr4p complex (L iu  et aL 1997), 
did not coimmunoprecipitate with the LexA -Dhhl fu­
sion (Figure 3 , lane 4 ). These results suggest that D hh lp  
is physically associated with the CCR4 complex, and
that Pop2p can physically interact with both Ccr4p and 
D hhlp .
Genedc interaction between POP2 and P K C l-M P K l
pathways: Because P K C I was isolated as a weak m ulti­
copy suppressor o f  the pop2 mutation, and the pheno­
types o f pop2 cells and mpt cells are similar to cells carry­
ing mutations involved in the P K C l-M P K l pathway, we 
determined the epistadc relationship among these genes. 
Overexpression o f POP2, CCR4, or DHH1 in p k c l\, bcklA, 
mkklA mkkZA, and m pklk  m utant cells did not suppress 
any o f their phenotypes, including temperature-sensi­
tive growth and caffeine sensitivity. PK C I suppressed
TABLE5




BCalactosidase activity (U /m g protein) 
Activation hybrid
GaMAD GaI4AD-Ccr4 Gal4AD-DhhI
L40 LexA 25 27 61
LexA-Pop2 430 4.400 1.700
(1.0) (10.2) (4.0)
L40/ cer4 LexA 0.7 2.4 1.2
LexA-Pop2 20 660 67
(1.0) (31) (3.2)
Transformants were grown in selective CSM medium. Values arc averages o f assays of three to five different 
transformants. Standard errors were <15%. Parentheses indicate fold of induction.
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1 2 3  4  5  6
F ic u k e  3.—LexA-Dhhlp coimmuncprecipiotej with 
Pop2p. Crude extracts (lanes 1-3) were prepared from dip­
loid EGY188/EGY191 containing the LexA. and B42 (HA1) 
fusion proteins as indicated. Immunopredpitations (lanes 4 - 
6) were conducted from these extracts using an antibody di­
rected against LexA. Extracts and immunoprecipitaied sam­
ples were separated by SDS-PAGE, and proteins were identi­
fied by using an antibody directed against the HA l epitope. 
LexA-Dhhlp and LexA-Vpu were expressed to comparable 
extents (data not shown). The protein that comigrates with 
HAl-Pop2p in lane 1 is a degradation product of HAl-Siplp 
and does not coimmunopredpitate with LexA-Dhhlp (sec 
lane 4).
F i g u r e  4.— PKCI and 
M PT) suppressed the mpkl 
mutation. Homozygous dip­
loid cells carrying the mpkl 
deletion mutation (DL456) 
were transformed with 
YEp213 bearing various 
genes indicated. The trans­
formants were suspended 
in water and spotted on Y PD  
plates and a YPD plate con­
taining 2 M-g/ml staurospo- 
rine. The plates were incu­
bated at 24“ or 35* for 4 days. 
MKK1-6 encodes a domi­
nant active form of Mkklp 
kinase (L e e  et aL 1993b).
the tetrads analyzed (10 for pop2A and pkclA, eight for 
dhh/A  and pkcl A , and eight for mptSA and pkcl A ), most 
tetrads contained less than three viable spores, even on 
the YPD plate containing 1 M  sorbitol (data not shown). 
Judging from  the disruption markers, all the dead celb 
were found to carry either pop2A pkclA , dhhl A pkclA, 
or mpl5A pkcl A . This synthetic lethality displayed phe­
notypic additivity and suggested that the POP2 pathway 
and PK C I function independendy. Taken together, the 
phenotypic sim ilarity and genetic suppression among 
these mutants suggest that POP2 and P K C I pathways 








the temperature-sensitive growth o f m pkl deletion ceUs 
at 35° (Figure 4 ). Overexpression o f STM 1  suppressed 
the staurosporine- and caffeine-sensitive growth, not 
only o f pop2A mutants, but also o f pkclA , bcklA, mkklA 
mkk2A. or mpkl A  mutants. Thus, S T M  I  may function 
downstream o f these genes. M P TS  overexprcssion sup­
pressed temperature-sensitive growth defect o f mpklA 
deletion celb at 35° (Figure 4 ), but no other phenotype 
o f this m utant These results suggest an interaction be­
tween the POP2 and P K C l-M P K l pathways, and that 
Ccr4 and D hh l may function downstream o f both the 
POP2 and P K C l-M P K l pathways.
POP2 and PK C I pathways may function indepen­
dendy but have overlapping functions. To examine these 
possibilities, double-mutants carrying pop2A dhhl A, pop2A 
mpt5A, and dhhlA mplSA were constructed. They all 
showed temperature-sensitive phenotypes. No pheno­
typic additivity was observed, except that the tempera­
ture-sensitive growth o f dhhl A  mpl5A double-mutant celb 
was not suppressed by 1 M  sorbitol (data not shown). 
On the other hand, haploid celb carrying pkclA  pop2A, 
pkcl A dhhl A, or pkclA mptSA were not recovered. Among
DISCUSSIO N
D hhlp , a putative RNA helicase, associates with 
Pop2p and Ccr4p physically and functionally: We iden­
tified five multicopy suppressor genes o f the pop2 dele­
tion mutation. Two o f these, CCR4 and D H H 1, appear 
functionally related to POP2. The ovcrexpression o f 
D H H 1  or CCR4 rescues all the pop2 defects tested, in­
cluding higb-temperature-sensitivc growth, cold-sensitive 
growth, the inability to use glycerol, and staurosporine 
and caffeine sensitivity (Tables 2 and 3). Overexprcs­
sion o f D H H 1  abo suppresses the growth defects in ccr4 
celb. In  addition, dhhl A  celb display a spectrum o f phe­
notypes similar to pop2A or ccr4A cells. Importantly, D H H 1  
was required fo r the fu ll expression of the A D H 2  gene 
(Table 4 ), another phenotype shared by pop2 and ccrf 
celb. Furtherm ore, celb carrying the double mutations 
pop2A ccr4A, pop2A dhh I  A , or ccrdA dhh IA  showed no 
phenotypic additivity (data not shown; D r a p e r  et aL 
1995). These results suggest that there exists a dose ge­
netic interaction among the POP2, CCR4, and D H H 1  
genes, and that these three proteins function together 
to control transcriptional processes. Because D h h lp  b
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a putative RNA helicase but no defect in  RNA process­
ing was apparent in  dhh l cells, we think that D hh l p is 
involved in  a novel aspect o f gene expression.
Pop2p and D h h lp  were found to interact physically 
(Tabic 5, Figure 3 ), suggesting that D hh lp  is associated 
with the Ccr4p regulatory complex. Because we have 
no evidence to suggest an interaction between C crlp  
and D h h lp  by two-hybrid analysis, it cannot be ex­
cluded that D h h lp  interacts with Pop2p in a complex 
separate from that which associates with Ccr4p. This 
seems unlikely, however, since D hhlp  has also been 
found to coimmunoprecipitate with Db£2p and C afl 7p, 
two other Ccr4p com plex components (unpublished 
observations; L iu  etaL  1997). More importantly, nearly 
all the Ccr4p in the cells copurifed with Pop2p (C aflp; 
M. Liu, personal comm unication), suggesting that there 
is no separate complex. Because there are m ultiple 
components o f the Ccr4p complex, it  is difficult at this 
point to clearly determ ine the order and directness o f 
the interactions between these proteins.
Because overexpression o f P K C I, STM  I,  and MPTS  
suppressed some phenotypes o f pop2A cells, these 
genes m ight function further downstream o f POP2 or 
bypass some Pop2p functions (Table 3). Stm lp has G4 
nucleic acid-binding activity ( F r a n tz  and G ilb e r t  
1995), and a null allele o f the stm l mutation does not 
cause phenotypes, as observed with the other mpt muta­
tions. The relationship between the G4 nucleic acid- 
binding activity and POP2 function remains to be eluci­
dated. M PTS  is required fo r growth at high temperatures 
and for the recovery from  mating factor-induced G1 
arrest ( K ix u c h i et aL 1994), and it is involved in yeast 
cell aging by redistribution o f the Sir2p-Sir3p-Sir4p 
complex from the telomeres to the nucleolus (K e n n e d y  
et aL 1997). M P TS  has been shown to interact with 
Sst2p and Cdc28p, which is involved in the pheromone 
signaling pathway and the cell cycle control pathway, 
respectively ( C h e n  and K u r ja n  1997). Since the M PTS  
gene is also involved in  the stress response, it may be a 
general suppressor o f tem perature stress effects.
Since the pop2A and mptSA showed no phenotypic 
additivity, POP2 and M PTS  also appear to function in  
the same pathway. Based on the facts that overexprcs- 
sion o f D H H 1 o r M P TS  can  suppress the ccr4A mutants, 
whereas overexpression o f CCR4 had no effect on dhhlA  
or mptSA cells (Tabic 3 ), we hypothesize that D H H 1  
and M PTS  function genetically downstream o f CCR4. 
Overexpression o f D H H 1 , however, could not suppress 
any phenotypes o f mpt5A cells and vice versa. Further­
more, the dhhlAmptSA double-mutant cells showed tem­
perature-sensitive growth, and this defect was not sup­
pressed by 1 M  sorbitol (data not shown). These results 
suggest that D H H 1  and M P TS  genetically function in 
two independent pathways that act after POP2 and 
CCR4.
Interaction between the POP2 and P K C l-M P K l path­
ways: The protein kinase C pathway, including PK C I,
BCK1, M K K 1  or M KK2, and M PK1, is im portant fo r cell 
w all integrity in yeast ( T h e v e l e i n  1994). Mutants o f 
P K C I require an osmotic stabilizer (e.g., 1 M  sorbitol) 
for survival. Also, cells carrying the pkclA  o r m pklA  
m utation cannot use glycerol as a sole carbon source 
( C o s t t g a n  et aL 1994, Table 2 ) .  This may suggest that 
the P K C l-M P K l pathway activates the transcription o f 
genes that require nonfermentabie carbon sources and 
those that are involved in cell wall integrity. Since P K C I 
was isolated as a multicopy suppressor o f pop2A, and 
most o f the mpt mutants including pop2 itself showed 
staurospotine-sensitive phenotypes and inability to uti­
lize nonfermentabie carbon sources, and the tem pera­
ture-sensitive cell lysis phenotype o f pop2A and the cold 
sensitivity phenotypes o f ccr4, pop2(cafl), and db/2, were 
suppressed by 1 M  sorbitol (L iu  et aL 1997), it  was o f 
great interest to us to investigate the relationship be­
tween the POP2 pathway and P K C I pathway.
Overexpression o f P K C I suppressed temperature-sen­
sitive growth o f dhhl A or mptSA mutants (Table 3 ) .  This 
suggests that D H H  I  and M PTS  function upstream o f 
P K C I. But cells carrying double mutations o f pop2ApkclA, 
dhhJA pkclA , or mptSA pkclA  were synthetically lethal, 
ruling out a direct and dependent interaction among 
P K C I and POP2, D H H  I,  and M PTS  (data not shown). 
In  addition, the dhhl A  and mptSA mutations were sup­
pressed by overproduction o f P K C I but not by M PK1 
(data not shown), and overproduction o f M PTS  sup­
pressed the mpkl mutation (Figure 4 ). Because cpista- 
sis among these genes is unclear, we speculate that the 
POP2 pathway and the P K C I pathway are two indepen­
dent pathways that have overlapping functions. To clar­
ify this, we are currently searching for the common target 
o f the two pathways. It  should be noted that a w ell- 
accepted model o f the P K C I pathway suggests that 
M PK 1 is cpistatic to P K C I ( T h e v e l e i n  1994). O ur find­
ing that overproduction o f P K C I suppressed the m pkl 
m utation (Figure 4) seems to conflict w ith this model. 
It  is possible that this m ight not be a d irect effect, o r 
that overproduction o f P K C I m ight activate another 
pathway ( L e e  et aL 1993).
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The CCR4 and CAF1 Proteins of the CCR4-NOT Complex 
Are Physically and Functionally Separated from 
NOT2, NOT4, and NOT5f
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The CCR4-NOT complex (I mDa in size), consisting of the proteins CCR4, CAF1. and .NOT1 to NOT5, 
regulates gene expression both positively and negatively and is distinct from other large transcriptional 
complexes in Saccharomyces cerevisiae such as SNF/SWI, TFIID, SAGA, and RNA polymerase II hnioenzyme. 
The physical and genetic interactions between the components of the CCR4-.NOT complex were investigated in 
order to gain insight into bow this complex affects the expression of diverse genes and processes. The CAFI 
protein was found to be absolutely required for CCR4 association with the NOT proteins, and CCR4 and CAFL 
in turn, physically interacted with NOT1 through its central amino acid region horn positions 667 to 1152. The 
NOT3, NOT4, and NOT5 proteins had no significant effect on the association of CCR-1, CAFI. and NOT1 with 
each other. In contrast, the NOT2, NOT4, and NOT5 interacted with the C-terminal region (residues 1490 to 
2108) o f NOT1 in which NOT2 and NOT5 physically associated in the absence of CAFI, XOT3, and NOT4. 
These and other data indicate that the physical ordering of these proteins in the complex is CTR4CAFI- 
i\'OTl-(NOT2, KOT5), with NOT4 and NOT3 more peripheral to N0T2 and NOT5. The physical separation 
of CCR4 and CAFI from other components of the CCR4-NOT complex correlated with genetic analysis 
indicating partially separate functions for these two groups of proteins, ecrd or cafl deletion suppressed the 
increased 3-aminotriazole resistance phenotype conferred by nor mutations, resulted in opposite effects on gene 
expression as compared to several nor mutations, and resulted in a number of synthetic phenotypes in 
combination with not mutations. These results define the CCR4-NOT complex as consisting o f at least two 
physically and functionally separated groups of proteins.
The CCR4-NOT complex from Saccharomyces cerevisiae dis­
plays both positive and negative roles in the regulation of 
diverse genes and processes (6. 9, 20, 25). This complex, dis­
tinct from other large transcriptionally important complexes 
such as SNF/SWI, SAGA, SRB-containing polymerase I I  ho- 
loenzyme. and T F IID  (10, 13, 20), consists of two forms, a 
1.9 x IQ6-Da (1.9-mDa) and 1-mDa complex(20).The smaller 
complex consists of CCR4, CAFI (POP2) (24), the five NOT 
proteins, and several unidentified proteins (20, 22,23). Defects 
in components of this complex reduce expression o f A D H 2  and 
other nonfermentative genes, affect the expression of genes 
involved in cell wall integrity, and suppress rpt(0-induced ex­
pression at the A D I 12 locus (9, 11. 13, 20, 22). Furthermore, 
mutations in CCR4 or C A FI affect cell cycle progression in late 
mitosis (22). The N O T  genes, in turn, were originally identified 
as repressing H1S3 expression from a noncanonical TATA  
(TATA-lcss) element (5, 6), as well as affecting a number of 
other genes and processes (1.8, 16). The recent demonstration 
that not and cafl mutations can suppress a defect in SRB4, a 
key component of the RNA polymerase II holoenzyme re­
quired for the transcription of most genes in yeast (19), further 
indicates a very general repressor role for the CCR4-NOT 
complex. It has been proposed that the NOT proteins inhibit
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transcriptional initiation by affecting TATA binding protein 
access to TATA-lcss sequences (4). a model in agreement with 
the fact that NOT! has been found to associate with TATA 
binding protein (TBP) (19).
Of the proteins of the CCR4-NOT complex, only NOT1 is 
an essential protein (5). The C-tcrminal residues 1319 to 2108 
of NOT1 are sufficient, however, for cells to remain viable (26). 
Pairwise combinations of not mutations do not in general lead 
to synthetic lethality (except for noi4 with notS), suggesting 
chat they form a complex displaying overlapping functions (6, 
23). However, CCR4 and CAFI appear in certain contexts to 
be distinct from the other NOT proteins. Mutations in the five 
N O T  genes result in increased resistance to 3-aminotriazolc 
(3-AT) in a partially defective GCN4 background (6). This 
phenotype is not associated with CCR4 or CAFI detects (20). 
Moreover, not mutations lend to increase 1/O-lacZ and FKSl- 
lacZ expression, whereas a ccr4 or cafl deletion reduces ex­
pression or has little effect on these promoters (20). The CCR4 
and CAFI proteins also appear to be strongly associated: par­
tial disruption of C A FI inhibits the association of CCR4 with 
the NOT1 and NOT2 proteins (20). Therefore, while not al­
leles have several phenotypes in common with card and cap 
defects (20), notably caffeine, temperature, and magnesium 
sensitivities, effects on A DH2 and C Y C I gene expression, and 
suppression of spr/0-enhanced expression, CCR4 and CAFI 
proteins may functionally and physically represent a separate 
group of proteins within the CCR4-NOT complcx.
Wc have analyzed the association of CCR4. CAFI. and the 
NOT proteins and related these associations to the phenotypes 
of the constituents of this complex. The central segment of
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TABLE 1. Yeast strains used Cr. Extract CCMfc
Genotype
-MATa ara7 his3 leu2 ura3A 7 9 0 .
A 7 9 2 ____________MATa aro7 hu3 leu2 m 3  pop2-N3'.tl£U2
K Y 8Q 3  '  ‘  ‘  “  “
K Y 803-1 
K Y 803-C 1.
M Y 8 - 
M Y 8 - ld -  
M Y 8 -c lc _ _
M Y 1 7 3 7 -
M Y 173 8 ..
 MAT* !eu2 PET56 trp l-ltl um3-S2gat2 gcn4-M
 Isogenic to KY803 except cct4 ::U R A 3
 Isogenic to KY803 except cafl\\LEU2
-Isogenic to KY803 except notl-2 
-Isogenic to MY8 except ccr4::USA3 
': to MY8 except cafl vJJTU2 
: to KY803 except hisSr.TKPl ru*lt±EU2  
pRS426-NOTl(396-2108)
..Tsogrnir to KY803 except M A T a  n o tl.-T .E U 2
pRS426-NCm (1319-2108)
MY16________ Isogenic to KY803 except not2-l
MY16-lc---------- Isogenic to MY16 except ccr4~URA3
MYS08________Isogenic to KY803 except not3'-URA3
MY508-clb____Isogenic to MY508 except cafl~LEU2
MY25________ Isogenic to KY803 except not3-2
MY25-lb_____ Isogenic to MY2S except ccr4::URA3
MY537------------ Isogenic to ICY803 except not4-.:URA3
MY537-1----------Isogenic to MY537 not4:im3
MY537-l-lb------ Isogenic to MY537-1 ccr4::URA3
MY1735----------- Isogenic to KY8Q3 except notS~URA3
EGY188______ MAT* um3 hii3 trpl LezA-LEU2
EGY188-1_____Isogenic to EGY188 except ccr4::URA3
EGY188-C1-------Isogenic to EGY188 except cafl-URA3
EGY18S-1-1___ Isogenic to EGY188 except ccr4ram3
EGYISS-cl-l___Isogenic to EGY188 except caflzum3
787-fib________ MATa adkl-11 ADRl-S^-TRPl ura3 his3 leu2 trpl
1076-2c-l  —MATa ura3 his3 Ieu2 trpl ccr4:utm3::TRPl
1278-5d MAT* um3 Us3 Ieu2 trpl cafl\tLEU2
1393-4a------------ MATa his3!his2 Ieu2 um3 noOzTTtPl
1 4 0 2 -la  MATa ura3 HU3 leu 2 trpl nol4-URA3
1402-ta MATa ura3 his3 leu2 trpl not4zURA3
1422-21_______ MATa adhl-11 ura3 hu3 leu2 trpl natIr±EU2
pRS426-NOTl(1490-2108)
1469-2-lc  MAT* ura3 his3 leu2 trpl cet4cura3-TRPl
1462-3 c  MAT* u ra j his3 Ieu2 trpl not5::URA3
NOT1 (residues 667 to 1152) binds CCR4 and CAFI, whereas 
the C-terminus of NOT1 (1490 to 2108) associates with NOT2, 
-4, and -5. We provide evidence that the arrangement of 
the proteins in the complex is CCR4-CAFl-NO"n-(NOT2, 
NOT5), with NOT3 and N0T4 peripheral to NOT2 and 
NOT5. Further, the physical separation of CCR4 and CAFI 
from the other NOT proteins correlates, in general, with phe­
notypes associated with defects in CCR4 and CAFI compared 
to the other N O T  mutations. The CCR4-NOT complex ap­
pears, therefore, to be composed of at least two physically 
separate groups of proteins that can function dilTcrently de­
pending on the promoter context.
M ATERIALS AND METHODS
Yeast stra ins, grow th rnaiHtHas. and rvzyaic assays. Yeast strains (Tabic I )  
were grown a t 30*C on YEP medium (2% yeast extract, 1% Bacto Peptone) o r 
selective m ediant (7 ) supplemented w ith s% glucose o r w ith  2%  galactose and 
2% raihnose unless otherwise indicated. fi-G alactoiidase assays and alcohol 
dehydrogenase (A D H ) assays were carried ou t as described previously (12). 
Assay values represent the averages o f at least three independent assays. The 
yetut transform ation protoco l was as described previously (7, 17).
DNA c o u ili i t  liens The LexA -N O Tl pi««wirf« containing various length o f 
\O T l were constructed as fioOows. For expression o f LexA -N O T l(fi67-1152). 
pLesA -N O T l was cut w ith  dua l H I and X hot and the segment carrying codons 
667 to  1152 was ligated w ith  pLexA2Q2-4 (7 ) cut w ith  the same two ettxymcsL For 
expression o f LexA-N C m (14M -2108). pET28a-NO Tl (Xbcl-SalT) was cu t w ith  
B am H l and S a fi and the segment carrying codons 1480 to 2108 was inserted  in to 
the Bum H I and S a il sites o f pLexA-202-2. F or expression o f L c x A -N O H (l- 
667), pLcxA -N O T l was cut w ith  Ssm HI and S afi, the ends were fille d  in  w ith  the 




FIG . I. CCR4 requires C A F I to  nnm uoopr cr ip io tc  N O T proteins. Im am - 
nopredpitaiions w ith  CCR4 antibody were conducted in  c a fl (A792, p op !) and 
w ild-type (A790) strains. Lanes I  and 2. pro fem  extracts from  strains A790 and 
A792, respectively; lanes 3 and 4. im rm inoprecjp ita tcd (Ip ) proteins analyzed  by 
W estern analysis using antibodies directed against N O T I through NOT5 and 
CCR4. The NOT1 antibody used in  these experim ents could not detect N O TI 
prote in in  crude (c r.) extracts (lanes I  and 2>. bu t other results indicate tha t 
N O TI is  present in  both C A F I- and ca fl-con  tam ing  strains (20).
religated. For expression o f L cxA -N O T l(I—IL 5 2 ), pLexA -N O Tl was cut w ith 
EcoR l asd X h o l and the fragm ent encoding residues 1 to  1152 o f N O T I was 
ligated w ith  pLexA202-2 cut w ith  EcoR I atu t SalL  F o r expreaaoo o f L rxA - 
N O Tl(667-2t08%  pLexA -N O Tl was cut w ith  B am lU  and S a il and the piece 
encoding residues 667 to  2108 was inserted in to  the BamH I  and S a il sites o f 
pLexA2Q2*2. Expression o f a ll fusion prote ins was con firmed by Western bloc 
analysis.
Antibodies and jiw u n o prec ip lta ttoo . F o r W estern analysis, the antibodies 
were directed against glutathione 5-transfcrase (G S T )-C A F  I . GST-NOT2, H ii* - 
NO T5, G ST-NO Tl(1480-2108), and G ST-D H H 1(2£7-S06) fusioc protein*. 
W estcm analysis was conducted as described previously (13). Im m unopretiptta- 
tions were earned ou t as previously describ ed  (12). The C A F I antibody was 
pa rtia lly  purified as described elsewhere (14).
G d filtra tio n  U u iw a lug iapby. The procedure fo r gel filtra tio n  cferom jtogra- 
pby using a Supetose 6 1<V30 column was perform ed as described in  detail 
elsewhere (20) except tha t the running buffe r consisted o f 50 m M  T tis , 150 m M  
potassium acetate, am i 0.02%  Tween 20 only. T h e  Raw ra le  was 0L2 m i/rain, and
0.5 m l was collected per fraction. M olecu lar weights fo r each fraction were 
calculated based on the e lation volumes o f blue dextras (7.5 m l), thyroglobin (12 
m i), and bovine serum album in (16 m l).
RESULTS
CAFI is required for CCR4 association with the NOT pro- 
teins. We had shown previously that deleting C A FI removed 
CCR4 completely from the 1-mDa CCR4-NOT complex and 
reduced significantly but did not eliminate CCR4 association in 
the 1.9-mDa complex (20). We have also shown that CCR4 is 
dependent on CA FI in its association with N O TI and NOT2 
(20). Using a complete deletion of C A F I, we further investi­
gated the dependency on CAFI for CCR4 for interaction with 
the other NOT proteins. In a wild-type strain, immunopredpi- 
tation of CCR4 with anti-CCR4 antibody brought down NO TI 
through NOT5 (Fig. 1, lane 3). In contrast, in a cafl deletion 
strain, none of the NOT proteins coimmunoprecipitated with 
CCR4 (lane 4), although all NOT proteins were present in the 
crude extract (lane 2). CAFI protein is therefore required for 
CCR4 to assodate with all NOT proteins.
Physical interactions o f CCR4-CAF1-NOT1 are indepen­
dent of the N O D , NOT4, and NOT5 proteins. Since the above 
results suggest that the arrangement of proteins is CCR4-
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FIG . 1  CCR4 i f i r i i f f  w ith  C A F I in  the abaeoce o f SO T3. KO T4, S 0T5. 
and the K-tcrmmml 396 re tid a c* o f N O T I. (A ) Im m anop rccip ita tions (Ip ) were 
conducted w ith «nti-CC R4 antibody. W estern analysis was conducted w ith  acti- 
body directed »g»«m N O T I, SO T3, CCR4, NO T4, C A F I. NOTZ, o r NOT5 as 
indicated. A n i-fj»m iiu |p jw F ifw uyA M ed system was used fo r N O TI.
CCR4, and NO T3 W estern b lots fo r lanes 1 to  4, whereas an alkaline phos­
phatase-baaed system was used fo r the rem ainder o f the results. S trains: w ild  type 
(w t), KY8Q3; no ti-2 , M Y8; m *3 , M Y508; not4, M Y537; not5, M Y 1735. (B ) Yeast 
extracts from  KY8G3 (w ild  type [w t]), 1393-4a (nor2), and M Y1735 (no<5) were 
analyzed by gel filtra tio n  chrom atography using a Superoae 6 1<V30 colum n. The 
prote in extracts were predeared by centnfugatioo a t 100,000 x  g  fo r I  m in, and 
200 (U o f sample was loaded onto the colum n. The flow  rate was 0.2 mlAmn, and 
a 05-m l volume arts collected in  each fra c tio n ; 100 pJ from  each fraction  were 
analyzed by sodium dodecyt sulfate-polyacrytam ide gel electrophoresis and 
W estern b lo tting  using CCR4 and C A F I antibodies. M olecular w eight markers 
fo r the gel filtra tio n  experim ent were blue dextran (2  x  10* D a ), thyroglobulin 
(0.67 x  10* Da), and bovine serum album in (& d  x  10* D a). (C ) lam njoopre- 
apitanons were conducted in  strain M Y  1737 [noel pN O T l (396-2108)1 *bd 
type backgrounds w ith  C A F I antibody. Lanes 1 and 2  contain I/IO  o f the crude 
c rtra c t (C r. Ex.) p ro te in  in pu t used fo r the im m unopredpitadocxs (Ip ) in  lanes 3 
and 4. Western analysis was conducted w ith  anti-CC R4 and anti-N O T  antibodies 
as indicated. NO T4 and N O T2 proteins in  the crude extracts in  lanes 1 and 2 
were visible in  the o rig in a l W estern Moca and were in  equal abundance fo r the 
two strains. tgG . im m unoglobulin G.
CAFl-NOTs, we subsequently examined what factors were 
required for CCR4, C A FI, and N O T I to associate. Immuno- 
predpitation of CCR4 shewed that N O TI and CAFI can be 
coimmunoprectpitated in noc3-, not4-, or notS-deleted back­
grounds (Fig. 2A, lanes 3 to 5). (For lane 5, the CAFI protein 
was dearly visible in the original Western results.) The same 
results were obtained when anti-CAFl antibody was used for 
immunopredpitatkra (data not shown). The observation that 
the CCR4-CAF1 interaction was not dependent on NOTS was 
further confirmed by gel filtration analysis (Fig. 2B, middle





1 2  3 4
panel). In a notS strain, CCR4 and CAFI cofractionatcd in 
both 1.9-mDa (fractions 3 and 4) and 0.8-mDa (fractions 11 to
13) complexes which have been previously described for CCR4 
and CAFI (20) (Fig. 2B, top panel. in which CCR4 migrates in 
fractions 3 and 4 and fractions 10 to 12). I t  should be noted 
that the smaller complex in the notS strain runs at a slightly 
smaller size (0.8 mDa) than the wild-type strain (0.9 oD a), 
probably due to loss of the NOTS and other potential proteins. 
Also, the 0.9-mDa CCR4-NOT complex observed for the wild- 
typc strain runs at slightly smaller size than in the strains used 
in our previous study (20).
We also conducted gel filtration analysis in nol3 and nol4 
backgrounds. In a noi3 deletion strain, CCR4 and CA FI still 
migrated in large and medium complexes but the proteins were 
dearly more spread out, suggesting that their stability in the 
complexes was being compromised (data not shown). A noi4 
deletion had no apparent effect on CCR4 or CAFI migration 
in the 1.9- and 0.8-mDa complexes (data not shown). CCR4
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and CAFI can therefore still associate in the CCR4-NOT 
complex in the absence of noi3, not4, or notS, although these 
deletions may cause subtle effects on the structure and integrity 
of the complex. It  should also be mentioned that in contrast to 
CCR4 and CAFI, the association o f several other components 
of the CCR4-NOT complex could not be determined by gel 
filtration chromatography- NOT2 protein was hardly detect­
able after Superose 6 chromatography, N O T! tended to mi­
grate at its monomeric size, and NOT5 and N O TI did not tend 
to migrate in well-defined peaks as was observed for CCR4 and 
CAFI (data not shown).
The above results indicate that CCR4 and CA FI can asso­
ciate with NOTI in the absence of NOT3, NOT4, or NOT5. In 
a not2 strain, however, the association of CCR4 with CAFI and 
the NOT proteins could not be ascertained by immunopredpi- 
tation due to the inability to immunopredpitate sufficient lev­
els of CCR4 and CAFI proteins. This may be partially the 
result of the very low amount of C A FI and several of the NOT 
proteins present in the extracts (data not shown; see also Fig. 
5), but it may also result from overall instability of the complex 
and susceptibility to proteolytic degradation in a not2 back­
ground. Our gel filtration analysis indicated that CCR4 still 
migrated in 1J9- and 0.9-mD complexes in a not2 background 
(bottom panel of Fig. 2B), but the presence of C A FI in the 
0.9-mDa complex could not be determined and only a very 
small amount of CA FI was visible in the 1.9-mDa complex 
(data not shown). In a not2-l strain background, CCR4 and 
CAFI migrated in both 1.9- and 0.9-mDa complexes (data not 
shown). These results suggest that NOT2 affects the overall 
integrity of the complex but may not be required for CCR4 
association in the CCR4-NOT complex.
It is also apparent in Fig. 2A that when CCR4 Is immuno- 
predpitated, NOT4 is not required for NOT2, -3, and -S to 
associate with CCR4, CA FI, and N O TI, and similarly, NOT3 
is not required for NOT2, -4, -5, to assodatc with CCR4, 
CAFI, and NO TI. In a notS background, however, because of 
the decrease in abundance of NOT3, NOT4, and NOT2 pro­
tein levels in the crude extracts used for the immunopredpi- 
tation (data not shown), we could not ascertain if these three 
NOT proteins assodatcd with CCR4, CA FI, and NO TI fol­
lowing the immunoprecipitation. These results confirm that 
CCR4 and CAFI are tightly if not directly linked, that NOT3 
to NOTS are not required for CCR4 and C A FI association or 
with their assotiation with N O TI, and that neither NOT3 nor 
NOT4 is required for NOT2 and NOTS assodation with 
CCR4, CAR, and N O TI.
The C terminus of NOTI is not required for CCR4 and 
CAFI association. We used several complementary ap­
proaches to identify the region of N O T I which interacted with 
CCR4 and CAFI. Since a notl deletion is lethal, we initially 
used two truncated versions of N O T I to assess the NOTI 
requirement for CCR4 and CAFI association. First, we ana­
lyzed the notl-2 allele. The notl-2  allele results in a NOTI 
protein that is about 120 IcDa in size (Fig. 2A, lane 2) and has 
been reported to be the result of a stop codon located in the 
region between residues 396 and 1318 of N O TI (26). About 
10% of the notl-2 protein is full length, which is apparently 
sufficient for the yeast to survive. The truncated notl-2 protein 
still coimmunopredpitatcd with cither CCR4 or CA FI (Fig. 
2A, lane 2, and data not shown). However, NOTS and NOT4 
no longer immunoprecipitated with CCR4 in a notl-2  strain 
(Fig. 2A, lane 2), and the amount of NOT2 was significantly 
reduced in the immunoprecipitation. The reduced amount of 
NOT2 that coimmunoprecipitated could be derived horn 
NOT2 binding to the full-length NO T! protein (Fig. 2A, lane 
2). NOTS, NOT2, and NOT4 appear, therefore, to interact
with the C-tenninal region of N O TI, a result confirmed by 
other results described below.
Second, we examined whether the CCR4-CAFI interaction 
required the N-terminal 395 codons of NO TI. Immunopredpi- 
tating CAFI coimmunoprecipitatcd a significant amount of 
CCR4 in a strain carrying N O TI (396-2108) (Fig. 2C, lane 3). 
The central region of N O TI (residues 396 to about 1100) 
appears sufficient, therefore, for CCR4 interaction with C A F I, 
although the N-terminal 39S residues of NOTI appear to aid 
the stable association of CCR4 with CAFI (Fig. 2C; compare 
lane 3 with lane 4).
An internal segment (residues 667 to 1152) of NOTI is 
sufficient for binding CCR4 and CAFI. To examine more thor­
oughly the region of N O T I that interacted with CCR4 and 
CAFI. we expressed in yeast several LexA-NOTl fusions and 
determined their ability to be coimmunopredpitated with 
CCR4 and C A FI. Three LexA-NOTl fusions, LexA-NOTl 
(667-1152). LexA-NOTl (667-2108), and LcxA-NOTl(l-1152). 
were coimmunoprecipitatcd with CCR4 (Fig. 3A, lanes 6, 9, 
and 10) or C A FI antibody (data not shown). In contrast, the 
LexA-NOTl (1-667) and LexA-NOTl( 1490-2108) could not 
be coimmunoprecipitatcd with CCR4 or CAFI (Fig. 3A , lanes 
7 and 8, and data not shown). Residues 667 to 11S2 of N O T I 
are. therefore, sufficient for binding CCR4 and CAFI, a con­
clusion that agrees with the ability of CCR4 and/or C A FI to 
immunopredpitate both the truncated notl-2 protein and 
NOTI (396-2108).
Tbc N-terminal 1318 residues of NOTI are required for 
assodation of CCR4 with CAFI in the 0.9-mDa complex. We 
further analyzed CCR4-CAF1-NOT1 interactions by Superose 
6 gel filtration. Removing the N-terminal half of NOTI (resi­
dues 1 to 1318) caused the dissodation of CCR4 from the 
0.9-mDa complex peak fractions 10 to 12 (compare Fig. 4B 
with Fig. 4 A ), suggesting that residues 1 to 1318 of N O TI are 
required for the physical integrity of CCR4 in this complex. 
Very little C A FI protein could be detected following Superose 
6 chromatography (data not shown). The total C A R  protein 
level was reduced in the strain carrying NO TI (1318-2108) 
(Fig. 5), but that reduction alone cannot explain the extremely 
low level o f total CAFI in all Superose 6 fractions. The C A FI 
protein may be particularly sensitive to degradation without 
the presence of the N terminus of NO TI. Deleting the N- 
terminal 395 codons of N O TI had no effect on CCR4 migra­
tion in either the 1.9- or 0.9-mDa complex (Fig. 4C). The gel 
filtration profile of CCR4 in the notl-2  strain showed that 
CCR4 migrated at 1.9 mDa and about 700 kDa (fractions 12 to
14). The shift o f the 0.9-mDa peak may be the result of both 
the truncated notl-2 protein being about 70 kDa smaller than 
NOT! and the loss of the NOT5 and NOT4 proteins (Fig. 2A). 
CAFI was also found to migrate in 1.9- and 0.9-mDa peaks in 
the notl-2 strain and in 1.9- and 0.9-mDa complexes in the 
N O TI {396-21OS) strain (data not shown). These gel filtration 
results agree with the above immunoprcdpitation results and 
indicate that in order for the CCR4-CAF1-NOT1 proteins to 
assodate in the 0.9-mDa complex, NO TI must contain resi­
dues 396 to about 1100.
The C-terminai region from residues 1490 to 2108 of NOTI 
interacts with NOT2, NOT4, and NOTS. Because the C-termi- 
nal part of N O TI was required for NOT5, NOT4, and NOT2 
to assodatc with CCR4, CA FI, and NOT! (Fig. 2A, lane 2), 
we initially used two-hybrid analysis to examine interactions of 
LexA-NOTl(1490-2108) with the NOT components of the 
CCR4-NOT complex (20). B42-NOT2, B42-NOT4, and B42- 
NOT5 all interacted with LexA-NOTl(1490-2108) (410, 520, 
and 77 U of [3-gaIactosidasc/mg, respectively). As expected 
from the immunoprcdpitation analysis, neither B42-CAF1 nor
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F IG . 3. Loca liza tion  o f the N O T I p ro te in  region that a  sufficient fo r binding CCR4. (A ) LexA -N O T l(667-I15Z) is sufficient fo r binding to  CCR4 and C A F I. 
LexA -N O T l fusions as indicated were expressed in strain EGYLS8, and im m uaopredpttations were conducted w ith snu-CCR4 antibody. W estern analysis was 
conducted w ith  a n ti-LexA  antibody. The erode protein extracts in  lanes I  to  5 contain 1/10 o f the am ount o f extract used fo r the im atm opreciptta tions (Ip ) displayed 
in  lanes 6 to  10, respectively. IgG , im m unoglobulin G . (B ) The C  tenninus o f N O T I binds NO T2, NO T4. and NOTS. Strain EG YIS8 containing e ithe r L e x A -N O T l(l- 
1152) o r LexA -N O T l(1 *W “ Z108) was im m unoprecipitated w ith  LexA  antftody. W estern analysis using the antibodies as indicated was conducted as detailed in  Fig.
1. C r. E l,  crude <
B42-CCR4 interacted with the C-terminal region of NO TI (55 
and 3.0 U of 0-galactosidasc/mg, respectively; values for B42- 
NOT1, B42-NOT3, and B42 were 5.8, 43, and 3.2 U  of 0-ga- 
Iactosidase/mg, respectively). To further analyze the interac­
tion of the C terminus of N O TI with other components of the 
CCR4-NOT complex, we immunoprecipitated LexA-NOTl 
(1-1152) and LexA-NOTl(149O-2108) with LexA antibody. 
As displayed in Fig. 3B, lane 4, the C-terminal portion of 
NOT1(1490-2108) was able to immunopredpitate NOT2, 
NOTS, and NOT4. In  contrast, LexA-NOTl(l-1152) did not 
immunopredpitate these proteins and instead immunopredpi- 
tated CAFI (Fig. 3B, lane 3) and a small amount of NOT3 (not 
shown). While CCR4 did not immunopredpitate with either 
LexA fusion, in Fig. 3A it dearly interacted with residues 667 
to 1152 to N O T I. The above immunoprecipitation, gel filtra­
tion, and two-hybrid analysis indicate, therefore, that the 
NO TI protein contains two separable domains, 667 to 1152 for 
binding CAFI and CCR4 and 1490 to 2108 for interacting with 
NOT2, NOT4, and NOTS.
The effects of deleting the different regions of N O T I on 
AD H 2  expression were subsequently analyzed. NOTl(1318- 
2108) resulted in a two- to threefold decrease in ADH II  
activity compared to NOT1(396-2108) or full-length NOTI 
(Table 2). LexA-NOTl(1490-2108) resulted in a similar low 
level of A D H 2  expression (Table 2). Cocxpressing in yeast 
LexA-NO Tl(l—1152) along with NOT1(1318-2108) allowed a 
twofold increase in A D H  □  activity. In contrast, coexpressing 
LexA -NO Tl(l-667) was insuffident for recovering the ability 
of NOT1(1318-2108) to fully activate ADH2. The 667-1152 
region of NO T! that binds CAFI and CCR4 appears, there-
NOT1 g
CCR4
N O T I-1319-2108
CCH4
2 3 4 g g 7 8 9 10 11 12 13 141$ 18 17 18 I t  80
NOT1-399-2106
4 S « 7 8 t  10 11 I t  1314 IS 1817 18 1 t
D not1-2
CCR4 j
2 3 4 8 •  7 8 9 10 11 13 13 14 IS 1« 17181 8 »
F IG . 4. G el filtra tio n  analysis o f CCR4 in  N O TI m utant backgrounds. (A ) 
Strum  KY803 (w ild  type); (B ) strain MY173S [n o tl pN O T l(1319-2108)); (C ) 
stra in  M Y1737 [n o tl pN O T l(396-21OS)]; (D ) strain M Y8 (n o tl-Z ). G el filtra tio n  
chrom atography was conducted as described fo r F ig. 2B. A nti-C C R 4 antibody 
was used to  detect the CCR4 protein.
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FIG . 5. CCR4. C A F I, aod .VOT5 prote in ic rc lt in  not o u ts a t backgrounds. 
A il strains were grown to  m id-tog phase in  YEP m edium containing S% gin cose. 
Cells were harvested and tyted, and 40 }Lg o f to ta l protein >ras loaded in  each 
lane. The R N A  helfcaac bomofog D H H 1 was used as an in te rn a l contro l to 
dem onstrate equivalent Inarimg on the sodium dodccvl sulfate-polyacrylam ide 
gel. S trains used: KY8Q3 (w ild  type [w tj); h fV 8 M Y1737 [n o tl pN O TI
(396-2106)]; M Y17M  [n o tl pN O n(1319-2l08)I; M Y16 (m x l-fy  1393-la <«x2); 
M Y508 (hocT); M Y537 (no**); MY173S (norS). W estern b lo t analysis was con­
ducted w ith  antibodies directed against CCR4, C A F I. NOTS. and DHH1 as 
indicated.
fore, to be necessary for recovering in mans NOT1(1318-2I08) 
function and confirms the existence of two distinct functional 
regions of N O TI.
NOT2 and NOT5 associate closely and in the absence of 
CAFI, NOT3, or NOT4. NOT5-NOT2 interactions were also 
analyzed following the observation that when LexA-NOT5 is 
immunoprecipitated with anti-LexA antibody, all components 
of the CCR4-NOT complex can be coimmunoprecipitatcd 
(Fig. 6A, lane 1). Immunoprccipitau'on of LexA alone does not 
coimmunopredpitate any of these proteins (reference 20 and 
data not shown), indicating that it is the NOTS moiety which is 
interacting with these proteins. As shown in Fig. 6A , lanes 2 to 
4, NOT2 was capable of immunopredpitating with LexA- 
NOT5 in the absence of CAFI, NOT3, or NOT4. As expected 
no CCR4 was capable of coimmunopredpitating with LexA- 
NOT5 in the absence of CAFI (Fig. 6A, lane 2). It  should be 
noted that in the original results (Fig. 6A, lane 3) some CCR4 
protein was immunoprecipitated with LexA-NOTS in a not3 
strain. These results arc in agreement with the physical sepa­
ration of CA FI and CCR4 from the NOT2 and NOTS proteins 
and the dependency on CAFI for CCR4 association with these 
other factors. Moreover, NOT3 and NOT4 had no effect on the 
ability of LexA-NOTS to coimmunopredpitate C A FI, NOT2, 
or NO TI, although NOT3 may play a role in stabilizing CCR4 
interactions with the complex. We subsequently used anti- 
NOT5 antibody to analyze more completely the NOT5-NOT2 
assodation. Anti-NOTS antibody immunopredpitatcd only 
NOTS, NOT2, and a small amount of N O TI (Fig. 6B, lane 2). 
While the NOTS antibody may interfere with the association of 
NOT5 with the rest of the CCR4-NOT protein components, its
ability to immunopredpitate NOT2 confirms a dose physical 
association of NOT2 and NOTS.
NOTS associates with the CCR4-NOT complex indepen­
dently of CCR4, CAFI, or NOT4- Immunopredpitating NOT3 
was also found to coimmunopredpitate the whole CCR4-NOT 
complex (Fig. 6C, lane 1). We therefore investigated the effects 
of various deletions in CCR4-NOT components on NOT3 im- 
munopredpitation of the complex. Deleting CCR4 bad no ef­
fect on NOTS associations (Fig. 6C, lane 2), whereas cafl, as 
expected, resulted in only CCR4 not being able to associate in 
the complex (lane 3). Deleting NOT4 also had no effect on 
NOT3 interaction with the other components of the complex 
(Fig. 6C, lane 4). In notl-2, not2, or notS strains, NOT3 could 
not be immunopredpitatcd, suggesting that NOT2. NOTS, and 
the C-terminal region of N O TI are required for stable NOT3 
assodation with the rest of the complex or existence in an 
immunoprccipitablc form.
CAFI and CCR4 can act phenotypically opposite NOT2, 
NOT4, and NOTS. Previously we had shown that a cafl orccr4 
deletion resulted in no or very little increased 3-AT resistance 
(20) whereas mutation or deletion of the N O T  genes is known 
to cause increased 3-AT resistance, indicative of increased 
HIS3 gene expression (6, 23). The not4 and not5 deletions also 
resulted in increased A D R l-f- activation of A D H 2  under glu­
cose growth conditions (ADH I I  activities of 370 -  24 and 
220 z: 10 mU/mg. respectively, versus 94 ±  7.6 mU/mg for 
A D R I-S0), whereas a cafl deletion had no effect aziADRI-S*- 
activation of ADH2 and a ccr4 deletion reduced twofold the 
ability of A D R 1 -S to activate (A D H  II activities of 95 — 7.4 
and 45 = 1.4 mU/mg. respectively). Similar differences be­
tween the effects of cafl and ccrt effects on gene expression 
and the effects of the not alleles were reported previously (20). 
The most salient of these is the reduction in HO-tacZ and 
FKSl-lacZ expression caused by ccr4 and cafl alleles and the 
two- to threefold increases in H O -lacZ  or FKSl-lacZ  expres­
sion caused by notl-2, not2, and not4 defects (20). These phe­
notypic effects support the existence of the separate location of 
these groups of proteins within the CCR4-NOT complex.
Since deleting N O T I is lethal, we examined the effects of 
deleting components from the two separate groups of proteins 
in the CCR4-NOT complex. Suitable crosses were made be- 
tween either ccrt or cafl deletions and not deletions, and the 
viability of different deletion combinations was analyzed by 
tetrad analysis. As shown in Table 5, not2 and notS were lethal 
in combination with either ccr4 or cafl. Lethality was con-
TAB1.K 2. Effects of n o tl truncations on A D H 2  expression*
N O T I plasmid LexA  plasm id
A D H  IT activ ity 
(mV/m g: mean 
:  SEMT
N O T I (396-2108) N o ne 2 ^0 0  =  450
N O T I(1 3 19-2108) N o ne
L e x A -N O T l( 1-2108 ) 
L c x A -N O T l( l- l 152) 
L c x A -N O T T ( 1 -6 6 7 )
910 — 150 
2 J 0 0 -e  150 
1.800 r  120 
* 3 0 -  100
N one L c x A -N O T l( 1 -2108 ) 
L c x A -N O T I (1 4 9 0 -2 1 0 8 )
2 3 0  =  320 
1,000 -  230
* A D H  I t  assays were conducted a fte r grow th o f stra in  1422-21 on YEP 
medium  containing 3 ethanoL A D H  I I  activ ities in  a strain carrying an in te ­
grated fulM cagth N O TI gene is generally 3-500 tn  3.000 tn lf/m g . LexA plasmids 
contain S O T] sequences fused to LexA-202 \7 ). N O T I plasmids were pRS426 
derivatives.
*  Average o f a t least three separate transform ants.
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FIG . 6. N O T S co im m u o o p re a p ita *« « rith N O T 2 iB iiie it« e n ce o fC A F l.N O T 3 .» a d N O T 4 .(A )L c iA -N 'O T S im flju n o p rte ip tc« t< 3 N O T 2 in th e ita ra ce o fC A F I. 
NO T?, u id  NO T4. tm m onoptxc ip ira tio tis  (Ip ) * * rc  conducted w ith  »3ti-LexA  antibody, and W estern analysis used antibodies as indicated; LexA-NOTS is ftiU-Jength 
NOTS fused to  L *xA (l-2 0 2 ). Lane*: 1. KY803 (w ild type [w t]); 2 . KY8Q3-C1 (c a fl): 3 . MYSC6 (n o tl); 4, M Y537 (no t*). In the orig ina l W estern b lots. CCR4 was 
im m unoprccip itaied in  la tte  3. (B ) NO TS antibody im nrnnopreapitales NO T2. A ntibody against CCRa (lane 1) o r NOTS (lane 2) was used fo r h rununoprecip ita tio iu  
from  stra in KY803. (Q  NO T3 inununoprecipitates NO TL NO T2. and NOTS in  the absence o f CCR4. C A F I. and NOT4. Anu-N'OT3 andbody was used to  conduct 
the im m unoprecipitationa. W T (w ild  type), strain KY803; c tr i.  KYS03-1: c a fl. KYSQ 3-el: n o t*. M Y537. W estern analysis was conducted as deta iled above.
firmed in ail cases by ascertaining whether a plastnid-bomc 
copy of one of the deleted genes could rescue the lethality. In 
addition, in all cases where the lethality was rescued by the 
plasmid-borne gene, the plasmid could not be lost from the 
cell, confirming the lethality of the double deletion. These 
synthetic lethalities are consistent with the importance of 
N'OT2 and NOTS to the integrity and function of the CCR4- 
NOT complex and to a role that is in addition to and/or 
separate from CCR4 and C A FI. Whereas deleting not3 did not 
result in synthetic phenotypes with either cafl or ccr4, the 
notl-2  mutation dearly resulted in exacerbated growth pheno­
types with ccrt (Tabic 3). notl-2  also displayed synthetic 
growth defects with a ccr4 or cafl deletion (Table 3), consistent 
with the observation that in a notl-2  strain, NOT2, NOT4, and 
NOTS assodatc in the complex less well due to the increased 
levels of C-terminally truncated N O TI protein (Fig. 2A, lane 
2)-
The hallmark of the not alleles is their increased resistance 
to 3-AT, yet the ccrt and ca fl alleles do not display this phe­
notype (20). Because of the possible antagonistic behavior of 
CCR4 and CAFI in relation to the other NOT proteins, we 
tested the effect of a ccr4 or cafl deletion on the ability of not 
alleles to confer increased 3-AT resistance. We observed that 
a cafl or ccrt deletion suppressed the increased 3-AT resis­
tance o f notl-2, not3-2, and nott alleles (Table 4), confirming 
that CCR4 and CAFI can act in an opposite manner to the 
NOT proteins in certain promoter contexts.
DISCUSSION
CCK4-CAFI interact with the N-terminal 1152 residues of 
NOTI, whereas NOT2, NOT4, and NOTS interact with the 
C-terminal 149A-2IM region of NO TI. It was shown previ­
ously that disrupting the C A FI gene blocked the ability of
CCR4 to associate with NOTI (20). In this report, we showed 
that CA FI is required for CCR4 to associate with all o f the 
NOT proteins. NO T3, NOT4, and NOTS were, in turn, found 
not to be required for CCR4-CAF1-NOT1 association or for 
CCR4 and CAFI association in the 1-mDa complex. Relatedly, 
immunopredpitating NOT3 or LexA-NOTS did not coimmu- 
noprecipitate CCR4 when CAFI was deleted. These results 
clearly indicate that CCR4 binds through C A FI to associate 
with N O TI and the other components of the complex (Fig. 7 
summarizes the interactions in the CCR4-NOT complex).
The region of N O TI with which CCR4 and C A FI physically 
associate was found to be distinct from that bound by the 
NOT2, NOT4, and NOTS proteins. Several lines of evidence 
indicate that the region of NOTI binding CAFI is localized to 
residues 667 to 1152. First, CCR4 or CAFI could immunopre­
dpitate an internal segment of NO TI (residues 667 to 11S2). 
Second, when the immunoprecipitation was conducted in the 
reverse direction, LexA -NO Tl(l-l 152) immunopredpitatcd 
CA FI but LexA-NOTl(1490-2108) did not. Third, in a notl-2  
strain wherein the major NOTI species contains only the N - 
terminal 1,000 residues or so of NO TI, both CCR4 and CA FI 
immunoprecipitated with the notl-2 protein. Fourth, removing 
the N-terminal 39S residues of NO TI did not abrogate the 
ability of CAFI to immunopredpitate CCR4, although the 
N-terminal segment of NOTI dearly played some role in sta­
bilizing the CCR4-CAF1 interactions. Finally, when the N- 
tcrminal 1,318 residues of NOTI were removed, neither CCR4 
nor CA FI was able to assodatc in the 1-mDa complex.
In contrast to the above results, the region of N O T I that 
associates with NOT2, NOT4, and NOT5 was localized to the 
C-terminal portion of NO TI (residues 1490 to 2108). The 
NOT2, NOT4, and NOTS were found to display two-hybrid 
interactions with LexA-NOTl(149O-2108), and immunopre-
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T A B L E  3 . S y n th e tic  le th a litie s  betw een d e le tio n s  in  c c r t  and  c a fl 
an d  m u ta tio n s  in  th e  n o t genes*
C onstruct
G row th
w t ccr* c a fl
w t + +
n o tl-2
30°C + + -*•
34°C + - -
p N O T I(1 4 9 0 -2 i0 8 )
n o tl + L e th a l N D
n o tl — L e th a l L e th a l
n o (2 -l
30°C + N D
34*C + — N D
n o t3 + + -i-
n o t3 -2
30*C _ N D
37*C + - N D
n o t4 + + -r
notS + L e th a l L c th a l
'  G row th was determ ined a t 30*C on YEP medium supplem ented w ith  2%  
glucose onless otherw ise indicated, f  .g row th ; no grow th; le tha l, the  gene p a ir
resulted in  ce ll death; N D , not done. Isogenic strains used: w ild  tvpc (w t), 
KYS03; n o tl-2 *  M Y 8; n o tl-2  ccr*, M Y S -ld ; n o tl-2  c a fl, M Y S ^ Ic ; n o d , M Y508; 
notS c a fl. M Y S O frclb ; noC -1, M Y16; noC-1 c a *, M Y lS -lc ; notS, M Y508; noeS 
c a fl. M Y 50S -clb; not3-2. M Y25; noe3-2 ccr4, M Y2S -lb; n o t*. M Y537-1; n o t*  
ccr*, M Y 5 3 7 -l-lb . not3 c a *  aegregan a  were obtained from  I076-Zc-1 x  M Y508 
crosses, and no t4 c a fl aeg reg n tt were obtained from  1278-5d x  1402-la and 
1278-5dx 1402-4a cos ie s . pN O T 7(l480-2 l06) n o tl a r fle ih a & y w a i confirm ed 
by analysis o f scgregnnts o f d ip lo id  1471 [1422-2l/pNO T1(1480-2108)/pLcxA - 
N O T l x  1469-2 -lc], ccr4 n o tl le th a lity  was conf irmed from  s tra in  1441 (188*1/ 
pLexA-NTO T2 x  1393-4a ), ccr* notS le th a lity  w»  confirm ed from  strain 1469 
(1076-2c-l/pLexA N O T5 x  1462-3a), c a fl n o tl le tha lity  was confirm ed from  
stra in  1442 (188 -c l/pLexA -C A F l x  1393-4*), and c a fl notS  le th a lity  was con- 
finned from  stra in  1469 (1076-2c-l/pLcxA-N O T5 x  1462-3c)-
ripitating LexA-NOTl(1490-2108) coimmunoprecipitatcd 
NOT2, NOT4, and NOT5. As a comparison, immunopre- 
cipitating LexA -N O Tl(l-1152) failed to coimmunoprecipi- 
tate these proteins. Moreover, in the notl-2 strain, NOTS and 
NOT4 did not immunopredpitate with CCR4 or CA FI and 
only a limited amount of NOT2 coimmunoprecipitatcd (pos­
sibly due to assodation with the residual full-length N O TI still 
present in the cell). Finally, NOT2, NOT4, and NOT5 were 
coimmunoprecipitatcd tn the absence of C A FI when either
T A B L E  4 . c a fl and  c c r*  d is ru p tio n s  suppress n o r-in d u ce d  
3 -A T  phenotypes*
Relevant genotype
Growth on 3 -A T  (m M )
0 5 10
W ild  typ e + - —
c a fl + — -
car4 -r — —
n o tl-2 + -i- +
n o tl-2  c a f l w —
n o tl-2  c c r* F — —
n o t3 -2 + +
n o t3 -2  c c r* + — —
n o t4 t- — 4-
n o t*  c a fl + — -
n o t*  c c r* + - -
'  A ll strains are isogenic to  KY803 except fo r the indicated a lle le . G row th was 







F IG . 7. M odel fo r prote in co n ttcu  in  the C C R 4-N O T com plex. Based on the 
results presented herein .  C A F I is presumed to b in d  to  residues 667 to  1152 o f 
NO T1.C C R 4 binds to  C A F I, and NO T2 and NO T5 in te ra c t w ith  the C -tena ios i 
residues 1490 to  2108 o f N O T I in  no p a rticu la r o rde r. N O T4 is placed on the 
periphery o f NOT2 and NO T5, and it  is presumed th a t NO T3 makes contacts 
w ith  both NO T2. NOT5. o r N O T* and the N  term inus o f N O T L
NOT3 or LexA-NOTS was immunoprecipitated. These results 
indicate that it is the C-terminal portion of N O TI protein 
(residues 1490 to 2108) that binds NOT2, NOT4, and NOT5. 
These data establish a clear physical separation of CCR4 and 
CA FI from NOT2, NOT4, and NOT5 through their binding to 
separate regions of N O TI. Other limited interactions between 
these two groups of proteins can not be excluded, however.
Our data further show that NOT2 and NOTS are closely 
linked. First, deletion of either of these components tends to 
result in decreased abundance of several other components in 
the complex. NOT2 and NOTS appear to have general effects 
on the integrity or stability of the CCR4-NOT complex. Sec­
ond, both proteins interacted in the two-hybrid system with the 
C-terminal segment of N O TI and immunoprecipitated with 
the same segment of N O TI. Third, NOT3, NOT4, C A FI, or 
CCR4 defects did not affect the ability of LexA-NOTS to 
immunopredpitate NOT2. Fourth, NOT5 antibody coimmu- 
nopredpitated NOT2, some N O T I, and no other CCR4-NOT 
component. These data implicate a dose physical assodation 
between NOT2 and NOT5 that is important to the stability of 
the CCR4-NOT complex.
While NOT3 and NOT4 appear to be peripheral to NOT2 
and NOT5, the location of the NOT3 protein could not be 
readily determined. For one thing, in all mutant strains that we 
analyzed by gel filtration analysis, NOT3 migrated at or near its 
monomeric size. NOT3 appears to be less stably associated 
with the CCR4-NOT complex. Immunopredpitating CCR4 
and CAFI showed that NOT3 failed to coimmunopredpitate 
in a notl-2  strain, suggesting NOT3 assodatcd with the C 
terminus of NO TI. However, when LexA -NO Tl(l-1152) was 
immunoprecipitated, a small and reprodudble amount of 
NOT3 was coimmunopredpitated. No NOT3 was observed 
to coimmunopredpitate with LexA-NO Tl(l490-2108). Also, 
NOT3 did not require NOT4 for assodation with N O T I, 
CCR4, or CAFI. Since neither a not3 nor a not4 deletion 
affected the ability of LcxA-NOT5 to immunopredpitate 
N O TI, CCR4. CAFI, or NOT2, it appears that NOT3 and 
NOT4 are peripheral to NOT2 and NOTS. However, a not3 
deletion did reduce the ability of LexA-NOTS to immunopre­
dpitate CCR4. In Fig. 7. we therefore assign NOT3 a place 
that includes contacts to the N terminus of N O TI and binding 
to the outskirts of NOT2 and NOTS.
In our model for the physical arrangement of the compo­
nents of the CCR4-NOT complex based on the above data 
(Fig. 7), CCR4 assodatcs at one end of the complex through 
binding CAFI, which in turn binds the central portion of 
N O n  (residues 667 to 1152). NOT2 and NOTS bind the
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C-terminal region of N O TI (residues 1490 to 2108). NOT4 is 
on the outside of NOT2 and NOTS. NOT3 may display mul­
tiple contacts both to the N  terminus of N O TI and to NOT2 
and NOTS.
CCR4 and CAFI differ phenotypkaUy bom  NOT2 to NOTS. 
The above biochemical data define CCR4 and CAFI as a 
separate group of proteins within the CCR4-NOT complex 
that contacts the N O T I protein in a distinct location from the 
NOT2, NOT4, and NOTS proteins. Based on these identified 
separate locations within the complex, we would expect these 
subgroups of proteins to exhibit specific differences in both 
function and the proteins with which they interact. Phenotyp­
ically. CCR4 and C A FI can display a number of functions that 
arc different from those displayed by the other NOT proteins. 
This distinction correlates with the above-defined physical in­
teractions. First, the N O TI protein [NOTI (1490-2108)] which 
lacks the binding site for CAFI and CCR4 is defective in 
A D H 2  derepress ion. Adding back to yeast in irons the N- 
tenninal segment of N O TI (residues 1 to 1152) can rescue this 
defect in A D H 2  expression, implicating the binding of C A FI 
and CCR4 to this region as important for full ADH2 expres­
sion. Second, the not4 and not5 disruptions augment ADR1- 
5*--induced A D H 2  expression under glucose growth conditions, 
whereas cafl has no effect and ccr4 causes a reduction in 
expression. Third, at other promoters such as HO -lacZ  and 
FK Sl-lacZ, the no tl, nol2, and not4 defects (notS was not 
tested) result in increased expression whereas cafl and ccr4 
result in defects in expression (20). Fourth, the not alleles were 
identified in a genetic screen for increased 3-AT resistance. In 
contrast little or no effect on 3-AT resistance is observed for 
cafl or ccr4 defects (20). Fifth, whereas not alleles cause in­
creased 3-AT resistance, ccr4 and cafl defects can suppress 
these effects.
In addition, the ccr4 and cafl defects when combined with 
not alleles resulted in synthetic phenotypes. ccr4 or cafl were 
lethal with either not2 or notS deletions, whereas c c t4 cafl and 
n otl notS double knockouts are viable. Although other expla­
nations are possible with respect to synthetic growth defects, 
the synthetic defect of ccr4 and cafl with that of not2 and notS 
is consistent with the idea that these two groups of proteins 
display separate functions that arc important for the overall 
integrity and activity of the CCR4-NOT complex. It is also 
possible that NOT2 and NOTS display functions redundant 
with those of CCR4 and CA FI, although we feel that this is 
unlikely because of their dissimilarity in protein sequence and 
their actual physical separation and distinctiveness within the 
CCR4-NOT complex. Similarly, ccr4 notl-2  and cafl n o tl-2  
knockouts also displayed synthetic phenotypes, notl-2 results 
from a stop codon (26) that causes 90% of the N O TI protein 
to be about 1,100 amino adds long, which confirms that loss of 
the C terminus of the notl-2 protein in combination with ccr4 
or cafl defects results in a synthetic phenotype. The nonlethal- 
ity of this combination is most likely due to the existence of 
some full-length N O T I protein. These data also suggest that 
the lethality that results from deleting the notl gene may be 
caused by the combined loss of essential parts of the CCR4- 
CAF1 components and the NOT2 to NOTS components. 
N O TI may, therefore, be an essential protein due to its struc­
tural role in forming and maintaining the CCR4-NOT com­
plex. However, the C-tcrminal region of N O TI (residues 1490 
to 2108) encompassing the site of binding NOT2, -4, and -5 by 
itself can complement a notl disruption, unlike the region of 
NO TI binding CCR4 and CAFI (residues 667 to 1152). The C 
terminus of N O TI may be essential due to its ability to bind 
multiple NO T proteins, and/or the C terminus of NO TI con­
veys another, as yet undetermined essential function.
It  should also be noted that not4 or not3 deletions in com­
bination with ccr4 or cafl did not result in synthetic pheno­
types. Therefore, although NOT2 and NOT5 appear important 
to the integrity of the complex, the lethality between not2 or 
notS and that of ccr4 or cafl is not simply due to loss of 
structural roles for NOT2 and NOTS and their presumed im­
portance for binding NOT3 and NOT4. Instead, NOT2 and 
NOTS must play an important biochemical role independent 
of their mere physical presence in the CCR4-NOT complex. 
The observation that not3 and not4 deletions do not display 
synthetic growth defects with that o f ccr4 and cafl suggest 
either that these proteins as a group arc not required for the 
function of any essential genes or that they actually function in 
the same pathway. It  should be noted, though, that the noc3-2 
allele in  combination with ccr4 resulted in a synthetic growth 
defect, suggesting that the not3-2 protein affects a particular 
interaction in a negative manner that is worse than the com­
plete loss of the NOT3 protein.
Roles of the 1.9- and 0.9-mDa CCR4-NOT complexes. 
CCR4, CA FI, N O TI, NOT3, and NOTS have all been found 
to associate in 1.9- and 0.9-mDa complexes (reference 20 and 
results herein), and NOT2 has also been shown to migrate at 
0.9-mDa (unpublished observation). The association of CCR4 
in the 0.9-mDa complex requires C A FI (20) and, as we have 
shown here, the N-terminal region o f N O T I. A  cafl deletion 
reduced significantly the ability of CCR4 to associate in the
1.9-mDa complex (20) but did not eliminate it entirely. CCR4 
must, therefore, be able to interact in the 1.9-mDa complex 
independently of CAFI or its association with N O TI. The 
contacts and function for CCR4 in the 1.9-mDa complex may 
be separable from or additional to those it displays in the
0.9.mDa complex. Rclatedly, CCR4 must express a function 
separate from its presence in the 0.9-mDa complex since a c c t4 
deletion was lethal when combined with the strain expressing 
only pNO Tl(1490-2l08). It remains possible that CCR4 exists 
in multiple 1.9-mDa complexes (3).
Other proteins that have been found to associate with 
CCR4, CA FI. or NOT proteins arc DHH1 (15), CAF4, 
CAF16 (21), DBF2 (22), and MOB1 (18). These proteins may 
all be candidates for components of the 1.9-mDa complex. 
DH H1, C A FI6, and MOB1 (3a) do not immunoprecipitate 
with CCR4 and arc not components of the 0.9-mDa complex. 
However, CAF16 (21), DBF2, and MOB1 (unpublished obser­
vation) have been found to migrate in a 1.9-mDa complex. The 
complete components, assembly, and functional significance of 
the two CCR4-NOT complexes remain to be clarified. Char­
acterizing the 1.9-mDa complex, understanding how the 
CCR4-NOT complexes interact with other transcriptional fac­
tors, and defining the particular roles o f CCR4 and CAFI in 
contrast to NOT2, NOTS, NOT3, and NOT4 should lead to a 
better conception of how the CCR4-NOT proteins function in 
both activated and repressed transcription.
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